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Abstract
Exposure to stressful events during early development has consistently
been shown to produce long lasting effects on the hypothalamic-pituitary-adrenal
(HPA) axis, which may increase vulnerability to mood and anxiety disorders.
Recently reported genetic association studies indicate that these disorders may
be influenced, in part, by gene-environment interactions (GxE) involving
polymorphisms within the corticotrophin-releasing hormone and monoaminergic
system genes. However, little is known about how genetic variants and life stress
work to shape children’s neuroendocrine reactivity and emerging symptoms.
Therefore, the aim of this thesis is to examine main effects of candidate genes
and GxE on the neuroendocrine stress response and internalizing symptoms in a
community sample of 409 preschoolers.
In Chapter 2 analyses show associations between variants of the CRHR1
and CRHBP genes and children’s cortisol responses to a standardized laboratory
stress task. I also found evidence for GxE, where variants of the CRH system
genes moderated the impact of childhood stress on early-emerging symptoms of
depression and anxiety.
A functional polymorphism of the catechol-O-methyltransferase (COMT)
gene, the val158met, has been implicated in the etiology of stress-related mood
disorders. Therefore, in Chapter 3, I examined links between the val158met
polymorphism, cortisol reactivity to stress, and internalizing symptoms. I found
evidence for association between the val158met genotype and cortisol reactivity
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to stress. Additionally, the val158met genotype moderated the link between
childhood stress and emerging symptoms of anxiety.
Due to the proposed role of dopamine and serotonin gene polymorphisms
in research on GxE in internalizing disorders, in Chapters 4 and 5, I examined
whether associations between dopaminergic and serotonin candidate gene
polymorphisms and childhood cortisol reactivity and internalizing symptoms were
moderated by childhood life stress. Analyses showed evidence for GxE
predicting children’s symptoms. Specifically, polymorphisms of DRD2 and DAT1
genes moderated the effect of childhood stress on emerging symptoms of
anxiety. With regard to serotonin pathway polymorphisms, I found associations
between the serotonin transporter promoter polymorphism (5-HTTLPR) and
children’s anxious symptoms. Additionally, consistent with previously reported
findings, the interaction between MAOA 30bp VNTR and childhood stress
predicted child anxiety symptoms. Limitations of this work include a relatively
small sample size for genetic analyses, as well as the examination of a limited
number of markers at each gene. Additionally, I did not correct for multiple
statistical tests in some analyses due to the hypothesis-driven nature of the work.
Taken together, the analyses show the complex underpinnings of
individual differences in stress regulation, and highlight specific genetic
vulnerabilities that influence early psychophysiological reactivity, that may in turn
contribute to the development of stress-related disorders later in development.
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Keywords: HPA axis, childhood stress, cortisol, haplotype, polymorphism, early
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1

Introduction – Hypothalamus-pituitary-adrenal axis stress reactivity:

The role of genetics, environment and implications for emerging risk for
depression and anxiety

1.1

The hypothalamic-pituitary-adrenal axis
The hypothalamic-pituitary-adrenal (HPA) axis is the primary physiological

regulator of environmental stress in humans (Selye, 1973). In his seminal work,
Selye defined stress as the result of an organism’s failed attempt to respond
appropriately to a physical challenge (Selye, 1936). Since then, this definition has
been further elaborated to include psychological threats, including both
anticipation and ideation of impending stressors, not just those actually present in
the current environment (Schulkin et al., 1994). Expanding on this work, an
alternative view of stress is encapsulated in the concept of allostasis and
allostatic load (McEwen, 1998; Sterling & Eyer, 1998). Allostatic responses are
those physiological changes that occur in response to environmental
disturbances. These responses are not inherently negative, but instead play an
important positive role in helping an individual adapt to a changing environment.
Importantly, the concept of allostasis focuses on the mediators of adaptation,
such that the HPA axis not only promotes adaptation to stressors, but also
contributes to pathophysiology when it is overused or dysregulated (McEwen,
2006). For instance, inflammatory cytokines can stimulate the production of
corticosteroids, which in turn can suppress inflammatory cytokine production.
Similarly, the sympathetic and parasympathetic systems exert differential effects
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on inflammatory cytokines, with the former stimulating their production and the
latter inhibiting them (Sapolsky et al., 2000). However, under allostatic load when
cortisol is too high, these systems become unbalanced leading to inhibition of an
appropriate inflammatory response during immune challenge. Conversely, if
corticosteroid levels are too low, a ‘normal’ immune response can become
overactive and result in excessive inflammation (Karatsoreos & McEwen, 2011).
As described by McEwen and Wingfield (2003), when environmental
stress is encountered, the HPA neuroendocrine cascade (Figure 1.1) initiates the
release of corticotrophin-releasing hormone (CRH) in the hypothalamus into the
hypothalamic-pituitary portal. CRH triggers the release of adrenocorticotrophic
hormone (ACTH) in the anterior pituitary by binding to its receptor, the
corticotrophin-releasing hormone receptor-1 (CRHR1). The cascade culminates
at the adrenal cortex with the release of cortisol in primates and corticosterone in
other mammals (e.g., rodents). Glucocorticoids in turn act on the hypothalamus
and pituitary to suppress CRH and ACTH production in a negative feedback
cycle, thus downregulating these hormones once the stressor has terminated.
Cortisol is a potent glucocorticoid hormone and a key biomarker of HPA axis
activity in mammals (McEwen, 2007) and its broad role in physiology and
psychology are briefly reviewed in the following sections.
1.1.1 Cortisol and its importance in physiological metabolism
Cortisol is one of the few hormones essential for life; for example,
adrenalectomy in humans is fatal unless glucocorticoids are administered
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(Karatsoreos & McEwen, 2011). Cortisol exerts an anabolic effect, such as
conversion of glucose to glycogen in the liver, and catabolic effects such as
proteolysis and lipolysis in other tissues including skeletal muscle, adipose
tissues and lymphoid tissues (Spiga et al., 2007). Further, cortisol also facilitates
the function of other hormones. For example, cortisol must be present in order for
glucagon to exert its calorigenic action, and for catecholamines such as
dopamine, epinephrine and adrenaline to exert their lipolytic effects (Spiga et al.,
2007). Cortisol also acts as an inhibitor of CRH and ACTH secretion by the
hypothalamus and pituitary glands.
In addition to its effects on the organs and tissues directly involved in
metabolic homeostasis, cortisol influences a number of other organs and
systems. For example, cortisol maintains the responsiveness of vascular smooth
muscle to catecholamines and therefore participates in blood pressure regulation
(Danhof-Pont MB, van Veen & Zitman, 2011). When blood pressure is low,
decreased muscle responsiveness, together with the associated hypovolemia
caused by mineralocorticoid deficiency, can result in severe hypotension
(Veldhuis et al., 1987).
Excessive cortisol production has been etiologically implicated in many
medical conditions such as inflammatory diseases, musculoskeletal disorders,
asthma, and heart disease (Negrao et al., 2000; Sharpley, 1998; Sternberg et al.,
1990; Wright et al., 1998). Our understanding of the deleterious effects of
excessive cortisol production (hypercortisolemia) comes from studies of people
with Cushing’s disease (for an in-depth review, see Prague, May & Whitelaw,
3

2013). Individuals
iduals with hypercortisolemia in Cushing’s syndrome present with
excessive abdominal fat, obesity and significantly higher risk factor for
or
cardiovascular disease, Type
ype-II diabetes, and stroke (Miller & O’Callaghan,
2002). Further,, along with the effects of excessive cortisol exposure on physical
health, maladaptive cortisol responses to stress have also been linked to
psychiatric disorders such as depression, anxiety and panic disorders (McEwen,
2004, 2008).

hypothalamic-pituitary-adrenal
adrenal axis. The red line indicates the
Figure 1.1. The hypothalamic
negative feedback loop of the signalling cascade.
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1.1.2 Cortisol function and depression
HPA axis dysregulation has been a well-documented neuroendocrine
feature in individuals with depression and anxiety. Abnormal levels of cortisol in
saliva, plasma, urine, and cerebrospinal fluid have long been known to be
present during episodes of depression (Carroll, Curtis, & Mendels, 1976;
Charney, 2004; Heim & Binder, 2012). Cortisol responses are also exaggerated
after CRH and ACTH administration in patients with depression compared to
healthy controls (Amsterdam et al., 1986; Nelson & Davis, 1997). Aberrant
patterns of HPA axis activity is not only found in many adults with depression, but
has also been reported in depressed children and adolescents. For example,
compared to healthy controls, depressed children were found to exhibit a
stronger ACTH response to CRH administration (Kaufman et al., 1997). Similarly,
an increased cortisol response to psychosocial stress was observed in
depressed children aged 3 through 6 compared to their healthy counterparts
(Luby et al., 2003). A recent meta-analysis has confirmed these findings in
patients with depression (Stetler & Miller, 2011). Literature also suggests that
normalization of the HPA system may be necessary for stable remission of
depression and successful antidepressant treatment has been shown to
attenuate and normalize HPA axis abnormalities (De Bellis et al., 1993; Kling et
al., 1994; Nemeroff et al., 1991; Ising et al., 2005).
1.1.3 Salivary cortisol as a biomarker for HPA axis reactivity

5

The primary biomarkers of the HPA axis include CRH, ACTH, and cortisol.
In studies of human participants, CRH is measured in cerebrospinal fluid, which
means that this biomarker must be measured in controlled clinical settings. In
contrast, ACTH and cortisol can be assessed in blood, and unbound levels of
cortisol can be measured in saliva. Unbound cortisol diffuses from the blood
stream into salivary glands and is highly correlated with serum cortisol levels
(McEwen, 2004). As cortisol is transferred from plasma to saliva within a few
minutes, the short time lag makes it useful in research investigating HPA axis
responses (Harmon et al., 2007). There are many advantages to using salivary
biomarkers in stress research. First, sampling is non-invasive and eliminates the
possibility of needle puncture injuries. Stress related to blood draws during
collection, which may bias the results, is also minimized, making it useful in
studies of children. Salivary biomarkers are also useful for research involving
children as it avoids ethical concerns associated with invasive measures.
Furthermore, saliva collection can be performed at participants’ homes and does
not require skilled healthcare professionals, making it highly useful in
assessments in the subjects’ natural environment, such as at a child’s home.
Cortisol is also relatively stable in saliva; thus, saliva samples can be stored at
room temperatures for at least for a couple of weeks (Kirschbaum & Hellhammer,
2000). For these reasons, salivary cortisol has been widely used in HPA axis
research and is considered a well-established biomarker of HPA axis function.
1.2

Correlates of the HPA axis response
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As previously discussed, literature suggests that HPA axis dysregulation
measured via cortisol reactivity is a prominent neuroendocrine feature in
psychiatric disorders such as depression (Charney & Manji, 2004). However, the
developmental correlates of the cortisol stress response are poorly understood
(Krishnan & Nestler, 2008). Extant research points to the role of environment and
individual diatheses in contributing to cortisol reactivity to stress. Therefore, the
following sections will briefly review current knowledge of the environmental and
genetic determinants of the HPA axis reactivity to stress.
1.2.1 Life stress during early childhood and the HPA axis
Early caregiving has been shown to contribute to the lifelong
responsiveness of the HPA axis to stressors (Meaney et al., 1988, 1991).
Perhaps the strongest evidence for the environmental regulation of the
development of responses to stress comes from postnatal handling research with
rodents. Handling involves a brief (i.e., 3–15 min), daily period of separation of
the pup from the mother for the first few weeks of life, and results in hyperreactivity to stress in adulthood (Levine et al., 1967; Zarrow et al., 1972; Meaney
et al., 1989; Viau et al., 1993; Bhatnagar et al., 1995). As adults, rats exposed to
extended positive maternal care show decreased fearfulness and more modest
HPA responses to stress; such effects are apparent in animals tested as old as
26 months of age (Meaney et al 1988, 1992). The handling effects on the
development of HPA responses to stress have important consequences for
health. Glucocorticoid levels often rise with age in rats and are associated with
hippocampal degeneration and the emergence of learning and memory deficits
7

(Landfield et al., 1981, Landfield & Pitler 1984, Sapolsky et al., 1984, Issa et al.,
1990). Such age-related increases in basal and stress-induced pituitary-adrenal
activity is significantly less apparent in the control or non-handled animals; thus,
these animals show little evidence of hippocampal aging (Meaney et al., 1988,
1991).
Research with rodents has been complemented by work with nonhuman
primates where maternal separation during early childhood leads to higher
plasma cortisol levels (Bayart, et al., 1990; Levine, 1993; Sanchez et al., 2005).
Primate infants separated from their mothers and raised with peers have greater
HPA axis reactivity in adulthood (Heim & Nemeroff, 1999). In addition to maternal
separation stress, poor early caregiving can be observed in non-human primates
as well, where a small number of primate mothers are actively abusive to their
offspring, subjecting them to behaviours that include dragging, crushing, hitting,
and biting the infant (Maestripieri, 1998). The infants of abusive and nonabusive
mothers were administered CRH and their basal cortisol and cortisol reactivity
tested every 6 months for up to 3 years of age. The authors found no effects of
abuse on basal cortisol levels but offspring of abusive mothers had greater
cortisol reactivity to stress contexts (such as facing aggressive males of higher
social rank) when compared to their nonabused counterparts (Sanchez et al.,
2010).
In addition to research on links between poor early caregiving and
abnormal cortisol response in rodents and non-human primates, similar findings
have been reported in humans as well. For example, Heim and colleagues
8

(2002) and in a later study by Rao and colleagues (2008) showed that a history
of childhood adversity was associated with increased neuroendocrine stress
responses in adolescents and adult women. Elevated cortisol reactivity has also
been documented in children in daycare centers with lower quality of care (Tout
et al., 1998) and children with poor care in foster homes (Dettling et al., 2000).
However, the literature also yields contradictory findings as well. For example
Carpenter and colleagues (2007) and MacMillan and colleagues (2009) failed to
replicate earlier findings of increased neuroendocrine reactivity to stress and
found attenuated neuroendocrine stress responses in maltreated adolescents
and adults, suggesting that the effect of exposure to adversity and caregiving on
stress reactivity is not straightforward (Ellis & Boyce, 2008; Del Giudice, Ellis &
Shirtcliff, 2011). However, it is of note that the literature has focused largely on
extreme forms of negative early care such as physical and sexual abuse,
although more normative aspects of early care are also likely relevant, and would
have implications for a larger number of children. For example, a recent study by
Hackman and colleagues (2013) explored the role of common parenting
behaviours on adolescents’ stress responses, demonstrating that positive early
childhood parental care directly predicted adolescent cortisol reactivity to
psychosocial stress.
1.2.2 Genetic bases of cortisol responses to stress
In addition to the influence of early care, genetic factors have been linked
to cortisol response to stress. Literature from twin studies suggests that salivary
cortisol responses to acute challenge are significantly influenced by genetic
9

factors. For example, in a seminal pilot study, the heritability of salivary cortisol
responses was investigated in a sample of 124 monozygotic and 155 dizygotic
twins who were exposed to laboratory stressors such public speaking, a complex
arithmetic task, and exhausting physical exercise (Kirschbaum et al., 1992). The
proportion of variance in cortisol reactivity attributable to heritable factors was
estimated at 48%. Research over the past decade has supported these findings
via replications in large independent samples (Bartels et al., 2003; Steptoe et al.,
2009). Therefore, these heritability studies suggest a moderate genetic
component of cortisol reactivity, and in addition to environmental influences on
cortisol reactivity. However, only a small number of studies have examined
associations between polymorphisms of the HPA axis genes and childhood
cortisol reactivity.
Due to the genetic underpinnings of HPA axis function, and its links to
complex traits such as internalizing symptoms, in psychiatric research, cortisol
reactivity is considered an endophenotype of mood and anxiety disorders.
Endophenotypes such as cortisol reactivity are quantifiable components in the
genes-to-behaviors pathways, distinct from psychiatric symptoms, which make
genetic and biological studies of etiologies for disease categories more
manageable. Endophenotypes provided a means for identifying the
“downstream” traits or facets of clinical phenotypes, as well as the “upstream”
consequences of genes and, in principle, could assist in the identification of
candidate genes in the hypothesized polygenic systems conferring vulnerabilities
to disorders (Gottesman & Gould, 2003). Therefore, research is needed to

10

document specific genetic variants linked to individual differences in childhood
cortisol reactivity to stress, the endophenotype of depression and anxiety.
1.2.3 Gene-environment interactions influence HPA axis response to stress:
Implications for etiology of depression and anxiety
Although so far the extant literature suggests that genes and
environmental factors influence early cortisol reactivity to stress, a large body of
molecular genetics research has documented that the impact of genes on
phenotypes is dependent on environmental exposure (e.g., Kendler et al., 2007).
Therefore, it is the joint consideration of interactions between genetic diathesis
and environmental exposure that can help unfold the complex biological
pathways that contribute to psychological risk. However, limited research in
adults has examined the role of gene-environment interactions as predictors of
cortisol responses to stress. For example, Tyrka and colleagues (2009) have
reported that an interaction between childhood trauma and CRHR1 genotype
predicted cortisol reactivity in a sample of adults. Expanding on this study, Heim
and colleagues (2009) reported that interactions between the CRHR1 genotype
and history of childhood physical abuse predicted significantly higher increases in
cortisol responses to stress stimuli in a standardized laboratory task in depressed
patients when compared to healthy controls. Additionally, a study by Alexander
and colleagues (2009) reported interactions between a functional polymorphism
of the serotonin transporter gene (also known as 5-HTTLPR) and stressful life
events predicted cortisol reactivity in a non-clinical sample. To my knowledge,
the studies of adults briefly reviewed here are the only examples of GxE
11

predicting cortisol reactivity. However, no prior research has examined the role of
GxE as a predictor of cortisol reactivity in young children; thus, this topic will be
one focus of this dissertation.
Even though only a few studies have reported on the role of GxE in
shaping cortisol responses to stress, a large literature has reported on GxE
predicting stress-related psychopathologies such as depression and anxiety.
Specifically, gene polymorphisms of the CRH system and the aminergic
pathways (serotonin and dopamine) have been shown to interact with early
childhood adversity to predict later risk for mood and anxiety disorders (for an in
depth review see Mandelli & Serrtti, 2013). For example, the effect of early
caregiving on risk for depression and anxiety was moderated by gene
polymorphisms of serotonin (Eley et al., 2004; Huang et al., 2004; Karg et al.,
2011), dopamine (Hayden et al., 2010), norandrenergic (Sun et al., 2008; Xu et
al., 2009) and glutamate pathways (Sokolowski et al., 2013). In sum, based on
these studies in addition to GxE role on intermediate phenotypes that may
contribute risk for mood and anxiety problems, I also intend to examine whether
GxE predict emerging symptoms.
1.2.4 Rationale for conducting study in preschoolers
As described above, studies of GxE (see reviews by Heim et al., 2009;
Uher, 2007) indicate that variation in CRH and monoaminergic system genes
may influence risk for depressive and anxious symptoms based on early
childhood environment. One possible explanation for these findings is that a
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critical period exists for the normative development of an emotional regulatory
system. A few studies suggest that there might be timing-dependent effects of
early stress on depression risk. For example, Agid and colleagues (1999) report
that parental loss before 9 years of age was associated with higher depression
risk compared to parental loss between 9 and 17 years of age. Although there
are very few studies that have systematically evaluated neurobiological
outcomes of childhood stress experienced at different developmental stages,
studies of rodents and non-human primates suggest that the direction of the
effects of early life stress on the CRH/HPA system depend on timing of the early
life stress (Coplan et al., 2006). For example, early weaning of 21-day old rats
causes faster myelination in the amygdala, decreased brain-derived neurotrophic
factor protein levels in the hippocampus and prefrontal cortex, and reduced
neurogenesis in the dentate gyrus (Kikusui & Mori, 2009). Although limited
evidence from human studies for age-dependent effects of early caregiving have
been reported, a study by Rogeness and McClure, (1996) showed abnormal
dopamine metabolism in children who were maltreated in the first 3 years of life,
but not in children maltreated later in childhood. Carpenter and colleagues (2004)
reported that preschool life stress, but not later childhood stress, modulates
adulthood cerebrospinal fluid CRH levels. The same group reported that cortisol
response to stress in adults decreases with increasing onset age of emotional
abuse (Carpenter et al., 2009). Taken together, the data described here suggest
that early childhood is a critical period with consequences for later mental health
outcomes.
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In addition to the role of biological mechanisms underlying the phenotype
in question (internalizing problems) and the environmental factors that may
contribute to the expression of said phenotype, the study of emerging symptoms
in preschoolers is an informative tool in the understanding of the etiology of
depression and anxiety. For example, evidence exists that early symptoms, even
subthreshold ones of anxiety and depression such as the ones found in
preschoolers have heterotypic and homotypic continuity for later disorders.
Specifically literature from our group and others has shown that early emerging
symptoms of depression and anxiety predict internalizing symptoms later in life
(Costello et al., 2003; Klein et al., 2008; Luby et al., 2009). Therefore findings in
this study would help inform early prevention and intervention.
1.3

Neurotransmitters as mediators of links between early life stress and

HPA axis response
The search for candidate genes that shape cortisol responses to stress
must be informed by an understanding of the neurobiological systems that
regulate the function of the HPA axis. The hypothalamus and pituitary glands are
heavily innervated by aminergic neuronal inputs from the limbic system region
including the prefrontal cortex, hippocampus, and amygdala (Herman et al.,
1996). The two major aminergic neurotransmitter systems linked to HPA axis
regulation are the dopaminergic and serotonergic systems: these are briefly
reviewed here.
1.3.1 The dopaminergic system
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Dopamine (DA) is released predominantly from the ventral tegmental area
of the brain and is involved in the control of locomotion, cognition, affect, and
neuroendocrine secretion (Bunney et al., 1980; Jaber et al., 1996; Smythe,
1977). At the synaptic level, DA exerts its effects through its interaction with the
DA receptors. Molecular biology and pharmacology studies have identified two
classes of receptors consisting of at least five DA receptor subtypes: D1, D2, D3,
D4, and D5, with the most widely expressed subtypes in the prefrontal regions of
the brain being the D2 and D4 receptors (LaHoste et al., 2000). On binding an
agonist, DA receptors activate the adenylate cyclase second messenger system,
elevating intracellular cyclic adenosine monophosphate concentrations. Cyclic
adenosine monophosphate increases protein kinase-A activity with resulting
changes in expression levels of a wide range of proteins within the cell (Dunlop &
Nemeroff, 2007). DA signalling is terminated via either its reuptake by the
dopamine transporter (DAT) into the presynaptic neurons or DA inactivation by
two catabolic enzymes, namely, the catechol-O-methyltransferase (COMT) and
the monoamine oxidase-A (MAOA).
DA innervation of the medial prefrontal cortex (mPFC) appears to be
particularly sensitive to mild and brief stress (Deutch et al., 1985). In addition to
genetic influences, animal studies of rodents and non-human primates show that
both acute and chronic stress influence the functioning of the DA system. For
example, rodents exposed to brief stressors such as low intensity foot shock and
short periods of restraints show DA release and metabolism in the prefrontal
cortex (Deutch & Roth, 1990; Thierry et al., 1998; Kalivas & Duffy, 1989). In
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contrast, chronic stress over time may enhances DA degradation in areas that
receive DA innervations, such as the hypothalamus and hippocampus, leading to
overall DA depletion and DA mediated signalling in these important stress
regulating brain regions (Roth et al., 1988). Thus, mPFC DA metabolism and
release is related to the occurrence of stress, and suggests the importance of DA
in stress regulation (Abercrombie et al., 1989; Deutch et al., 1985; Deutch &
Roth, 1990; Mantz et al., 1989).
1.3.2 The serotonergic system
Serotonin (5-HT) is involved in a wide variety of processes including
anxiety, arousal, vigilance, aggression, mood, impulsivity, and regulation of
appetite (Charney & Manji, 2004). There is both anatomical and functional
evidence for a regulatory role of 5-HT on stress-induced HPA activity (Dinan,
1996; Phelix et al., 1992). Animals exposed to a variety of stressors, including
restraint and maternal separation, show an increase in 5-HT turnover in limbic
regions, such as the medial prefrontal cortex (Adell et al., 1988; Inoue et al.,
1994; Pei et al., 1990; Petty & Sherman, 1983), amygdala, and hypothalamus
(Kaehler et al., 2000). Animals exposed to social stress such as maternal
separation during early life, also had an increase in activation of 5-HT receptors
in the hippocampus and dentate gyrus, two regions widely implicated in
regulation of stress stimuli (McKittrick et al., 1995). Studies of non-human
primates have provided evidence that increased 5-HT metabolism during
exposure to inescapable stress prevents anhedonic behaviours, evinced by lack
of caloric intake (loss of appetite), decrease in sexual activity and withdrawal
16

from social exploration (Ronan et al., 2000), behaviours usually associated with
depression in humans. 5-HT antagonists also produce behavioural deficits while
drugs that enhance 5-HT neurotransmission (SSRI) are effective in reversing
anhedonia-like symptoms (Martin et al., 1990; Sherman & Petty, 1980).
Additionally, injection of 5-HT into the frontal cortex after stress exposure in adult
rats reverses stress-related behavioural deficits, such as anhedonia-like
symptoms described above (Sherman & Petty, 1982).
There are two key regulators of serotonin levels in the limbic system. First,
is the 5-HT transporter (5-HTT), which regulates serotonin neurotransmission
through precise control of extracellular 5-HT levels (Lesch et al., 1996). This
process is driven by the 5-HTT, which belongs to the sodium ion dependent
transporter family (Nelson, 1998; Rudnick & Clark, 1993). 5-HTT assumes the
uptake of extracellular 5-HT across the cell membrane of neuronal and nonneuronal cells, such as serotonergic neurons of raphe nuclei, basal nuclei and
platelets. Dysregulation of the tightly controlled external concentration of 5-HT is
linked to a host of metabolic and psychiatric disorders, including depressive,
anxious, and obsessive-compulsive disorders (Charney & Manji, 2004). The
second regulator of synaptic 5-HT levels is the MAOA enzyme, which catabolizes
serotonin in the neuronal synapse (Martin et al., 1990). In brains of MAOA
knockout mice, 5-HT concentrations were increased up to nine-fold compared
with wild-type mice. Additionally, adrenergic concentrations in the prefrontal
cortex and basal nuclei were increased up to two-fold; however, relative to 5-HT,
only a small increase in DA levels was observed in infant mice brains (Cases et
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al., 1995), suggesting that MAOA has a greater affinity for degrading serotonin
when compared to DA. MAOA deficient mice show a significant increase in brain
serotonin levels and attenuated reactivity to stress, suggesting a link between
serotonergic metabolism and HPA axis function (Shih et al., 1999). Due to its
ability to regulate serotonin availability in the brain, MAOA inhibitors have been
widely used in psychiatric populations for the treatment of depression, anxiety
and posttraumatic stress disorder (Liebowitz et al., 1990). Doyle and colleagues
(1996) reported that an increase in salivary MAOA activity was also correlated
with levels of life stress. Additionally, MAOA inhibitor therapy in adult patients
diagnosed with posttraumatic stress disorder leads to normalization of diurnal
cortisol rhythm (Liebowitz et al., 1990). Taken together, these studies suggest a
role of serotonin and DA pathways in HPA responses to stress and stress-related
psychopathologies such as mood and anxiety disorders.
1.4

Candidate genes examined in the current study
Based on current literature implicating the dopamine and serotonin

systems in HPA axis responses to stress (Figure 1.2), a logical starting point for
examining the underpinnings of psychological risk is to focus on gene variants
implicated in aminergic signalling. This method (also known as the gene-pathway
approach; Mormede et al., 2002) of candidate gene identification utilizes a priori
knowledge of the metabolic pathway involved taking advantage of data from
previous cellular, biochemical, molecular, or pathological experiments. Candidate
genes and their variants investigated in this study are listed in Table 1.1. DA
signalling is widely documented in regulating HPA axis response to stress and
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stress-related disorders such as depression and anxiety. Therefore, the current
study will explore common variants of the DA pathway, specifically the D2 and
D4 receptors (Chapter 4). Additionally, as both COMT and DAT directly affect the
availability of synaptic DA, thereby controlling the intensity of DA
neurotransmission in response to stress, genetic variants of the COMT and DAT
genes will be investigated (Chapters 3 & 4). Similarly, as the serotonin
transporter gene (commonly known as 5-HTT) and MAOA also regulate the
availability of the limbic systems extracellular serotonin, the current thesis will
also examine the role of the variants of the two genes in stress response and
emerging risk for psychopathology in Chapter 5.
As discussed in previous sections, the intensity of the cortisol response at
the adrenal level is based on the release of CRH in the hypothalamus (McEwen,
2007). The availability of CRH in the brain is directly regulated by the CRHBP
protein, which sequesters and inactivates CRH and its receptor in the pituitary
gland (CRHR1) that initiates the release of ACTH. However, the common genetic
variants that may be associated with cortisol stress reactivity in young children
are unknown. Therefore, the current study aims to examine the genetic variation
of the entire coding and regulatory regions of the CRH system genes. These
associations will be based on constructing haplotypes based on linkage
disequilibrium. Haplotypes refer to combinations of marker alleles which are
located closely together on the same chromosome and which tend to be inherited
together (van West et al., 2004). Methods based on haplotypes can be more
powerful than those based on single markers in association studies of mapping
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complex disease genes. The power of single marker-based methods depends on
the linkage disequilibrium (LD) between the tested marker locus and the diseasesusceptibility locus (Akey et al., 2001). LD information contained in flanking
markers is not incorporated into such methods, which can result in potential
reduction of power. In addition, even if the tested marker locus is in strong LD
with the disease locus, power can be quite low if the frequencies of the marker
and disease alleles are different (e.g., Kaplan & Morris, 2001). Therefore,
haplotype-based association methods are generally regarded as being more
powerful than methods based on single markers (Akey et al., 2001; Morris and
Kaplan, 2002) as these analyses can detect the combined effects of multiple
sequence variants on promoter activity or protein structure and/or function
(Devlin & Roeder 1999; Drysdale et al. 2000; Joosten et al. 2001). The work of
the International HapMap Project (International HapMap Consortium 2003;
International HapMap Consortium 2005), dedicated to describing the patterns of
human genetic variation by developing a map of the linkage maps in the human
genome, provides a valuable resource for efficient SNP selection in haplotypebased association studies and forms the basis of Chapter 2 of this thesis.
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Table 1.1. List of genes investigated for associations with childhood cortisol reactivity to stress and emerging internalizing
symptoms.
Gene1

Chromosome

Functional mutation

Behavioural associations

CRH

8q13

None reported

↑behavioural inhibition in children at risk
for panic disorder (Smoller et al., 2005)

CRHR1

17q12

None reported

Increased risk for internalizing problems
(Bradley et al, 2008)

CRHBP

5q11

18 amino acid exon 7 deletion leads to
truncated messenger RNA

Suicidal ideation (Roy, 2012)

COMT

22q11

MAOA

X

SLC6A4
(5-HTTLPR)

17q11

SLC6A3
(DAT-1)

5p13

30bp VNTR in exon 4 leads to
differential dopamine binding

DRD2

11q23

Single nucleotide polymorphism in the
promoter region

Associated with cortisol reactivity in mice
and non-primate humans

DRD4

11p15

48bp VNTR polymorphism in exon 3
leads to altered receptor function

Interaction between this variant and early
life stress predict anxiety problems

Exon 4 Val→Met substitution at
position 158 leads to changes in
enzyme activity
30bp VNTR polymorphism in gene
promoter region leads to decreased
function
44-48bp VNTR polymorphism in gene
promoter region leads to decreased
transporter protein

Linked to multiple internalizing disorders
Polymorphism linked to externalizing
behaviours such as aggression
↑ depression and anxiety incidence
among short allele carriers (Wust et al.,
2009)
Associated with major depression and
bipolar disorder (Szczepankiewicz et al.,
2011)

Note: BDNF: Brain derived neurotrophic factor; SLC6A3: Solute carrier family member-3 (dopamine transporter); SLC6A4: Solute
carrier family member-4 (serotonin transporter); CRH: Corticotrophin releasing hormone; CRHR1: Corticotrophin releasing hormone
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receptor-1; CRHBP: Corticotrophin releasing hormone binding protein; COMT: Catechol-O-Methyltransferase; MAOA: Monoamine
oxidase-A; DRD2: Dopamine receptor D2; DRD4: Dopamine receptor D4; bp: base pairs; VNTR: Variable number tandem repeat.
Val: valine; Met: methionine; Leu: leucine; Phe: phenylalanine; Gly: glycine; Ile: isoleucine.
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Stress stimulus
Limbic System (PFC,
hippocampus, amygdala)
DA

5-HT
COMT
MAOA

5-HTT

Hypothalamus

DA receptors

CRH

Pituitary gland

ACTH cells

Adrenal gland

Cortisol cells

Figure 1.2. Overview of the limbic regulation of the HPA axis via central nervous
system neurotransmitters. Activation and inhibition of the signalling cascade is denoted
by the “+” and “-“ signs. Note: CRH: Corticotrophin releasing hormone; ACTH:
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Adrenocorticotrophic hormone; COMT: Catechol-O-Methyltransferase; MAOA:
Monoamine oxidase; DA: Dopamine.
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1.5

Hypotheses and thesis objectives
The main focus of this thesis is to investigate the link between genetic

variants of the dopamine, serotonin and CRH pathway genes and cortisol
responses to stress in a community sample of preschoolers. I hypothesize that
the genetic variants of the monoaminergic (DA and 5-HT) and CRH pathway
genes will be associated with individual differences in children’s cortisol
reactivity to stress. Further, GxE between candidate gene polymorphisms
and life stress will predict risk for emerging symptoms of depression and
anxiety in preschool-aged children.
Given the role of the HPA axis response to stress in the etiology of
internalizing problems, I will also examine associations between monoaminergic
and CRH pathway gene variants and emerging risk for psychopathology.
Specifically, the following chapters of this dissertation focus on three objectives
(see conceptual model in Figure 1.3):
1.

Examine the main-effects of CRH system, serotonin and
dopaminergic system gene variants on early age cortisol
reactivity to stress.

2.

Examine the main-effects of CRH system, serotonin and
dopaminergic system gene variants on early age emerging
symptoms of depression and anxiety.

3.

Investigate whether gene-environment interactions between
candidate gene variants and childhood stress predict cortisol
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response to stress and/or emerging symptoms in a community
sample of preschoolers.

HPA axis
Childhood stress
X
Genetic variants

Symptoms of
depression/anxiety

Figure 1.3. A conceptual model of life stress and genetics interacting through
HPA axis physiological response to influence emerging symptoms.
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Genetic variation of the CRH pathway genes and childhood cortisol

response to stress: The role of early life stress and implications for
emerging risk
2.1

Introduction
As discussed in Chapter 1, dysregulation of the HPA axis in patients with

major depressive disorder (MDD), demonstrated by abnormal plasma ACTH and
cortisol concentrations, is one of the most consistent biological markers identified
in the literature (Gillespie & Nemeroff, 2005; Holsboer et al., 1984). HPA axis
dysfunction is also often found among patients with anxiety, including panic
disorder (Abelson et al., 2007), social anxiety disorder (Condren et al., 2002) and
generalized anxiety disorder (reviewed in Martin et al., 2009). However, a
significant gap in knowledge remains in research on human participants
regarding the genetic mechanisms underlying cortisol reactivity to stress, which
may be an important mediator of genetic risk for depression and anxiety.
Research using murine and primate models has explored this question in greater
detail (McEwen, 1998), with extant literature implicating genes expressing the
cascade initiation molecule, the corticotrophin-releasing hormone (CRH), and its
components, the CRH receptors and CRH binding protein (CRHBP) in regulating
glucocorticoid reactivity in response to stress (Behan et al., 1995; Roy et al.,
2012). In this cascade, CRHBP is a passive ligand trap that neutralizes active
CRH by binding to it, thereby regulating bioavailability of free CRH and
influencing downstream release of glucocorticoids (Jahn et al., 2005). Null
mutants of the murine Crh gene (Crh -/-) have markedly impaired production of
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both ACTH and corticosterone under conditions of stress compared to wild-type
mice (Muglia, 1995). Other pituitary neuropeptides, such as oxytocin and
vasopressin, do not compensate for the loss of corticosterone reactivity under
stress (Schmidt et al., 2003; Venihaki & Majzoub, 2002), highlighting the
importance of CRH gene expression in normal HPA axis function. Consistent
with this, murine Crhr1 (Crhr1 -/-) knockouts lack a typical corticosterone
response to stress. Furthermore, conditional knockouts of Crhr1 in the
hypothalamus and pituitary lack a stress-induced corticosterone response
(Schmidt et al., 2003, 2006). Translational research on the effects of stress in
CRHBP knockout mice is limited, but these knockouts do exhibit higher free CRH
in their serum and increased anxious behaviours compared to wild-type animals,
supporting the role of CRHBP gene in the HPA axis function (Gammie et al.,
2008). These findings implicate the importance of CRH system genes in
maintaining HPA axis function and regulating glucocorticoid reactivity to stress.
Based on findings from animal studies, and the role CRH system genes
play in cortisol response in animals, a parallel line of research in humans has
increasingly focused on the GxE between CRH system genes and the early
environment in patients with internalizing disorders. For example, variants of both
CRHR1 and CRHBP genes have been shown to interact with early adversity,
such as child abuse or maltreatment, to predict risk of depression and even
suicidality later in life (Bradley et al., 2008; Heim et al., 2009; Grabbe et al., 2010;
Roy et al., 2012). Additionally, genetic variation in the CRHR1 gene has also
been linked to consolidation of aversive memories in adults and is thought to
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mediate the pathway from childhood maltreatment to adulthood depression
(Polanczyk et al., 2009). Similarly, variation in the DNA region containing the
CRH gene has also been linked to behavioural inhibition, a personality trait
associated with increased risk for internalizing disorders (Smoller et al., 2003,
2006). Taken together, these studies suggest that CRH system genes may play
a role in moderating the effect of childhood adversity on behaviour outcomes.
Little is known about whether links between CRH system gene variation
and cortisol reactivity or emerging risk for psychopathology exist in early
childhood. Therefore, the aim of this chapter is to examine the links between
common variation of the CRH system genes and early life cortisol reactivity and
emerging symptoms. The second aim of this chapter is to extend the adult
literature on CRH pathway gene variants as moderators of the effect of childhood
adversity on later psychiatric problems (Bradley, 2008; Ciccetti, 2011).
Specifically, we examined whether interactions between the CRH system gene
variants and childhood adversity predicted either cortisol response to stress or
emerging symptoms of anxiety or depression in young children.
2.2

METHODS

2.2.1 Participants
Participants were an unselected community sample of 409 children (201
boys; 49.1%) between 36 and 47 months of age (M = 40.72, SD = 3.51) from
southwestern Ontario, recruited for a study of child emotional development (see
Table 2.1 for further demographic details). Informed consent was obtained from
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children’s parents before data were collected. Children with significant medical or
psychological problems were excluded from participation via a screening
procedure administered by trained study personnel at the recruitment stage. The
sample was mostly Caucasian (90.5%) and of average cognitive ability (M =
111.94, SD = 14.32) as assessed by the Peabody Picture Vocabulary Test–
Fourth Edition (Dunn & Dunn, 1997; PPVT-4). The study protocols were
reviewed and approved by the University of Western Ontario Human Research
Ethics Review panel. Finally, as allele frequencies and correlation structures
between SNPs in a gene differ across populations, we limited all analyses to the
subsample of 371 Caucasian children in the sample.
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Table 2.1. Study sample demographics
Characteristic

Participants No. (%)

Sex
Male

201 (49.1)

Female

208 (50.9)

Caregiver-identified Race/Ethnicity
Caucasian

371 (90.5)

Asian American

6(2.3)

Other

28 (68)

Some high school

7(1.8)

High school graduate or some
college
College graduate or beyond

212 (52.8)

Parent Education

181 (45.4)

Household Income
<$20K

22 (5.5)

$20-40K

45 (11.0)

$40-100K

219 (53.5)

>$101K

120 (29.5)

2.2.2 DNA preparation
DNA samples were collected from all participants using buccal swabs
(Epicentre, Madison, WI, USA) and stored according to the manufacturer’s
instructions. Qiagen DNA MicroKit (Mississauga, ON, Canada) was used to
extract DNA from epithelial cells and stored according to the manufacturer’s
instructions. DNA was successfully extracted from the buccal swab samples of all
participants.
2.2.3 SNP selection and genotyping
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A SNP marker panel (Table 2.1) was used to tag the full-length CRH
(RefSeq NM_006180, 1.27 kilobases [kb]), CRHR1 (RefSeq NM_001145146,
27.3 kb) and CRHBP (RefSeq NM_001882, 16.6 kb) according to Human
HapMap Project phase II data for the central European population. The Tagger
program (http://www.broad.mit.edu/mpg/tagger/; de Bakker et al., 2005) was
used to determine the minimum set of SNPs necessary to capture or ‘‘tag’’ all
HapMap SNPs (through linkage disequilibrium) with minor allele frequencies >5%
among Caucasians. Tag-SNPs (tSNP) validated in Caucasian populations were
selected from public databases (dbSNP,
http://www.ncbi.nlm.nih.gov/projects/SNP/; HapMap, http://www.hapmap.org)
flanking ±10 kb of the respective gene coding regions. This strategy allowed us
to genotype variants in the gene promoter regions, which could be functionally
important in gene transcription. Specifically, this tagging approach allowed us to
select a limited number of SNPs that account for the entire genetic variation
across a sequence of DNA by taking into account SNPs that are highly correlated
with each other. SNPs tagged had a minimum r2 of 0.80 with the tagging SNP
(mean r2 was 0.98). The suggested number of tSNPs was four for CRH, seven
for CRHR1 and seven for CRHBP.
All SNPs were genotyped using a TaqMan allelic discrimination assay
(Livak, 1999), developed for use on the StepOne® instrument (Applied
Biosystems, Foster City, California). Assay identification numbers and primer
sequences for all of the TaqMan probes are provided in Table 2.2. Polymerase
chain reactions were performed in 10-µL reaction volumes in 48-well plates and
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contained 10 ng of DNA. Thermal cycler conditions were 95°C for 10 min and
then 40 cycles of 95°C for 15 s and 60°C for 1 min. The SDS 2.2 software
(Applied Biosystems) was used for allelic discrimination. For quality control, 10.0
% of the samples were randomly chosen and genotyped as duplicates across
and within a 48-well plate. The genotyping success rate for the CRHBP and
CRHR1 genes was 99.1 % or 369 participants, and 98.1 % or 364 participants for
the CRH gene. The final number of participants genotyped is provided in Table
2.1 for each gene region.
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Table 2.2. The CRH system genes: description of tSNPs.

SNPs

Nucleotide
variant

MAF in study
sample

MAF in HapMap,
CEU populationsa

HWE
p-values

3' region
Intronic
5' region
5' region

C>G
T>C
C>T
G>T

0.18
0.32
0.34
0.26

0.19
0.37
0.37
0.28

0.51
0.70
0.72
0.49

Intergenic
5' region
Intronic
Intronic
Intronic
3' UTR
Intergenic

C>T
T>C
T>C
T>C
G>A
G>T
A>G

0.36
0.45
0.22
0.41
0.24
0.12
0.17

0.34
0.48
0.20
0.47
0.24
0.10
0.14

0.15
0.44
0.26
0.91
0.42
0.49
0.33

3' region
Intronic
Intronic
Intronic
Intronic
Intronic
5' region

G>A
A>C
G>T
A>G
G>A
G>A
G>A

0.28
0.13
0.42
0.15
0.12
0.13
0.40

0.31
0.13
0.46
0.13
0.12
0.15
0.39

0.25
0.83
0.13
0.26
0.24
0.65
0.54

Chromosome location

CRH

Chr 8

rs9694082
rs6999100
rs1870394
rs11996294

67066780
67082732
67102818
67114738

Gene

N =364
CRHBP

Chr 5

rs1715751
rs1715747
rs32897b
rs7728378
rs10062367
rs10473984b
rs10514082
N = 369

76239704
76250378
76250972
76259350
76264354
76264982
76266447

CRHR1

Chr 17

rs12944712
rs16969853
rs242924
rs171441
rs1396862
rs17763104b
rs17689966
N = 369

43871147
43880159
43885367
43893345
43902997
43905795
43910455
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Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin
releasing hormone binding protein; Chr, Chromosome; MAF, Minor allele frequency; SNP, Single Nucleotide Polymorphism; HWE,
Hardy-Weinberg equilibrium.
a

Frequency in HapMap European (CEU) populations of the minor allele.

b

SNPs associated with cortisol reactivity (See Figure 2.1).
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Table 2.3: List of tag-SNP-specific primers and their annealing temperatures.
Gene

Allele-specific primer [5' to 3']

Annealing
temp. (°C)

CRH
rs9694082

AACAAAACAAATTTGAGTTCACTCT[C/G]CTGGTGCATGGTGACCTCACACCTG

60

rs6999100

ATGTATGCATGACATTTTGTTTATC[C/T]GCTTCTCCAAGGATGGACTCTTGGG

60

rs1870394

TAAGGTCAGGGTAATAGAAAAGAAT[C/T]ATTCATCATAAGTTTTAAAACTCCC

62

rs11996294

AGAGCCAATCCTTCAGTAAGATGTC[G/T]ATATAAATGCACTGCCCTGAGGTTA

59

rs12944712

TAAAGCTGACAGGGCAGGAGACCTG[A/G]GGTTGGAGCTGACTCAGCCACTTCT

62

rs16969853

AAGGGAAGACTAGCCCTTTGCCTGG[A/C]ATTTGGCTTCATTTTCTGACGAATC

60

rs242924

GCATGGCTGCTGCTGGGCAAAAATG[G/T]AGAGGGTCCCTGCACCTGAGTGTCT

60

rs171441

AAGGAGGGCCAACTTCATTTAGCTG[A/G]TTCTTCCCTGCAGGGCCAGGGTAGA

62

rs1396862

GTTGGACCAGGGCTTCTGAACTGCA[A/G]AGGTGCTTTTTCCTAAAACCAAGCT

63

rs17763104

CGGGGTTGCCCTGATGGTTTAAGAC[A/G]ATAACAGATATGAAAATCCTCTGTA

62

rs17689966

AAGCACTGTCCCTCCCCATGCCATC[A/G]AGGTGGACGCAGATGACCCTTCCTC

60

rs1715751

CACATGCAGAAACCAGAATGGGGCC[C/T]GAGGCAAAAGGAAAAGTCACTGACA

62

rs1715747

ACTTTAAGGGATGAGGAGTTACTTC[C/T]TTTGAATGAGCAAAGAAAGCGGTTT

60

rs32897

GTTCTTGACATTTTAAAGTAATATG[C/T]GATGATATTTTTAAAAAATGAGAAA

60

rs7728378

GATTAAAAAAAAATAAGCACTCCCC[C/T]AATATTTTCTACATTGGAAGGTGAG

61

rs10062367

ATGAGGAGAAAGACTGAATTCAATT[A/G]CACTATTCTATAACTAATTATAAGT

60

rs10473984

AATTTACAGTACCTTTACAGAAGGA[G/T]AAAGGTGCCTTCTTCAAAAGGTTTT

60

CRHR1

CRHBP

CTTCATTTCATAGAAACTAAATTCT[A/G]TGAAGCAGGAGGTTGAACCCTTTTC
rs10514082
60
Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin
releasing hormone binding protein.
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2.2.4 Linkage Disequilibrium
The linkage disequilibrium (LD) pattern and haplotype block delineation
were determined using Haploview software version 4.0.51. Blocks were defined
using the confidence interval method described by Gabriel et al. (2002) as
implemented in Haploview software. Our sample showed a modest LD in the
CRH, CRHBP and CRHR1 gene coding regions represented by one LD block in
of 26 kb, 8 kb and 22 kb respectively (Figure 2.1).
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Figure 2.1. The 5' to 3' gene structures, respective chromosome tracks and r2based linkage disequilibrium (LD) structures of CRH system genes included in
this study. A, CRH; B, CRHR1 and C, CRHBP LD structures, spanning across 31
kb, 25 kb and 47 kb respectively. Boxes and lines represent exons and introns.
Arrows represent location of tSNPs in relation to the gene coding region.
Average distance between SNPs was 7.75 kb for CRH, 3.57 kb for CRHBP and
4.10 kb for CRHR1. Inset shows expected haplotype frequencies for each block
based on HapMap CEU populations. dbSNP information for each SNP is
presented in Table 2.2. SNPs associated with cortisol reactivity are marked by an
asterisk.
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2.2.5 Stress task and cortisol sampling procedure
The stress task and cortisol sampling procedures for this study are
described in greater detail previously (Kryski et al., 2011) and are outlined in brief
here. Several steps were taken to increase the accuracy with which children’s
baseline cortisol levels were indexed. First, to eliminate the influence of a novel
laboratory setting, which has been shown to increase children’s cortisol (Donzella
et al., 2008), cortisol data were collected during a visit to the family’s home by a
female experimenter whom the child had met previously during a laboratory visit
unrelated to the present study. All visits began between 12:00 pm and 3:30 pm
to minimize the effects of diurnal variation on cortisol samples (de Weerth, Zijl &
Buitelaar, 2003; Donzella et al., 2008). Caregivers were asked to prevent
children from eating or drinking for a half hour prior to the visit to minimize the
influence of food/drink on cortisol assays (Magnano, Diamond & Gardner, 1989;
Schwartz et al., 1998). None of the children were taking corticosteroids. Finally,
the visit began with the child and a familiar experimenter playing quietly with a
set of unexciting toys to allow any effect of the experimenter’s arrival on
children’s cortisol to dissipate. After 30 minutes of quiet play, a baseline salivary
cortisol sample was collected, followed by the stress task described below.
The stress task was designed to emphasize social evaluation under
motivated and uncontrollable circumstances, which has been shown to elicit
large cortisol responses in both adults (Magnano, Diamond & Gardner, 1989)
and preschool-aged children (Dickerson & Kemeny, 2004; Gunnar, Talge &
Harrera, 2009). Briefly, each child attempted to complete a matching task by
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matching coloured game pieces to animal icons based on an answer key. A large
toy replica of a traffic light was placed adjacent to the board, and the child was
instructed that the traffic light would show how much time they had to complete
the task and win a prize, with “green” indicating that they had time to work, and
“red” indicating that they were out of time. The experimenter surreptitiously
controlled the traffic light via remote control to that no child could complete the
task on time during any of the three trials conducted. The mean duration of the
task for children who completed all three trials was 15.01 min (SD = 1.5),
including the instruction period. Supporting the validity of this task as a means of
inducing stress, our group has previously shown that it successfully elicited a
mean increase in children’s cortisol, and that child negative affect increased as a
result of participating in this task (Kryski et al., 2011). Following the stress task,
the child and experimenter resumed quiet play while the remaining cortisol
samples were collected every 10, 20, 30, 40, and 50 minutes.
To obtain cortisol, children chewed on a 2-inch absorbent cotton dental roll
until it was wet with saliva, which was expunged into a micro tube and frozen at 20°C. Studies consistently report high correlations in saliva to serum cortisol
concentrations (Daniel et al., 2006; Dorn et al., 2009; Eatough et al., 2009).
Saliva samples were assayed in duplicate using salivary cortisol enzyme
immunoassay kit (Salimetrics, PA, USA). Optical density was read on a standard
plate reader at 450 nm and corrected at 650 nm (Molecular Devices, Sunnyvale,
CA, USA). All samples from the same child were assayed in the same batch with
no duplicates varying more than 5%. The average intra- and interassay
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coefficients were 3.5 and 5.1%. Standard curve and concentration of unknown
samples were generated according to manufacturer’s instructions using a 4parameter sigmoid minus curve fit. Cortisol data were skewed and were therefore
log10 transformed prior to all analyses, a standard procedure with human cortisol
data (Schwartz et al., 1998).
Three aspects of cortisol stress reactivity were examined. I calculated
individual cortisol response for each participant by calculating post-stress-task
cortisol change scores [baseline cortisol – peak cortisol post stress task],
hereafter referred to as “baseline to peak change.” I also calculated the area
under the curve (AUC) as a measure of cortisol response. The AUC is comprised
two types of information; first, the intensity of the response or AUCi, and second,
the total response as a function of time or AUCg (Figure 2.2). With
endocrinological data, AUCg is assumed to be a measure more related to total
hormonal output, whereas AUCI is a parameter that emphasizes the changes
over time and is more related to sensitivity of the system (Fekedulegn et al.,
2007; Pruessner et al., 2010).
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Figure 2.2. Cortisol response over 3 time points in an arbitrary dataset. AUCI is
the area under the curve above the referent baseline measurement (shaded
region). (Adapted from Fekedulegn et al., 2007).
2.2.6 Behaviour measures
The child’s primary caregiver completed the Child Behavior Checklist
(CBCL; Achenbach, 2001), a standardized parent report measure of the
frequency and intensity of child behavioural and emotional problems exhibited in
the last 6 months. Since I was primarily interested in the presence and severity of
children’s specific internalizing disorder symptoms, alternative scale scores
derived to be consistent with DSM-IV diagnostic criteria for disorders were used
(Lengua et al., 2001) including empirically-derived scales indexing depression (α
= 0.81) and anxiety (α = 0.77).
2.2.7 Assessment of life stress
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Several factors known to contribute to children’s early development were
examined: familial chronic stress (Burge & Hammen, 1991); marital discord
(Hammen, Brennan, & Shih, 2004); and socioeconomic status (SES; Lupien et
al., 2000). The UCLA Life Stress Interview was used to assess chronic stress as
reported by the primary caregiver. Trained Ph.D. students in clinical psychology
gathered information from each child’s primary caregiver related to their intimate
relationships, close friendships, social life, family relationships, childcare hassles,
work, finances, health of the primary caregivers, and health of close family
members (Adrian & Hammen, 1993; Hammen, 1991). The interviewer then
assigned Likert style ratings to the level of stress present in each domain from
low (1) to high (5). Reliability was assessed by having a second coder rerate the
chronic stress descriptions for 12 of the interviews (average ICC = 0.78). Life
stress ratings for each domain were averaged to create an average life stress
variable.
Primary caregiver reports of relationship adjustment were collected using
the Dyadic Adjustment Scale (DAS; Spanier, 1976). The DAS is a 32-item
questionnaire of marital adjustment designed for use with either married or
unmarried cohabiting couples (Spanier, 1976). The instrument provides a global
score of dyadic adjustment which can range from 0 to 151, with higher scores
reflecting higher level of dyadic adjustment. For the purposes of this study, the
global score were reverse-coded so that higher scores reflect greater marital
discord. Previous research has demonstrated good psychometric properties
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(Baillargeon, Dubois, & Marineau, 1986). The internal consistency for global
dyadic adjustment was good (α = 0.83).
Family income was reported by one of the child’s caregivers as an index
of family socio-economic status. This data was collected on a generic
demographic form along with other basic demographic characteristics. Family
income scores were generated that ranged from < $20,000 coded as 1 to income
> $100,000 coded as 5. For the purposes of this study family income was reverse
coded so that higher scores reflect lower family income and greater
socioeconomic stress. Following Evans and colleagues (2013), an aggregate
index of children’s cumulative stress exposure was created by first standardizing
and then averaging these variables. This overall life stress aggregate, which isI
referred to as “childhood stress” or CS, was used in all subsequent analyses.
2.2.8 Data Analyses
Descriptive statistics for children’s genotypes, gender, age, cortisol
reactivity, CS and symptoms are presented in Table 2.1. Next, bivariate
correlations between the main outcome measures were tested using Pearson
correlation analysis (Table 2.1). I used linear regression to assess whether SNPs
in the CRH, CRHR1 and CRHBP genes predicted child cortisol reactivity scores.
I first considered single-SNP analyses that regressed cortisol reactivity on tSNP
genotype (coded under additive, recessive & dominant models). I also
investigated whether epistatic interactions between CRH system polymorphisms
predicted cortisol reactivity using regression models. I established the
significance of genotype–mean cortisol reactivity using permutation-based
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procedures (Schmidt et al., 2002, 2003a) that randomly assigned the sample
cortisol reactivity scores to subjects (sampled without replacement) while holding
each subject’s genotype fixed. This permutation method is preferred as it
accounts for LD among SNPs in a haplotype block therefore conserving power
compared to commonly used correction techniques such as the Bonferroni
method (Schmidt et al., 2003b). For each analysis, the empirical P value was
based on 10,000 permutations. I conducted these analyses using appropriate
components of PLINK (Purcell et al., 2007).
To examine whether CRH gene pathway tSNPs moderated associations
between CS and child internalizing symptoms, multiple regression was used as
implemented in the macro developed by Hayes (2012). This macro uses a
regression-based path analytical framework for estimating direct and indirect
effects in simple and multiple moderation models, two- and three-way
interactions in moderation models along with simple slopes and regions of
significance for probing interactions. Bootstrap methods are implemented for
inference about indirect effects in both unmoderated as well as mediated
moderation models. All predictor values were centered as needed.
2.3

RESULTS

2.3.1 Associations between study variables and CRH system gene
polymorphisms
We first looked at whether links existed between study demographics and
cortisol reactivity measures. Table 2.4 presents correlations between all major
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study variables. Cortisol response measures (i.e., AUCi, AUCg and baseline to
peak cortisol change scores) were highly positively correlated with each other. As
baseline to peak cortisol change and AUCi are highly correlated and capture the
intensity of cortisol response, we chose to present only the AUCi as a dependent
variable in subsequent sections. As is frequently found in the literature on cortisol
reactivity, higher family income was associated with lower cortisol reactivity
(Chen et al., 2010; Lupien et al., 2001) and with fewer depressive and anxious
symptoms. Child sex was associated with symptoms such that girls had more
anxious and depressive symptoms compared to boys in the sample. No
significant associations between child sex and the three measures of cortisol
response were found, as expected based on the literature (Mackinaw-Koons &
Vasey, 2000; Stroud et al., 2004). Anxious symptoms were positively correlated
with all measures of cortisol reactivity (AUCi, AUCg and baseline to peak cortisol
change). All symptom measures were positively correlated. Finally, the CS
measure was positively associated with all measures of cortisol response and
internalizing symptoms, but negatively correlated with family income.
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Table 2.4. Correlations among study variables

1

2

3

4

5

6

7

8

9

1. baseline to peak change
[peak – baseline]
-2. AUCi

.881***

--

3. AUCg

.686**

.724***

--

4. PPVT

-.026

.006

.003

--

5. Family Income

-.074

-.090

-.123*

.092

--

6. Child Sex

.002

.030

-.008

.064

.009

--

7. Anxious Symptoms

.116*

.114*

.117*

.041

-.125*

.133*

--

8. Depressive Symptoms

-.018

-.002

.006

-.032

-.120

.144**

.313**

--

9. Childhood stress

.146**

.141*

.176**

-.118*

-.624**

.017

.161**

.264**

--

Mean

0.065

.050

.180

111.98

3.76

1.498

1.258

1.273

0.096

(SD)

(0.053)

(.090)

(.123)

(14.11)

(1.10)

(.500)

(1.442)

(1.533)

(.645)

Note: Child gender was coded as males = 0 and females = 1; Family income was coded as 1 = < $20,000; 2= $20,000$40,000; 3= $40,001-$70,000; 4 = $70,001-$100,000; 5 = > $100,001. AUCi = area under curve with respect to baseline;
AUCg = area under curve with respect to ground; PPVT = Picture Vocabulary Test–Fourth Edition (Dunn & Dunn, 1997).
*p < 0.05; **p < 0.01; ***p < 0.001.
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Regression analyses showed no significant associations between
demographic variables and the 18 tSNPs genotypes in this study (ps > 0.11). Of
the 18 tSNPs genotyped, only two tSNPs were significantly associated with
cortisol reactivity or AUCi after correcting for multiple tests, CRHR1 tSNP
rs17763104 and CRHBP tSNP rs10473984. The CRHR1 tSNP rs17763104
genotypes predicted child AUCi under an ancestral recessive model, with the
CRHR1 tSNP rs17763104 GG homozygote children having significantly lower
cortisol reactivity (AUCi) relative to heterozygotes and AA homozygotes (β =
0.13, se = 0.05, t = 1.98, p = 0.01) (Figure 2.3A). Similarly, an association also
existed between children’s AUCi and CRHBP tSNP rs10473984 when coded
under a recessive model (β = 0.05, se = 0.03, t =1.14, p = 0.02), such that the
GG homozygote children had significantly higher AUCi than their counterparts
who have at least one copy of the T allele (Figure 2.3B).
An association also existed between children’s total cortisol response or
AUCg and CRHBP tSNP rs10062367 and cortisol reactivity when coded under a
recessive model (β = -0.04, se = 0.01, t = -2.74, p < 0.01), such that the GG
homozygous children had significantly higher AUCg than children with at least
one copy of the A allele (Figure 2.3C).
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A.
*

0.06
0.05

AUCi

0.04
0.03
0.02
0.01
N=258

N=142

0
GG

AA/AG
CRHR1 rs17736104
genotype

B.
*

0.07
0.06

AUCi
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0.04
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0.02
0.01

N=277

N=58/9

0
GG

AA/AG

CRHBP rs10473984
genotype
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C.

*

0.225
0.2
0.175

AUCg

0.15
0.125
0.1
0.075
0.05
0.025

N = 226

N = 134

GG

GA + AA

0
CRHBP rs10062367
Genotype

Figure 2.3. Distribution of AUCi (±SEM) in children with the (A) CRHR1
rs17763104 and (B) CRHBP rs10473984. AUCg as a function of CRHBP
rs10062367 genotypes (C)).
Note: CRHR1, Corticotrophin releasing hormone receptor
receptor-1;
1; CRHBP, Corticotrophin
releasing hormone binding protein; tSNP, tagging Single Nucleotide Polymorphism.
Inset, N, represents number of children in each genotypic group. * p < 0.05.
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2.3.2 CRHR1 haplotypes are associated with cortisol reactivity to stress
One haplotype block extended distally across the gene and included four
tSNPs from rs16969853 to rs1396862 (Figure 2.1B). There were five haplotypes
with a frequency > 0.05 accounting for 94% of haplotype diversity. Figure 2.4
shows the relationship between CRHR1 haplotype carriers inferred from the 22kb
LD block and children’s cortisol reactivity measured via AUCi. Children with the
GGTC and AAGC haplotypes had significantly lower cortisol reactivity than the
GAGT, GGGC and GAGC haplotype groups (all ps < 0.05) but these two
haplotypes were not significantly different in cortisol reactivity (all ps > 0.05). All
four tSNPs were in strong LD for the 26kb CRH gene region. There were four
haplotypes with a frequency of > 0.05 that accounted for 99% of haplotype
diversity. Similarly two tSNPs were in strong LD in a 8kb CRHBP gene region (all
ps > 0.23). There were two haplotypes with a frequency of > 0.05. The CRHBP
haplotypes were also not associated with measures of cortisol reactivity (all ps >
0.14).
No links were found between the CRHR1 haplotypes and cortisol
response measured via AUCg (all ps > 0.05).
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Pairwise comparison (p-values)
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b
c
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b
.04
c
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d
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AUCi

0.04
0.03
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N=151
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N=40

N=37
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GGGC
GAGC
CRHR1 LD block haplotypes

AAGC

Figure 2.4. Mean salivary AUCi as a function of CRHR1 haplotypes in linkage block 1 (Figure 2.1). Two haplotype groups
showed significantly lower cortisol reactivity compared to the rest of the haplotype groups.
Note: Inset represents pairwise comparisons between haplotype groups.
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2.3.3 Gene–gene interactions and cortisol reactivity
I also investigated pairwise interactions between tSNPs genotypes in
predicting cortisol reactivity, finding effects of three tSNP pairs, illustrated in
Figure 2.5. Regression analyses showed a significant interaction between two
tSNP pairs on chromosome 8 and 17. The first significant interaction was
between CRH rs9694082 and CRHR1 rs171441 (β = -1.10, se = 0.52, corrected
p < 0.01; Figure 2.5A), such that CRHR1 rs171441 heterozygotes had
significantly lower cortisol reactivity than their homozygous counterparts (all ps <
0.01). Figure 2.5B illustrates the second significant interaction that was found
between CRH rs11996294 and CRHR1 tSNP rs12944712 (β = -2.97, se = 0.50,
corrected p < 0.01) such that carriers who were heterozygous for the CRH
rs11996294 tSNP but homozygous for the rs12944712 G or A alleles had
significantly higher cortisol reactivity than their rs12944712 GA heterozygous
counterparts (all ps < 0.001). Figure 2.5C illustrates the interaction between the
CRHR1 rs171441 and CRHBP rs32897 predicting child cortisol reactivity (β
=1.41, se = 0.25, corrected p = 0.01). Carriers homozygous for the rs32897 G
allele substitution had significantly higher cortisol reactivity compared to carriers
with at least one copy of the rs32897 A allele (all ps < 0.01).
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0.06
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0.045
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N=41

N=53
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0.025
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rs171441 (CRHR1)
genotype

ene interaction
interactions predict cortisol reactivity measured via AUCi.
Figure 2.5. Gene-gene
A, Interaction effect between CRHR1 tSNP rs171441 and CRH tSNP rs9694082
genotypes with respect to AUCi. B, Interaction effect between CRHR1 tSNP
rs12944712 and CRH tSNP rs11996294 genotypes with respect to AUCi. C,
Interaction effect between CRHR1 tSNP rs171441 and CRHBP tSNP rs32897
genotypes with respect to AUCi. Data are presented as mean AUCi (±
±SEM).
Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing
hormone receptor-1;
1; CRHBP, C
Corticotrophin
orticotrophin releasing hormone binding protein; Chr,
Chromosome; tSNP, tagging
tagging-Single Nucleotide Polymorphism. *p < 0.05, ** p < 0.01,
***p < 0.001.
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Gene-gene interactions also predicted overall cortisol response or AUCg.
Figure 2.6A illustrates the interaction effect between CRHR1 tSNP rs242924 and
CRHR1 tSNP rs12944712 genotypes predicting AUCg (β =2.81, se = 0.25,
corrected p = 0.001) such that children heterozygous for the two tSNPs had
lower cortisol response than children who were not heterozygous for these
tSNPs. Figure 2.6B illustrates the interaction between CRHR1 tSNP rs16969853
and CRH tSNP rs17689966 genotypes predicting child AUCg (β =2.07, se = 0.18,
corrected p < 0.01) such that children homozygous for the G allele had lower
cortisol response when compared to children who were either heterozygous or
homozygous for the A allele.
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Figure 2.6. Gene-gene
ene interactions predict total cortisol response measured via AUCg. A, Interaction effect between
CRHR1 tSNP rs242924 and CRHR1 tSNP rs12944712 genotypes (A) and CRHR1 tSNP rs16969853
6969853 and CRH tSNP
rs17689966 genotypes (B) as a function of AUCg.
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Note: AUCg, area under curve with respect to ground; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin
releasing hormone binding protein; Chr, Chromosome; tSNP, tagging-Single Nucleotide Polymorphism. *p < 0.05, ** p < 0.01, ***p <
0.001.
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2.3.4 CRH pathway tSNPs are associated with emerging symptoms of
depression and anxiety
Based on the hypotheses that the CRH system gene variants may
contribute to depressive and anxious symptoms, I examined such links in this
sample of preschoolers. Results of these analyses are presented in Table 2.5. I
found significant main effects of the tSNPs and genotype on children’s symptoms
of depression and anxiety. First, the CRH gene tSNP, rs9694082, was
associated with child anxious symptoms (Figure 2.7A), such that the carriers for
at least one copy of the G allele had significantly higher anxious symptoms than
their counterparts homozygous for the C allele (t = 2.30, df = 368, p = 0.02).
Similarly, the CRHR1 tSNP, rs242924, was also associated with
symptoms of depression and anxiety in preschoolers (results presented in
Figures 2.7B and 2.7C). Children who carried at least one copy of the G allele
had significantly higher depressive (t = -2.48, df = 368, p = 0.01) and anxious
symptoms (t = -2.27, df = 368, p = 0.02) compared to children homozygous for
the T allele.
One tSNP in the CRHBP gene region was also associated with child
anxious symptoms (Figure 2.7D), such that children who were carriers of the
major allele or A allele had significantly higher anxious symptoms than children
carrying the minor allele or G allele (t = 3.67, df = 360, p < 0.01).
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Table 2.5. Main effects of CRH system gene variants on emerging depressive and anxious symptoms.

Gene (N=369)
CRH

tSNP
rs9694082*
rs6999100
rs1870394
rs11996294

Depressive symptoms

Anxious symptoms

Additive model
Allelic model
p-value
0.58
0.41
0.92
0.85
0.60
0.51
0.16
0.06

Additive model
Allelic model
p-value
0.06
0.02
0.65
0.71
0.73
0.66
0.75
0.25

CRHR1
rs12944712
rs16969853
rs242924**
rs171441
rs1396862
rs17763104
rs17689966

0.19
0.55
0.26
0.81
0.53
0.22
0.18

0.20
0.01
0.14
0.94
0.27
0.15

0.80
0.81
0.05
0.97
0.13
0.47
0.60

0.55
0.05
0.31
0.66
0.68
0.49

rs1715751**
rs1715747
rs32897
rs7728378
rs10062367
rs10473984
rs10514082

0.32
0.41
0.98
0.48
0.71
0.08
0.55

0.08
0.26
0.88
0.31
0.56
0.11
0.31

0.15
0.86
0.99
0.29
0.94
0.37
0.36

0.01
0.73
0.94
0.31
0.82
0.22
0.58

CRHBP

Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin
releasing hormone binding protein.
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A.

B.

N=303
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C.

D.

Figure 2.7. CRH pathway gene tSNPs are associated with emerging symptoms of depression and anxiety. Results
derived from the best genetic model are reported. Symptoms are plotted as a function of genotype for A) CRH tSNP,
rs9694082, and anxiety symptoms; B, C) CRHR1 tSNP, rs242924, and depressive and anxious symptoms; D) CRHBP
tSNP rs1715751 and depressive symptoms in preschoolers. *p < 0.05; **p < 0.01.
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2.3.5 Interactions between CRH system gene variants and childhood stress
predict cortisol response to stress in preschoolers
In the next set of analyses, I examined whether the interactions between
CRH system tSNPs and CS were associated with children’s cortisol AUCi (Table
2.6). I found two tSNPs in the CRHBP coding region which acted as moderators
of the association between CS and children’s AUCi. The first significant
interaction term included CRHBP rs1715747 tSNP and CS. To understand the
moderation effect, I plotted the association between cortisol and CS for the two
allelic groups (Figure 2.8A). My analysis showed that children with at least one
copy of the G allele showed higher AUCi, as CS levels increased (β = 0.09, se =
0.02, p < 0.001, 95% CI: 0.04 – 0.13, N = 71); in contrast, the association
between AUCi and CS in children homozygous for the T allele was not fully
significant (β = 0.02, se = 0.01, p = 0.07, 95% CI: -0.00 – 0.03, N = 300).1
I also found a similar evidence for moderation in the CRHBP gene variant
as well. The interaction term for CRHBP rs32897 tSNP and CS was also
significant (Table 2.6). I plotted the levels of CS for the two allelic groups (Figure
2.8B). My analysis showed that children with at least one copy of the G allele
showed higher AUCi as CS levels increased (β = 0.21, se = 0.04, p < 0.001, 95%
CI: 0.13 – 0.29, N = 219); in contrast, the association between AUCi and CS in

1

The gene-environment interaction term did not predict AUCg, p > 0.66.
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children homozygous for the T allele was not significant (β = 0.01, se = 0.01, p =
0.31, 95% CI: -0.01 – 0.03, N = 148).2

2

Similar to rs1715747 tSNP, the interaction between the rs32897 tSNP and CS did not

predict AUCg, p > 0.23.
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Table 2.6. Interaction between CRH system tSNPs and childhood stress (CS)
effect on stress response measured via cortisol AUCi.
Gene

SNP x CS

model

rs9694082

β

se

p-value

REC

-0.01

0.02

0.59

rs6999100

REC

0.00

0.02

0.99

rs1870394

ADD

-0.02

0.02

0.25

rs11996294

REC

-0.02

0.02

0.17

rs12944712

ADD

0.00

0.01

0.96

rs16969853

ADD

0.01

0.02

0.73

rs242924

ADD

0.01

0.01

0.95

rs171441

REC

-0.02

0.03

0.37

rs1396862

ADD

0.01

0.02

0.69

rs17763104

ADD

0.03

0.02

0.18

rs17689966

REC

0.02

0.02

0.33

rs1715751

ADD

-0.02

0.02

0.26

rs1715747*

DOM

0.24

0.01

0.04

rs32897***

REC

0.19

0.04

0.00

rs7728378

ADD

0.01

0.01

0.70

rs10062367

REC

-0.13

0.02

0.07

rs10473984

ADD

0.00

0.02

0.91

CRH

CRHR1

CRHBP

rs10514082
ADD
0.02
0.02
0.41
Note: SNP, single nucleotide polymorphism; AUC, area under curve; ADD, additive
model; REC, recessive model; DOM, dominant model; CRH, Corticotrophin releasing
hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin
releasing hormone binding protein.
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Figure 2.8. Relationship between childhood stress and AUCi by CRHBP
CRH
tSNP
rs1715747 (A), and (B) CRHBP tSNP rs32897 genotypes.
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2.3.6 GxE between CRH system genetic variation and childhood stress predict
emerging symptoms of depression and anxiety
Based on recent findings (Heim et al., 2009), I investigated whether CRH
pathway gene variation would moderate the link between CS and internalizing
symptoms in preschoolers. I found three tSNPs which acted as moderators of the
association between CS and children’s depressive or anxious symptoms. The
interaction terms for CRHR1 rs242924 tSNP and CS were significant for both
depressive and anxious symptoms (Table 2.7). I plotted levels of child depressive
and anxious symptoms as a function of CS and CRHR1 rs242924 tSNP
genotype (Figure 2.9A). My analysis showed that children with at least one copy
of the G allele showed an increasing levels of depressive symptoms as the levels
of CS increased (β = 0.20, se = 0.07, p < 0.001, 95% CI: 0.06 – 0.34, N = 275); in
contrast, the link between depressive symptoms and CS in children homozygous
for the T allele was not significant (β = 0.06, se = 0.13, p = 0.38, 95% CI: -0.07 –
0.14, N = 96). Similarly, my analysis showed that children with at least one copy
of the G allele showed increasing levels of anxious symptoms as CS increased
(β = 0.58, se = 0.16, p < 0.001, 95% CI: 0.26 – 0.90, N = 275); in contrast, the
link between anxious symptoms and CS in children homozygous for the T allele
was not significant (β = 0.08, se = 0.18, p = 0.65, 95% CI: -0.28 – 0.44, N = 96;
Figure 2.9B).
I also found similar evidence for moderation in the CRHBP gene variant as
well. The interaction term for CRHBP rs7728378 tSNP and CS was also
significant (Table 2.8). I plotted levels of child depressive symptoms and CS for
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the two allelic groups (Figure 2.9C). My analysis showed that children with at
least one copy of the A allele showed an increasing levels of depressive
symptoms as the life stress increased (β = 0.26, se = 0.29, p = 0.35, 95% CI: 0.30 – 0.82, N = 217); in contrast, the link between depressive symptoms and CS
in children homozygous for the G allele was not significant (β = - 1.16, se = 0.33,
p < 0.001, 95% CI: 0.51 – 1.79, N = 145).
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Table 2.7. Summary of interactions between CRH system tSNPs and childhood
stress (CS) predicting emerging anxiety symptoms. Significant model p-values
are in bolded text.
Gene

β

se

p-value

REC

0.23

0.35

0.51

rs6999100

REC

0.40

0.29

0.17

rs1870394

ADD

0.32

0.30

0.28

rs11996294

REC

0.16

0.26

0.54

rs12944712

ADD

0.20

0.23

0.38

rs16969853

ADD

-0.27

0.35

0.44

rs242924*

REC

0.38

0.18

0.03

rs171441

REC

-0.45

0.40

0.26

rs1396862

ADD

0.02

0.27

0.93

rs17763104

ADD

0.28

0.31

0.48

rs17689966

REC

0.30

0.23

0.21

rs1715751

ADD

-0.18

0.27

0.50

rs1715747

DOM

-0.13

0.27

0.62

rs32897

REC

0.31

0.26

0.25

rs7728378

ADD

0.08

0.19

0.66

rs10062367

ADD

0.19

0.17

0.28

rs10473984

ADD

0.32

0.37

0.17

SNP x CS

model

rs9694082

CRH

CRHR1

CRHBP

rs10514082
ADD
-0.06
0.30
0.85
Note: SNP, single nucleotide polymorphism; ADD, additive model; REC, recessive
model; DOM, dominant model; CRH, Corticotrophin releasing hormone; CRHR1,
Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin releasing hormone
binding protein. *p < 0.05; †p < 0.10.
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Table 2.8. Summary of interactions between CRH system tSNPs and childhood
stress (CS) predicting emerging depressive symptoms. Significant model pvalues are in bolded text.
Gene

β

se

p-value

REC
REC
ADD
REC

0.43
0.20
0.51
0.38

0.25
0.28
0.29
0.34

0.09
0.48
0.08
0.26

ADD
ADD
ADD
REC
ADD
ADD
REC

0.12
-0.36
0.47
-0.66
-0.13
0.18
0.11

0.20
0.34
0.18
0.39
0.26
0.29
0.17

0.54
0.29
0.01
0.09
0.62
0.54
0.64

SNP x CS

model

rs9694082†

CRH
rs6999100
rs1870394†
rs11996294
CRHR1
rs12944712
rs16969853
rs242924*
rs171441†
rs1396862
rs17763104
rs17689966
CRHBP
rs1715751
ADD
0.26
0.25
0.30
rs1715747
DOM
-0.20
0.18
0.25
rs32897
REC
-0.13
0.22
0.55
0.02
rs7728378*
ADD
-0.42
0.18
rs10062367
REC
0.58
0.26
0.58
rs10473984
ADD
-0.55
0.36
0.13
rs10514082
ADD
0.30
0.31
0.34
Note: SNP, single nucleotide polymorphism; ADD, additive; REC, recessive; DOM,
dominant; CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing
hormone receptor-1; CRHBP, Corticotrophin releasing hormone binding protein. *p <
0.05; †p < 0.10.
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Figure 2.9. Relationship between levels of childhood stress and emerging
symptoms by CRHR1 tSNP rs242924 (A, B) and CRHBP tSNP rs7728378 (C)
genotypes.
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2.4

DISCUSSION
The first aim of this study was to explore links between genetic variation of

the CRH system genes and children’s cortisol responses to stress. Analyses
found evidence for associations between CRH pathway gene variations and both
the intensity (measured via AUCi) and total hormonal response measured via
AUCg. Specifically, tSNPs of the CRHR1 and CRHBP gene-coding regions were
associated with preschoolers’ cortisol responses to stress. The CRHR1 tSNP,
rs17736104 was associated with childhood AUCi. Even though the CRHR1 tSNP
rs17763104 is intronic, it is likely that this SNP is flanked by nonsynonymous
SNPs in CRHR1 gene exons 6 through 8. Although speculative, it is possible that
one of these SNPs may have functional effects on CRHR1 gene transcription,
thus influencing the number of functional CRH receptors on the pituitary gland
leading to changes in the release of ACTH, and ultimately affecting cortisol
release from the adrenal gland. Recent research indicates that most CRHR1
isoforms are a result of splicing variation within the exon 6 through 10-coding
regions (van Pett et al., 2000). Furthermore, intronic SNPs have also been
shown to exert functional effects on gene expression when the intron is part of
the gene’s regulatory region. It is likely that this tSNP may be linked to such a
variant, which may be regulating the CRHR1 gene expression. Future research is
needed to investigate the functional effects this SNP and either the regulatory
nature or the alternatively spliced variants from this coding region on ACTH
release from the pituitary and stress sensitivity.
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I also found associations between CRHR1 haplotypes and cortisol
reactivity. Children with the GGTC and AAGC haplotypes showed significantly
lower cortisol reactivity than those with the GAGT, GGGC and GAGC
haplotypes. The linkage block that encompasses these haplotypes contain exons
code for the transmembrane parts of the mature CRHR1 protein. It is plausible
that the genetic variation in this region may lead to changes in the
transmembrane protein structure, which initiates downstream signaling of this gprotein couple receptor. Differences in downstream activation could lead to
altered release of ACTH and eventually cortisol release from the adrenal
medulla. Animal knockout research lends some support to this hypothesis by
showing that the CRHR1 gene is critical for normative cortisol reactivity to stress.
To my knowledge, my study is the first to show that common genetic variation of
the CRHR1 gene loci is also associated with differences in cortisol reactivity in
children.
Association also existed between CRH system gene variants and
emerging symptoms of depression and anxiety. Specifically, the CRH rs9494082
and CRHBP rs1715751 were associated with anxious symptoms, whereas the
CRHR1 tSNP, rs242924, was associated with depressive symptoms. I also found
evidence for gene-environment interaction between CRH pathway genes and CS
on emerging symptoms of depression, with the interaction between CRHR1 tSNP
rs242924 and CS predicting symptoms of depression. Although no main effect of
these variants on depression or anxiety has been reported, a few studies have
implicated these variants in gene-environment interactions REFS. For example,
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polymorphisms within this region of the CRHR1 gene, and rs110402 and
rs242924 SNP genotypes in particular, have been shown to moderate the link
between early childhood maltreatment and the development of depressive
symptoms later in life (Bradley et al., 2008; Heim et al., 2009; Polanczyk et al.,
2009; Wasserman et al., 2009; Grabe et al., 2010), suggesting genetic
differences are shaped by the environment in CRH-dependent
neurotransmission. Similarly, Tyrka and colleagues (2009) report that variation in
the CRHR1 gene, and rs242924 GG homozygotes in particular, moderated the
effect of childhood maltreatment on cortisol responses to the
dexamethasone/corticotrophin-releasing hormone test. Thus, pathways between
CRH system genes and negative outcomes are clearly complex, with evidence
for both moderation and main effects. These findings contribute to this literature,
showing that the CRH system genetic variation is associated with early stress
reactivity and could act as a moderator of CS’ effects on emerging risk for
psychopathology.
My analysis also showed that a tSNP in the CRHBP-coding region,
rs10473984 was associated with intensity of cortisol reactivity, and that CRHBP
rs10062367 genotype was associated with total cortisol response or AUCg.
Additionally, the interaction between CRHBP tSNP rs7728378 and CS also
predicted childhood symptoms of depression. Once again, children homozygous
for the major allele (A allele) showed greater depressive symptoms as a function
of life stress; however, this relationship was nonsignificant for children with at
least one copy of the minor allele or the G allele. Since 65–90% of total CRH is
92

bound to CRHBP (Jahn et al., 2005), the effectiveness of CRH in stimulating
ACTH to release cortisol may be influenced by a variation in CRHBP expression.
A number of recent studies have focused on the CRHBP gene as a
candidate gene for stress-related disorders such as major depression and
suicidality (De Luca et al., 2010). A study by Binder and colleagues (2010) report
that allelic variants of rs10473984 are associated with higher ACTH
concentrations, and these data extend this finding by showing this SNP is
associated with early childhood cortisol reactivity as well. Although this SNP is
30kb upstream of the gene-coding region, it is likely that it is in linkage with
SNP(s) with functional consequences, resulting in decreased affinity for free
CRH, thus increasing the bioavailability of CRH to activate its receptor, the
CRHR1. Such a functional change could lead to an increase in subsequent
ACTH release from the pituitary gland and downstream cortisol release from the
adrenal glands. Recent work by Enoch et al. (2008) provides some support for
this speculation, identifying a second CRHBP isoform in the brain in which the
terminal exon (exon 7) is spliced out, resulting in a truncation of the messenger
RNA, such that the C-terminus of ancestral 52 amino acids is truncated to only
18 amino acids. This change in peptide sequence might affect protein folding and
stability, which might alter CRH binding affinity. Further research including ultradeep sequencing of this region and molecular analyses are needed to explain the
role of the genetic variation in this region and HPA axis function.
I also found evidence for gene-gene interactions predicting both AUCi
cortisol reactivity and total cortisol response. The interactions between CRH
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rs9698042 and CRHR1 rs171441 were such that children heterozygous for the
CRHR1 rs171441 showed lower cortisol reactivity than the homozygotes for
these loci. The second interaction, between CRH rs11996294 and CRHR1
rs12944712 also predicted lower cortisol reactivity for heterozygotes at both gene
loci. Although I did not find any main effects of genetic variation in the CRH gene
on cortisol reactivity, the interaction between the CRH and CRHR1 tSNPs
indicates that CRH gene variants are important in HPA axis function, but only by
virtue of epistatic effects. An interaction between CRHR1 rs171441 and CRHBP
rs32897 also predicted cortisol reactivity such that children homozygous for the
rs32897 GG genotype showed significantly higher cortisol reactivity than the A
allele carriers. The rs32897 tSNP has been implicated in other studies examining
the genetic bases of alcoholism (Enoch et al., 2008) and inflammation (Velez et
al., 2008). However, the interaction I found between the loci on the CRHR1 and
CRHBP genes and cortisol reactivity is novel. Taken together, the presence of
multiple interactions between genes that shape different levels of the HPA
signaling cascade highlights the complex nature of the genetic bases of HPA
function in humans.
Overall, these findings illustrate an important relationship between genetic
variation of the various CRH system genes and early cortisol reactivity and the
role of these variants in emerging risk for internalizing symptoms. Additionally,
these findings support and extend recent adult literature where CRH system
genes were found to moderate the early environment on psychopathological risk.
These findings have the potential to shed light on the mechanisms involved in the
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transmission of risk and the origins of stress sensitivity and resilience observed in
disorders such as major depression and post-traumatic stress disorder. I
demonstrated that cortisol reactivity to stress in humans has complex polygenic
underpinnings.

95

2.5

References

1.

Abelson JL, Khan S, Liberzon I, Young EA. (2007) HPA axis activity in

patients with panic disorder: review and synthesis of four studies. Depress
Anxiety 24:66–76.
2.

Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in

the physiopathology of depression. J Psych Neurosci 29:185-193.
3.

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview analysis and

visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4.

Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW

(1995) Corticotropin releasing factor (CRF) binding protein a novel regulator of
CRF and related peptides. Front Neuroendocrinol 16:362-382.
5.

Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, et al.

(2010) Association of polymorphisms in genes regulating the corticotropinreleasing factor system with antidepressant treatment response. Arch Gen
Psychiatry 67:369e79.
6.

Bonfiglio JJ, Inda C, Refojo D, Holsboer F, Arzt E, Silberstein S (2011)

The corticotrophin-releasing hormone network and the hypothalamic-pituitaryadrenal axis molecular and cellular mechanisms involved. Neuroendocrinology
94:12-20
7.

Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, et al. (2008)

Influence of child abuse on adult depression moderation by the corticotropinreleasing hormone receptor gene. Arch Gen Psychiatry 65:190-200.

96

8.

Brown EM, Barratt BJ (2007) The HapMap - A haplotype map of the

human genome. In Barnes, MR editor. Bioinformatics for geneticists, 2nd ed.
Sussex, England Wiley, pp 33-54.
9.

Charney DS (2004) Psychobiological mechanisms of resilience and

vulnerability implications for successful adaptation to extreme stress. Am J
Psychiatry 161:195-216.
10.

Condren RM, O’Neill A, Ryan MC, Barrett P, Thakore JH (2002) HPA axis

response to a psychological stressor in generalised social phobia.
Psychoneuroendocrinology 27:693–703.
11.

Dahl RE, Gunnar MR (2009) Heightened stress responsiveness and

emotional reactivity during pubertal maturation implications for psychopathology.
Dev Psychopathol 21:1-6.
12.

Daniel M, Moore DS, Decker S, Belton L, DeVellis B, Doolen A et al.

(2006) Associations among education, cortisol rhythm, and BMI in blue-collar
women. Obesity 14:327-335.
13.

de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D (2005)

Efficiency and power in genetic association studies. Nat Genet 37:1217–1223.
14.

De Luca V, Tharmalingam S, Zai C, Potapova N, Strauss J, Vincent J, et

al. (2010) Association of HPA axis genes with suicidal behaviour in
schizophrenia. J Psychopharm 24677:e82.
15.

de Weerth C, Zijl RH, Buitelaar JK (2003) Development of cortisol

circadian rhythm in infancy. Early Hum Dev 73:39-52.

97

16.

Dickerson S, Kemeny M (2004) Acute stressors and cortisol responses a

theoretical integration and synthesis of laboratory research. Psychol Bull
130:355—391.
17.

Donzella B, Talge NM, Smith TL, Gunnar MR (2008) To spear or not to

spear comparison of saliva collection methods. Dev Psychobiol 50:714-7.
18.

Dorn LD, Kolko DJ, Susman EJ, Huang B, Stein H, Music E et al. (2009)

Salivary gonadal and adrenal hormone differences in boys and girls with and
without disruptive behaviour disorders Contextual variants. Biol Psychology
81:31-39.
19.

Dunn LM, Dunn LM (1997) Peabody Picture Vocabulary Test (3rd edition).

Circle Pines, Minnesota American Guidance Service.
20.

Eatough EM., Shirtcliff, EA, Hanson JL, Pollak SD (2009) Hormonal

reactivity to MRI scanning in adolescents. Psychoneuroendocrinology 34:12421246.
21.

Enoch MA, Shen PH, Ducci F, Yuan Q, Liu J, White KV, et al. (2008)

Common genetic origins for EEG, alcoholism and anxiety the role of CRH-BP.
PLoS One 3:e3620.
22.

Epstein MP, Satten GA (2003) Inference on haplotype effects in case-

control studies using unphased genotype data. Am J Hum Genet 73:1316-1329.
23.

Evans GW, Li D, Whipple SS. (2013) Cumulative risk and child

development. Psychol Bull 136:1342-96
24.

Fries E, Hesse J, Hellhammer J, Hellhammer DH (2005) A new view on

hypocortisolism. Psychoneuroendocrinology 30:1010-6.

98

25.

Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et

al. (2002) The structure of haplotype blocks in the human genome. Science
296:2225-2229.
26.

Gammie SC, Seasholtz AF, Stevenson SA (2008) Deletion of

corticotropin-releasing factor binding protein selectively impairs maternal, but not
intermale aggression. Neuroscience 157:502-12.
27.

Gillespie CF, Nemeroff CB. (2005) Hypercortisolemia and depression.

Psychosom Med 67:S26–28.
28.

Gotlib IH, Joormann J, Minor KL, Hallmayer J (2008) HPA Axis Reactivity

A Mechanism Underlying the Associations Among 5-HTTLPR, Stress, and
Depression. Biol Psychaitry 63:847-851.
29.

Grabe HJ, Schwahn C, Appel K, Mahler J, Schulz A, Spitzer C, et al.

(2010) Childhood maltreatment, the corticotropin-releasing hormone receptor
gene and adult depression in the general population. Am J Med Genet B
Neuropsychiatr Genet 153B:1483–1493.
30.

Gunnar MR, Talge NM, Herrera A (2009) Stressor paradigms in

developmental studies What does and does not work to produce mean increases
in salivary cortisol. Psychoneuroendocrinology 34:953-967.
31.

Gunnar MR, Wewerka S, Frenn K, Long JD, Griggs C (2009)

Developmental changes in hypothalamus-pituitary-adrenal activity over the
transition to adolescence normative changes and associations with puberty. Dev
Psychopathol 21:69-85.

99

32.

Harkness KL, Stewart JG, Wynne-Edwards KE (2011) Cortisol reactivity to

social stress in adolescents role of depression severity and child maltreatment.
Psychoneuroendocrinology 36:173-81
33.

Heim C, Ehlert U, Hellhammer DH (2000) The potential role of

hypocortisolism in the pathophysiology of stress-related bodily disorders.
Psychoneuroendocrinology 25:1-35.
34.

Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2008) The link

between childhood trauma and depression insights from HPA axis studies in
humans. Psychoneuroendocrinology 33:693-710.
35.

Holsboer, F., Von Bardeleben, U., Gerken, A., Stalla, G.K., Muller, O.A.

(1984) Blunted corticotropin and normal cortisol response to human corticotropinreleasing factor in depression. N Engl J Med 311:1127.
36.

Jahn O, Radulovic J, Stiedl O, Tezval H, Eckart K, Spiess J (2005)

Corticotropinreleasing factor binding protein a ligand trap? Mini Rev Med Chem
5:953-960.
37.

Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression.

Nature 455:894-902.
38.

Kryski KR, Smith HJ, Sheikh HI, Singh SM, Hayden EP (2011) Assessing

stress reactivity indexed via salivary cortisol in preschool-aged children.
Psychoneuroendocrinology 36 1127-1136.
39.

Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky

PM. (2000) Long-term behavioural and neuroendocrine adaptations to adverse
early experience. Prog Brain Res 20:12281-103.

100

40.

Lengua, L. J., Sadowski, C. A., Friedrich, W. N., & Fisher, J. (2001)

Rationally and empirically derived dimensions of children's symptomatology:
Expert ratings and confirmatory factor analyses of the CBCL. J Cons Clin
Psychol 69:683-698.
41.

Liu Z, Zhu F, Wang G, Xiao Z, Wang H, Tang J, et al. (2006) Association

of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major
depression. Neurosci Lett 404:358-362.
42.

Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5’

nuclease assay. Genet Anal 14:143-149.
43.

Magnano CL, Diamond EJ, Gardner JM (1989) Use of salivary cortisol

measurements in young infants A note of caution. Child Dev 60:1099-1101.
44.

Martin, E.I., Ressler, K.J., Binder, E., Nemeroff, C.B. (2009) The

neurobiology of anxiety disorders: brain imaging, genetics, and
psychoneuroendocrinology. Psychiatr Clin North Am 32:549–575.
45.

McBurnett K, Lahey BB, Rathouz PJ, Loeber R (2000) Low salivary

cortisol and persistent aggression in boys referred for disruptive behaviour. Arch
Gen Psychiatry 57:38–43.
46.

McEwen BS (1998) Stress adaptation, and disease Allostasis and

allostatic load. Ann NY Acad Sci 840:33–44.
47.

McEwen BS, Stellar E (1993) Stress and the individual. Mechanisms

leading to disease. Arch Intern Med 153:2093-101.

101

48.

McEwen BS. (2004) Protection and damage from acute and chronic stress

Allostasis and allostatic overload and relevance to the pathophysiology of
psychiatric disorders. Ann NY Acad Sci 1032:1–7.
49.

Morris RW, Kaplan NL (2002) On the Advantage of Haplotype Analysis in

the Presence of Multiple Disease Susceptibility Alleles. Genet Epidem 23:221–
233
50.

Muglia L, Jacobson L, Dikkes O, Majzoub JA (1995) CRH deficiency

reveals major fetal but not adult glucocortioid need. Nature 373:427-32.
51.

Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM

(2002) Neurobiology of depression. Neuron 34:13-25.
52.

Pahl R, Schäfer H (2010) PERMORY an LD-exploiting permutation test

algorithm for powerful genome-wide association testing. Bioinformatics 26:2093100.
53.

Plotsky PM, Thrivikraman KV, Nemeroff CB, Caldji C, Sharma S, Meaney

MJ. (2005) Long-term consequences of neonatal rearing on central corticotropinreleasing factor systems in adult male rat offspring. Neuropsychopharmacology
30:2192-2204.
54.

Polanczyk G, Caspi A, Williams B, Price TS, Danese A, Sugden K, et al.

(2009) Protective effect of CRHR1 gene variants on the development of adult
depression following childhood maltreatment replication and extension. Arch Gen
Psychiatry 66:978-85.
55.

Purcell S (2007) Plink a tool set for whole-genome association and

population based linkage analyses. Am J Hum Genet 81:559–575.

102

56.

Rao U, Hammen C, Ortiz LR, Chen L, Poland RE (2008) Effects of early

and recent adverse experiences on adrenal response to psychosocial stress in
depressed adolescents. Biol Psychiatry 64:521-526.
57.

Risbrough VB, Stein MB (2006) Role of corticotropin releasing factor in

anxiety disorders A translational research perspective. Horm Behav 50:550-561.
58.

Roy A, Hodgkinson CA, Deluca V, Goldman D, Enoch MA (2012) Two

HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase
the risk for suicidal behaviour. J Psychiatr Res 46:72-79.
59.

Schmidt MV, Deussing JM, Oitzl MS, Ohl F, Levine S, Wurst W, et al.

(2006) Differential disinhibition of the neonatal hypothalamic- pituitary-adrenal
axis in brain-specific CRH receptor 1-knockout mice. Eur J Neurosci 24:2291-8
60.

Schmidt MV, Enthoven L, van der Mark M, Levine S, De Kloet ER, Oitzl

MS (2003) The postnatal development of the hypothalamic pituitary- adrenal axis
in the mouse. Int J Dev Neurosci 21:125–132.
61.

Schmidt MV, Oitzl MS, Muller MB, Ohl F, Wurst W, Holsboer F, et al.

(2003) Regulation of the developing hypothalamic-pituitary-adrenal axis in
corticotropin releasing hormone receptor 1-deficient mice. Neuroscience
119:589–595.
62.

Schwartz EP, Granger DA, Susman EJ, Gunnar MR, Laird B (1998)

Assessing salivary cortisol in studies of child development. Child Dev 69:15031513.
63.

Selye H (1973) The evolution of the stress concept. American Scientist

61:692-699.

103

64.

Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, Ebstein

RP, Kaitz M (2009). BDNF Val66Met polymorphism is associated with HPA axis
reactivity to psychosocial stress characterized by genotype and gender
interactions. Psychoneuroendocrinology 34:382–388.
65.

Shea A, Walsh C, MacMillan H, Steiner M (2005) Child maltreatment and

HPA axis dysregulation Relationship to major depressive disorder and post
traumatic stress disorder in females. Psychoneuroendocrinology 30:162-178.
66.

Smoller J, Rosenbaum J, Biederman J, Kennedy J, Dai D, Racette S, et

al. (2003) Association of a genetic marker at the corticotropin releasing hormone
locus with behavioural inhibition. Biol Psychiatry 54:1376–1381.
67.

Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird

NM, et al. (2005) The Corticotropin-Releasing Hormone Gene and Behavioural
Inhibition in Children at Risk for Panic Disorder. Biol Psychiatry 57:1485–1492
68.

Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL,

Toga AW (2003) Mapping cortical change across the human life span. Nat
Neurosci 6:309–315.
69.

Sumter SR, Bokhorst CL, Miers AC, Van Pelt J, Westenberg PM (2010)

Age and puberty differences in stress responses during a public speaking task do
adolescents grow more sensitive to social evaluation?
Psychoneuroendocrinology 35:1510-6.
70.

Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter

LL. 2009. Interaction of childhood maltreatment with the corticotropin-releasing

104

hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.
Biol Psychiatry 66:681-5.
71.

Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, et al. (2000)

Distribution of RNAs encoding CRF receptors in brain and pituitary of rat and
mouse. J Comp Neurol 428:191–212.
72.

van West D, Del-Favero J, Deboutte D, Van Broeckhoven C, Claes S

(2010) Associations between common arginine vasopressin 1b receptor and
glucocorticoid receptor gene variants and HPA axis responses to psychosocial
stress in a child psychiatric population. Psychiatry Res 179:64-8.
73.

Velez DR, Fortunato SJ, Thorsen P, Lombardi SJ, Williams SM, Menon R

(2008) Preterm birth in Caucasians is associated with coagulation and
inflammation pathway gene variants. PLoS One 3:e3283.
74.

Venihaki M, Majzoub J (2002) Lessons from CRH knockout mice.

Neuropeptides 36:96-102.
75.

Wasserman D, Wasserman J, Rozanov V, Sokolowski M. (2009)

Depression in suicidal males: genetic risk variants in the CRHR1 gene. Genes
Brain Behav 8:72–79.
76.

Weiser MJ, Goel N, Sandau US, Bale TL, Handa RJ (2008). Androgen

regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA
expression and receptor binding in the rat brain. Exp Neurol 214:62-8.
77.

Zhao JH, Curtis D, Sham PC (2000). Model-free analysis and permutation

tests for allelic associations. Hum Hered 50:133-139.

105

Chapter 3 - Catechol-O-Methyltransferase gene (val158met) polymorphisms
and anxious symptoms in early childhood: The roles of hypothalamuspituitary-adrenal axis reactivity and life stress

3.1

Introduction
Catechol-O-methyltransferase (COMT), a catabolic enzyme that degrades

cortical catecholamines including dopamine and epinephrine, plays a vital role in
regulating prefrontal cortex catecholamine levels (Meyer-Lindenberg &
Weinberger, 2006). The gene encoding COMT (Gene ID: 1312) is mapped to
chromosome 22p11, and contains four exons (Brahe et al., 1986). Further, a
non-synonymous G→A single nucleotide polymorphism (rs4680) in exon four
leads to a valine (val) to methionine (met) peptide change in the mature protein,
and is called the val158met polymorphism. This substitution impacts the
thermostability of the COMT protein and reduces the enzyme’s catabolic
function, thereby reducing dopamine degradation in carriers with at least one
copy of the met allele by more than one-third compared to carriers homozygous
for the val allele (Lotta et al. 1995; Chen et al. 2004). Thus, functional differences
in catecholinergic activity due to this genetic variation appear to lead to individual
differences in cortical dopamine availability, which may account for associations
between this gene and various forms of psychopathology (Dickinson & Elvevag,
2009). For example, Hamilton and colleagues (2002) reported an association
between the COMT val158met polymorphism and panic disorder in a familybased sample of 83 parent-offspring triads. Additionally, the val allele has been
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associated with early-onset major depression (Massat et al., 2005), and other
studies have shown that this variant may increase risk for panic disorders and
anxiety in adults (Rothe et al., 2006; Domschke et al., 2007; Hosak, 2007). A
recent study from our group reported associations between the val158met
polymorphism and emerging symptoms of depression and anxiety in two large,
independent community samples of preschoolers (Sheikh et al., 2013).
Specifically, in both samples, val homozygous children exhibited significantly
higher symptoms of depression and anxiety compared to children with at least
one copy of the met allele.
In addition to main effects on the development of symptoms, a few studies
have implicated this gene in gene-environment interactions. For example,
Baumann and colleagues (2013) reported that an interaction between childhood
adversity and the COMT gene locus predicted anxiety sensitivity and anxious
apprehension. Similarly, an interaction between COMT genotype and childhood
trauma predicted risk for psychotic symptoms in adolescents; specifically, val
homozygotes who were also exposed to childhood trauma also reported more
psychotic experiences compared to met allele carriers (Ramsay et al., 2013).
Other studies have linked interactions between the val158met polymorphism and
childhood maltreatment in shaping cognitive performance, neuroticism, and risk
for alcohol dependence (Goldberg et al., 2013; Hoth et al., 2006; Schellekens et
al., 2013). Taken together, recent literature suggests that the val158met
polymorphism may moderate the effect of childhood adversity on a broad
spectrum of psychological outcomes later in life, and could hold etiological
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significance for internalizing disorders. However, research is still lacking on
whether an interaction between COMT genotype and life stress predicts early
symptoms of internalizing disorders.
In addition to gene-environment interactions, a parallel line of research
has also focused on identifying the mechanistic processes (i.e., mediators)
through which COMT functional variance may contribute to maladaptive
outcomes. The hypothalamic–pituitary–adrenal (HPA) axis is widely posited to be
one such mediator of links between neurotransmitter gene function and risk for
future psychopathology (Charney, 2004; Krishnan & Nestler, 2008; McEwen,
1998; Mokrani et al., 1997; Pitchot et al., 2003). Dopaminergic metabolism is
known to regulate endocrine stress reactivity primarily by affecting extrahypothalamic brain structures that regulate HPA axis functioning, such as the
prefrontal cortex, hippocampus and the amygdala (for in depth reviews see
Locatelli et al., 2010; Vermetten & Bremner, 2002). For example, distribution of
dopamine was found to alter HPA axis reactivity in rodents and non-human
primates exposed to early life stressors paradigms such as maternal separation
and glucocorticoid administration (Kofman, 2002; Macri et al., 2009; Posener et
al., 1994, 1999). Additionally, the altered HPA axis functioning was linked to
anhedonia-like symptoms and high anxiety-like traits. Taken together, the extant
literature suggests a link between catecholamine metabolism and HPA axis
function (Moghaddam, 2002), and it is plausible that genetic variations leading to
functional differences within the catecholamine system, such as the COMT
val158met polymorphism, may also be linked to HPA axis reactivity.
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In a complementary line of research, studies have implicated COMT
val158met variation in stress sensitivity. For example, in a community sample of
adults, Jabbi and colleagues (2007) showed that the COMT met/met genotype
was associated with increased adrenocorticotropic hormone responses, although
the authors did not test cortisol function. Similarly, a recent study conducted in a
large community sample of adolescents demonstrated an association between
the COMT val158met polymorphism and cortisol reactivity to stress (Bouma et
al., 2012). However, the link between genotype and stress reactivity was genderspecific, such that boys with the met homozygous genotype had higher cortisol
levels than boys with the val homozygous genotype. Conversely, girls with the
val homozygous genotype had stronger cortisol responses than the met allele
carrier girls (Bouma et al., 2012). Recently, in a sample of 8-year-olds, met
homozygotes were reported to have a higher cortisol response to psychosocial
stress task when compared to heterozygotes and val homozygotes (Armbruster
et al., 2011). A brief review of these studies suggests a link between the COMT
val158met polymorphism and HPA axis function, but the literature is inconsistent
on the allele associated with cortisol reactivity. Considering the importance of
cortisol reactivity in the etiology of various mood disorders (McEwen, 2008),
further research is needed to clarify the link between the val158met
polymorphism and HPA axis response.
In sum, separate lines of research show links between COMT val158met
polymorphism and emotional problems. Literature also suggests that interactions
between the COMT functional polymorphism and early life stressors may predict
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psychological outcomes later in life. Additionally, research suggests that the link
between catecholamine signaling and risk for emerging internalizing symptoms
may be influenced by psychophysiological response of the HPA axis (Bouma et
al., 2012). However, whether these processes are at play during early childhood
and contribute to early symptoms of internalizing disorders has not yet been
explored. To address these gaps in knowledge, we investigated whether the
COMT val158met polymorphism would be associated with cortisol responses to
stress in a community sample of preschoolers. We also explored whether early
cortisol function mediated links between COMT and emerging symptoms. Finally,
in an effort to understand the process through which the gene-environment
interactions may influence early behaviour, we developed an integrated pathway
(Figure 3.1) where we tested the role of these variables on emerging symptoms
using path analysis.
3.2

Methods
Detailed sample demographic are provided in Chapter 2, pg. 42. Sample

demographics by COMT genotype are presented in Table 3.1. Children's mean
age was 36.2 months (SD = 0.16). As in the previous chapter, population
stratification was minimized by restricting all analyses to include Caucasian
participants (N = 371) only.
3.2.1 Genotyping
Genomic DNA was purified from buccal swab cellular extracts and stored
according to manufacturer instructions (Qiagen, Valencia, CA, USA). The rs4680
(val158met) SNP was genotyped using a TaqMan allelic discrimination assay
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(Assay ID: C_25746809_50), developed for use on the StepOne® instrument
(Applied Biosystems, Foster City, California). Polymerase chain reactions were
performed in 10µL reaction volumes in 48-well plates and contained 10 ng of
DNA. Thermal cycler conditions were 95 °C for 10 min and then 40 cycles of 95
°C for 15 s and 60 °C for 1 min. The SDS 2.2 software (Applied Biosystems) was
used for allelic discrimination. For quality control, 10.0% of the samples were
randomly chosen and genotyped as duplicates across and within a 48-well plate.
All genotyping was performed by technicians blind to other study data.
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Figure 3.1. Schematic diagram of the human COMT gene. Exon positions are indicated by solid black blocks and introns
are represented by lines. The location of the rs4680 val158met polymorphism in exon 4 is indicated (adapted from Brahe
et al., 1986).
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3.2.2 Behaviour and childhood stress measures
Similar to Chapter 2, we used the child’s primary caregiver reports on the Child
Behavior Checklist (CBCL; Achenbach, 2000). The stress task used to illicit children’s
cortisol responses to stress was described on page 54. As described in Chapter 2 (p.
58), the overall life stress aggregate score was used as a measure of stress during
childhood in all analyses in this chapter and will be referred to as CS (i.e., childhood
stress).
3.2.3 Data Analyses
To test the hypothesis that COMT val158met genotype moderated the influence
of CS on emerging symptoms of anxiety and depression, I analyzed the interaction
between life stress and genotypes using a macro for PASW developed by Hayes (2013)
with parent reports of children’s anxious and depressive symptoms as the dependent
variables. This macro uses a regression-based framework for testing two-way
interactions in moderation models along with simple slopes. All predictor values were
centered as needed. This same macro was used to test the hypothesis that HPA axis
reactivity mediates the link between COMT genotype and emerging symptoms. This
method uses a bootstrapping procedure which yields mean direct and indirect
(mediated) effects. The test also generates confidence intervals (CIs) for the means.
The estimated effect is only significant at a p-value less than 0.05, when CIs do not
contain a ‘zero’ within them. For further details on this method, see Hayes (2013). All
analyses were performed using the PASW 20 (IBM Inc., USA). All statistical tests were
two-tailed with alpha set at p = 0.05.
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Finally, I tested the integrated pathway in Figure 1.3 using a path analysis
framework using Mplus software. Path analysis is a form of structural equation
modeling, which takes a confirmatory (i.e., hypothesis testing) approach to the
multivariate analysis of a structural model (Byrne, 1998). Using this method, the causal
associations under investigation are represented by a series of structural (i.e.,
regression) equations, and these structural equations are modeled pictorially (Byrne,
1998). The chi-square statistic is used as a measure of fit between the sample
covariance and fitted covariance matrices (Byrne, 1998). The higher the probability
associated with chi-square, the closer the fit between the hypothesized model and
perfect fit. In addition, other indices are used to assess the appropriateness of the
proposed model to the sample data. These indices include the goodness of fit index, the
non-normed fit index, and the comparative fit index. Values for these indices, in the mid
.90 range and above, are indicative of optimal fit (e.g., Hu & Bentler, 1995; Schumaker
& Lomax, 1996). Furthermore, the Root Mean Square of Approximation (RMSEA) is yet
another fit index which takes into account the error of approximation in the population
(Byrne, 1998). Values less than .05 indicate good fit, and values of .08 or less indicate
acceptable fit (Byrne, 1998), whereas values of .08 to .10 indicate mediocre fit, and
values above .10 indicate poor fit (MacCullum, Browne, & Sugawara, 1996).
3.3

Results

3.3.1 Associations between COMT val158met polymorphism and major study variables
The genotype frequencies were as follows: 118 children (29.4%) were val
homozygous, 190 (46.3%) were heterozygous, and 93 (23.2%) children were
homozygous for the met substitution. This distribution was in Hardy-Weinberg
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equilibrium (χ21, 400 = 0.95, p = 0.33). Demographic variables such as child gender and
family income were not associated with child genotype (all ps > 0.22). However, positive
associations existed between child gender and symptoms of depression (F1, 369 = 17.89,
p < 0.01) and anxiety (F1, 369 = 13.50, p = 0.01); therefore, child sex was used a
covariate in subsequent analyses. No associations existed between COMT genotypes
and child gender (χ24, 380 = 1.73, p = 0.23) or family income (F1, 368 =.005, p = 0.94). No
evidence for associations existed between COMT genotype and child depressive
symptoms (mean difference: 0.13, t = 1.22, p = 0.31), but there was a significant
association between COMT genotype and child anxious symptoms (mean difference:
0.25, t = 6.74, p < .05). Specifically, children homozygous for the val allele had
significantly lower symptoms of anxiety when compared to children with at least one
copy of the met allele.
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Table 3.1 Demographic and study variables by child COMT val158met genotype.
COMT genotypes
val/val (N = 113)
val/met + met/met (N = 287)
SD
N
SD
N
Mean
Variable
Mean
Sex (N, boys)
61
134
PPVT
111.94
12.87
112.04
14.59
Family income
3.69
1.19
3.75
1.12
Cortisol response [peak – baseline]*
0.05
0.01
0.03
0.01
†
0.06
AUCi
0.13
0.04
0.09
AUCg
0.20
0.16
0.18
0.12
Depressive symptoms
1.38
1.62
1.25
1.62
Anxious symptoms*
1.40
1.69
1.15
1.29
Note: AUC = area under curve; PPVT = Peabody picture vocabulary test; val = valine; met = methionine. Family income
coded as 1 = < $20,000, 2 = $20,001 – $40000, 3 = $40,001 - $70,000, 4 = $70,001 – $100,000, 5 = >$ 100, 001.
†

p ≤ .10, *p < .05.
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Figure 3.2 shows the analysis of stress reactivity as a function of COMT
genotype. I found significant group differences in individual cortisol change scores [peak
cortisol response – baseline cortisol], such that children homozygous for the val allele
had significantly higher cortisol reactivity compared to the children with at least one
copy of the met allele (F1, 356 = 3.80, p < 0.05). Allelic group differences existed only at
the level of a trend (p = .08) when AUCi was used as the dependent variable. Total
cortisol response (AUCg) was not associated with the COMT genotype (Table 2).

*

baseline to peak change [ug/ul]

0.06
0.05
0.04
0.03
0.02
0.01
N=89

N=273

0
Val-allele

Met-allele
COMT genotype

Figure 3.2. Main effects of COMT val
val158met genotype on child cortisol reactivity. *p
* <
0.05.
met genotype coded as 0 = val/val genotype, 1 = val/met or
Note: Child COMT val158met
met/met genotype; cortisol reactivity was measured via individual
individualized cortisol change
scores [baseline – each child’s peak cortisol sample obtained post-stress
stress task].
task
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3.3.2 HPA axis reactivity mediates the link between COMT val158met polymorphism
and child clinical symptoms
I also conducted mediation analyses to examine whether links between COMT
genotype and emerging symptoms of depression or anxiety were mediated by child
cortisol reactivity. As a precondition for testing mediation, associations must be present
between the predictor and the outcome, the predictor and the hypothesized mediator,
and the hypothesized mediator and the outcome (Baron and Kenny, 1986). Table 3.1
shows the associations between COMT genotype and anxiety symptoms, and COMT
genotype and cortisol reactivity measured via baseline to peak cortisol change. After
confirming the significant association between cortisol reactivity and anxiety symptoms
(r = 0.13, p < 0.01), I proceeded with the mediation analysis. The bootstrapping
procedure showed a significant estimate of the indirect effect of COMT genotype on
anxiety symptoms mediated via child cortisol reactivity (B= -0.06, 95% CI: -0.17 to 0.01). The analysis also showed that the direct association between COMT genotype
and anxiety symptoms was also significant, indicating that the genotype-symptoms link
was only partially mediated by child cortisol reactivity (Figure 3.3).3

3

I also modeled child depressive symptoms as the dependent variable in my mediation pathway

but analysis showed that this model was not significant suggesting that the link between COMT genotype
and depressive symptoms was not mediated by cortisol response to stress.

118

Cortisol
reactivity
-0.08 (0.04)*

0.55 (0.22)**
c’ = -0.10(0.17)*

COMT
val158met

Anxious symptoms
c = -0.04 (0.04)*

Figure 3.3. Cortisol reactivity in early childhood mediates the link between the COMT gene and anxious symptoms. * p <
0.05, ** p < 0.01.
Note: Child COMT val158met genotype coded as 0 = val/val genotype, 1 = val/met or met/met genotype; cortisol reactivity
was measured via cortisol reactivity [baseline – peak cortisol post-stress task]; c = coefficient for direct path between child
COMT genotype and anxious symptoms; c’ = coefficient for path between child COMT genotype and anxious symptoms,
mediated by cortisol reactivity.
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3.3.3 COMT val158met polymorphism and childhood life stress interact to predict
emerging symptoms of anxiety but not depression
In an effort to replicate and extend findings where an interaction between COMT
val158met and CS was associated with adult internalizing symptoms (Ramsey et al.,
2013), I tested this interaction in this sample of preschoolers. The interaction term for
COMT genotype and CS did not predict child depressive symptoms (β = 0.54, se =
1.03, p = 0.73), but the interaction term was significant for child anxiety symptoms (β =
4.38, se = 1.98, p = 0.03). Analyses showed that children homozygous for the val allele
exhibited higher symptoms of anxiety with increasing life stress (β = 3.30, se = 1.14, p <
0.01), but the interaction between genotype and life stress was nonsignificant in the met
allele carriers (β = -1.08, se = 1.62, p = 0.51; Figure 3.4).
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8.0
Val-allele
Met
Met-allele

Childhood stress

7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
-1SD

mean
Anxiety symptoms

+1SD

ren’s anxious
Figure 3.4. Moderation of the main effect of childhood stress on children’s
symptoms by COMT val158met
met genotype. (N = 409).
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3.3.4 Path analyses
Figure 3.5A shows the results of our path analyses, which aimed to test the
integrated model of psychological risk based on Figure 1.3. CS was positively
associated with baseline to peak cortisol change (β = 0.28, p = 0.001), and significant
associations were found between genotype and cortisol response (β = -0.06, p < 0.05).
Child cortisol reactivity was also positively associated with symptoms of anxiety (β =
0.61, p < 0.01). The overall model fit was very good as indexed by chi-square (χ2 =
25.61, df = 7, p < 0.001), as well as the root mean square error of approximation
(RMSEA=.00) and the normed fit index, which was 1.00.
In the next path analysis (Figure 3.5B), we modeled AUCi as an index of total
cortisol produced post-stress task. Analysis showed that CS was positively associated
with AUCi (β = 0.19, p = 0.03), although nonsignificant associations were found between
genotype and this index of cortisol response (i.e., AUCi, β = -0.05, p = 0.30). Child AUCi
was positively correlated with symptoms of anxiety (β = 0.12, p = 0.01). The overall
model fit was very good as indexed by chi-square (χ2 = 20.46, df = 7, p < 0.001), as well
as the root mean square error of approximation (RMSEA=.00) and the normed fit index,
which was 1.00.
In our third model (Figure 3.5C), we modeled AUCg as an index of total cortisol
produced post-stress task. Childhood life stress was positively associated with AUCg (β
= 0.11, p = 0.001) and positive associations were also found between genotype and
cortisol response measured via AUCg (β = -0.04, p < 0.05). Child cortisol reactivity was
also positively correlated with emerging symptoms of anxiety (β = 0.13, p = 0.01). The
overall model fit was very good as indexed by chi-square (χ2 = 23.70, df = 7, p < 0.001),
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as well as the root mean square error of approximation (RMSEA=.00) and the normed
fit index, which was 1.00.4

4

We also modeled parent reports on child depressive symptoms as a dependent variable in our

path analysis. However, the overall fit for these models were poor when baseline to peak cortisol change
(RMSEA = 0.14, fit index = 0.31), AUCi (RMSEA = 0.10, fit index = 0.55) and AUCg (RMSEA = 0.11, fit
index = 0.53) were used in the path analyses.
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A.

Childhood Stress
(CS)
0.37 (.09)***

COMT
val158met

-.06 (0.06)*

0.14 (0.05)**
Cortisol reactivity
[peak – baseline]

Anxious symptoms

-0.22 (0.09)*
COMT x CS
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B.

Childhood stress
(CS)
0.05 (0.09)*

COMT
val158met

-0.04 (0.11)†

Total cortisol
response (AUCi)

0.96 (0.42)*

Anxious symptoms

-0.01 (0.03)
COMT x CS
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C.
Childhood stress
(CS)
0.35 (0.09)***

COMT
val158met

-0.05 (0.05)*

Total cortisol
response (AUCg)

0.10 (0.05)*

Anxious symptoms

-0.22 (0.09)*
COMT x CS

Figure 3.5. Pathway analysis. The path shows interaction between COMT val158met genotype and early life stress as
predictor of child anxious symptoms via baseline to peak cortisol change (A), AUCi (B) and AUCg (C). Child anxious
symptoms are based on parent reports from the Child Behavior Checklist (Achenbach et al., 1991). Standardized βweights are shown for each path. †p ≤ 0.10, *p < 0.05, **p < 0.01, ***p <0.001.
Note: val, valine; met, methionine; AUCg, Area under curve with respect to ground.
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3.4

Discussion
In this study, I examined whether the COMT val158met genotype and CS

were linked to emerging symptoms, and whether cortisol reactivity in children
played a role in this pathway. Based on previous literature linking
neurotransmitter gene polymorphisms and cortisol reactivity to stress (Derijk et
al., 2009; Wust et al., 2009), my first set of analyses examined whether the
COMT val158met genotype predicted early childhood cortisol reactivity to stress.
I found significant associations between the COMT val158met genotype and
cortisol reactivity such that children with two copies of the val allele had
significantly higher cortisol reactivity compared to children with at least one copy
of the met allele. These findings are consistent with previous studies in adults
that have found a link between the val allele and higher cortisol reactivity (Jabbi
et al., 2007; Ramsey et al., 2013). However, a recent study in 8-12-year-olds
found that the met allele was linked to higher cortisol reactivity to the Trier Social
Stress Task or TSST (Armbruster et al., 2012). The inconsistency in findings
could be due to a few reasons. The TSST-C is not only a social stressor but also
a cognitive challenge compared to the stress task used in the current study,
which is based on the social evaluative threat model (e.g., threat of social
rejection and evaluation). Although speculative, it is possible that the nature of
the stressor is differentially related to catecholamine activity. Supporting this
notion, studies have documented that met allele carriers perform better at
cognitive tasks compared to val allele carriers (Dumontheil et al., 2011; Egan et
al., 2001; Mier et al., 2010). However, additional research is needed to clarify
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whether associations between COMT val158met polymorphism differ depending
on stressor paradigms. Also, when compared to previous studies such as
Armbruster and colleagues (2012), additional factors such as the younger age of
this sample and a larger sample size may have contributed towards the
differences in findings.5
In addition to the association between the COMT val158met polymorphism
and cortisol reactivity in children, we also found evidence for mediation of links
between COMT genotype and emerging anxious symptoms by cortisol reactivity.
Extant literature is scarce on findings where HPA axis function is demonstrated
to mediate the link between a dopamine gene functional polymorphism and
emotional problems such as anxiety or depression. A recent study from Burghy
and colleagues (2013) demonstrated that HPA axis function is linked to anxiety
symptoms in adolescents via reduced activation of the amygdala-ventromedial
prefrontal cortex (vmPFC) functional connectivity. Although speculative, its is
possible that increased dopaminergic clearance in val allele carriers may be one
of the causes of reduced amygdala-vmPFC activation, which in turn may lead to
individual differences in evaluation of stress stimuli and HPA axis activation.
I found evidence for a gene-environment interaction, such that COMT
genotype moderated the association between childhood stress on child anxiety

5

Based on previous work by Bouma and colleagues (2012) where girls with the val

homozygous genotype had stronger cortisol responses than the met allele carrier girls, I also
conducted these analyses in my sample based on gender, However, I did not find any
associations between COMT val158met genotype and cortisol response when the sample was
stratified by gender (p = 0.25).
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symptoms. Specifically, my analysis showed that under high levels of life stress,
val allele carriers had significantly more symptoms of anxiety. A number of
studies have reported on interactions between monoaminergic gene variants and
childhood maltreatment as predictors of mood disorders. In a large study of over
5000 participants, significant interaction between COMT gene region haplotypes
(including the val158met polymorphism) and high early CS predicted depressive
symptoms during adulthood (Nyman et al., 2011). Similarly, in a study by Klauke
and colleagues (2012), COMT genotype moderated the effect of childhood
trauma on startle response, which is widely considered an endophenotype for
anxiety disorders. Specifically, the val homozygotes showed a higher increase in
startle response as a function of childhood traumatic events when compared to
the met allele carriers. Additionally, in a study by Kolassa and colleagues (2010),
an interaction between COMT genotype and recent traumatic events predicted
an increased risk for posttraumatic stress disorder but only in val homozygotes.
Thus, our findings are broadly consistent with research implicating the val allele
in anxiety disorder risk.
I did not find evidence for moderation of life stress by the val158met
polymorphism on emerging depressive symptoms. Depressive symptoms are
rare at preschool age and emerge during middle to late childhood (Kovacs,
1996). Therefore, it is possible that any gene-environment effect on depressive
symptoms may emerge in later childhood years when depressive symptoms are
more common. Overall, my findings extend existing literature and show that the
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moderation of CS by COMT genotype contributes to emerging anxiety symptoms
from an early age.
In order to understand the pathways by which COMT val158met genotype,
life stress, and their interaction may be linked to emerging symptoms, and the
possible role cortisol response may play in this pathway, we tested an integrated
model of emerging risk (Figure 3.5). My analyses showed that the COMT
genotype and CS are linked to emerging anxiety symptoms via early age cortisol
response. A few studies have reported on links between the COMT val158met
polymorphism and endophenotypes of anxiety. For example, carriers of the
COMT val allele showed an allele-dose effect on increased left amygdala activity
in response to fearful/angry facial stimuli (Domschke et al., 2012) and amygdala
activity has been linked to increases in neuroendocrine reactivity to stress
(Jankord & Herman, 2008). These findings compliment and extend this literature
and present a biological pathway in which interaction between catecholamine
metabolism and CS is linked to emergence of psychological risk. The path
analysis also demonstrates that the individual differences in neuroendocrine
stress response are an important part of this pathway and the interaction
between genotype and childhood stress contributes to childhood anxious
symptoms via physiological stress response.
In conclusion, I found an important link between life stress during early
childhood and emerging symptoms of anxiety in a community sample of
preschoolers. My findings suggest that functional variant of the COMT gene
moderated the link of life stress on emerging symptoms in early childhood and
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that the components of HPA axis function play a mechanistic role in this pathway.
To my knowledge this is the first study to demonstrate the role of these variables
in a relatively large community sample of young children. Thus, these findings
add to the knowledge of underlying pathways involved in emerging risk for
emotional problems and aid in our understanding of the complex etiology of
mood disorders.
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Chapter 4 - Dopamine pathway gene variants and early-emerging
internalizing symptoms: The roles of childhood stress and
psychophysiological reactivity
4.1

Introduction
As discussed in Chapter 1, dopamine (DA) receptors regulate a number of

neurological processes including cognition, memory, learning, and motor control,
as well as modulation of neuroendocrine signaling (Money & Stanwood, 2013);
thus, individual differences in DA receptor density are potentially relevant to
many psychiatric disorders (Nemoda, Szekely & Sasvari-Szekely, 2011). In
particular, evidence suggests that the limbic DA system may be involved in a
number of stress-related pathologies such as depression and anxiety (Willner,
1991). For example, DA may shape behaviour in the context of "learned
helplessness," a mental state in which an organism forced to endure aversive
stimuli, or stimuli that are painful or otherwise unpleasant, becomes unable or
unwilling to avoid subsequent encounters with those stimuli, even if they are
escapable, presumably because it has learned that it cannot control the situation
(Colelli et al., 2010). Animals trained in the learned helplessness paradigm
commonly exhibit widespread DA depletion in stress-regulating regions such as
the prefrontal cortex, the caudate nucleus, and the nucleus accumbens
compared to control animals (Charney, 2004). Similarly, prior treatment with a
DA agonist prevents the development of learned helplessness and associated
DA depletion in the prefrontal cortex (Boyce-Rustay, Janos & Holmes, 2008;
Colelli et al., 2010). Conversely, DA antagonists exacerbate learned
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helplessness and reduce the improvement produced by antidepressant treatment
(Mozhui et al., 2010).
Behavioural despair, which is often assessed using the forced swim test in
animals, is a model in which animals are forced to swim in a confined space.
After initial attempts to escape they assume an immobile posture. Animals prone
to high behavioural despair (i.e., those which do not attempt to escape or swim)
also show significantly lower levels of DA in the limbic structures of the brain,
regions commonly associated with stress regulation (Touma et al., 2008). Similar
to their effects on behaviour during learned helplessness paradigms,
antidepressants exert an anti-immobility effect whereas DA agonists augment the
anti-immobility effect (Cabib & Puglisi-Allegra, 2012; Orsini et al., 2002). The
most consistent finding in human studies is decreased turnover of DA in patients
with depressive disorders. Homovanillic acid (HVA) is the major metabolite of
DA, and almost all cerebrospinal fluid (CSF) HVA originates from the brain. Thus,
CSF HVA reflects CNS DA turnover. Studies have used probenecid to block the
transport of HVA from the CSF, to increase the validity of CSF HVA as a
measure of CNS DA turnover (Mineur, Belzung & Crusio, 2007). Most studies
have found a decrease in the CSF HVA of patients with depression (Nemeroff &
Dunlop, 2007). In sum, based on animal and human literature there is evidence
for an important role of DA in behaviours commonly related to depression and
anxiety; some of this risk may emerge based on genetic variation that influences
dopaminergic activity in the brain. DA pathway candidate genes commonly
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implicated in cortisol function and psychopathology are discussed in the following
sections.
4.1.1 DRD4
A number of dopaminergic candidate genes have been examined as
candidates for depression and anxiety, although most research has focused on
the major DA receptors and synaptic DA transporter (DRD2, DRD4 & DAT) due
to their widespread expression in brain regions commonly linked to emotion and
cognition. The human DA receptor D4 (DRD4) gene (Figure 4.1), located near
the telomere of chromosome 11p, exhibits an unusual amount of variation,
including single nucleotide polymorphisms (SNPs) and variable number tandem
repeats (VNTR). One of the common DRD4 polymorphism implicated in
psychiatric literature is a 48-bp VNTR in the third exon (Schoots & Van Tol,
2003). The VNTR consists of 2-11 repeats, with the most common versions
being 2 (2R), 4 (4R) and 7 (7R) repeats. Amongst these the 4R allele is the most
common, whereas 2R and 7R allele frequencies vary widely in Caucasians
(Zalsman et al., 2004). The 48-bp VNTR is part of the third cytoplasmic loop of
the receptor protein and molecular genetics studies have shown to affect the
function of the D4 receptor. Specifically, in vitro studies suggest that the 7R
variant exhibits decreased signal transduction efficiency relative to the 4R variant
(Asghari et al., 1995), and may have decreased RNA stability or translational
efficiency (Schoots & Van Tol, 2003). Furthermore, there are robust differences
between receptor variants in folding efficiency when shaping the final protein
product, such that the mRNA transcript of the DRD4 2R allele folds more quickly
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into a protein product than the transcripts of longer alleles, thus increasing DRD4
transmission (van Craenenbroeck et al., 2005). Cumulatively, these effects are
likely to have a significant impact on the signaling and functioning of neural
circuits involved in stress regulation.
Findings of main effects of DRD4 on internalizing problems are less
consistent. One study reported an association between the 2R of DRD4 and
unipolar depression (Leon et al., 2005). However, a recent study reported no
association between the DRD4 VNTR genotype and depression (Kang et al.,
2008) or suicide attempts (Persson et al., 1999; Zalsman et al., 2004). A few
studies have looked at GxE involving the DRD4 VNTR polymorphism and early
adversity predicting cortisol response to stress and internalizing outcomes during
adulthood. For example, Armbruster and colleagues (2011) found that
adolescent carriers of the 7R allele exhibited lower cortisol stress responses in
presence of early adversity such as parental loss. The DRD4 genotype also
moderated associations between stressors during early childhood such as
parental depression and depressive symptoms during adolescence and early
adulthood (Adkins et al., 2012). However, conflicting results were published by
Dragan and colleagues (2009), who reported that participants with at least 1 copy
of the DRD4 7R allele had more intense post-traumatic stress disorder (PTSD)
symptoms. Thus, although a number of studies have looked at the role of DRD4
gene variation and psychopathological outcomes, further research is needed to
clarify which DRD4 variant is associated with psychopathological symptoms.
Additionally, it remains unknown whether DRD4 variants are associated with
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early childhood cortisol response. Finally, whether the environment moderates
genetic influences on these outcomes merits further exploration.
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Figure 4.1. Diagrammatic representation of the human DRD4 gene. Exon positions are indicated by solid black blocks
and introns by lines. The location of the 48bp exon 3 variable number tandem repeat (VNTR) is indicated. The 2
2-repeat to
11-repeat
repeat variants of the VNTR are indicated below exon 3 (Adapted from Van Tol et al., 1992).
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4.1.2 DRD2
The DRD2 gene, first described by Grandy et al. (1989), is on 11q22 (Figure 4.2),
and consists of six exons spanning almost 14kb. The gene has a restriction fragment
length polymorphism downstream of the 3’UTR, called Taq1A (rs1800497) with two
alleles referred to as A1 and A2 (Eisenberg et al., 2007). Using radioactively labeled
agonists to detect D2 ligand binding, autoradiography of the caudate, putamen, and
nucleus accumbens in tissue from normal middle-aged and elderly individuals without
histories of substance abuse, neurological disorders, or psychopathology, it was shown
that one or two A1 alleles was associated with reduced receptor binding throughout the
striatum, with decreases found in the ventral caudate and putamen, brain regions
implicated in emotion regulation. This supports findings from a few studies linking the
Taq1A polymorphism with stress-related mood disorders. For example, a study of
Chinese participants with bipolar disorder reported an association with Taq1A
polymorphism (Li et al., 1999). A European multicenter study (Massat et al., 2002)
reported an association of the (AC)- repeat polymorphism and bipolar, but not unipolar
disorder. Additionally, studies have implicated the DRD2 A1 allele in posttraumatic
stress disorder or PTSD (Comings & Blum, 2000; Noble, 2000). The findings of one
study (Broekman, Olff & Boer, 2007) studied Vietnam veterans who had been exposed
to severe combat conditions. The authors examined the prevalence of the DRD2 TaqI
A1 allele in those who developed PTSD versus veterans without PTSD. The prevalence
of the A1 allele was 60% in those with PTSD compared to 5% in those without PTSD.
These findings were replicated in Caucasians where the frequency of A1 allele was
significantly higher in PTSD combat veterans than controls (Young et al., 2000). In
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addition to PTSD, a recent study has linked the Taq1A polymorphism with major
depressive disorders as well (Savitz et al., 2013). Additionally, research from our group
shows an association between the A1 allele and higher emerging symptoms of
depression and anxiety in preschoolers (Hayden et al., 2010), suggesting a role of this
variant in young children’s symptoms.
In addition to main effects on symptoms, a handful of studies have also examined
gene-environment interaction involving the Taq1A polymorphism. For example, in a
large study of almost 2500 participants, DRD2 Taq1A variants moderated the role of
violent victimization experiences on depression (Vaske et al., 2009). The results
suggest that females who carry the A1 allele of DRD2 may be more vulnerable to the
negative effects of violent victimization than females who do not carry at least one copy
of the A1 allele. Similarly, data from our laboratory shows that the interaction between
Taq1A genotype and early negative parenting, such as parental intrusion, predicted
children’s symptoms of depression and anxiety (Hayden et al., 2010). In sum, literature
suggests that the DRD2 polymorphism could have implications for emerging symptoms
and that this gene may act as moderator of the impact of early stress on negative
outcomes. However, to date no research exists in literature that has examined links
between the DRD2 Taq1A variant and cortisol responses to stress.
Furthermore, a gap in knowledge still remains as to whether this variant also
moderates the effect of normative aspects of early stress, which are much more
common for a majority of children, as compared to extreme forms of stress such as
violent victimization in adults. Exploring these questions is an important addition to
research examining the role of this variant in the etiology of depression and anxiety.
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Figure 4.2. A schematic showing DRD2 gene structure, and physical location of the rs1800497 polymorphism. Exons are
indicated with solid black boxes and connecting black lines indicate introns. White boxes represent the 5’
5’- and 3’ untranslated regions (Adapted from Eubanks et al., 1992)
1992).
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4.1.3 DAT1
The DA transporter (DAT1) gene (Figure 4.3), located on chromosome 5p15.3, is
heavily expressed in the human striatum, where it acts as the primary means of DA reuptake (Sesack et al., 1998). The most studied polymorphism is a 40bp VNTR in the 3’
untranslated region (UTR) of the DAT1 gene (Mitchell et al., 2000). Alleles from 3–13
repeats have been described, but alleles with 9- and 10- repeats are the most frequently
reported (Mitchell et al., 2000). Since this VNTR is not in the coding region of the gene,
it does not affect the protein sequence of the DA transporter. However, it is thought to
have functional significance, with in vitro studies indicating altered expression of the
transporter as a function of VNTR alleles (Fuke et al., 2001; Miller & Madras, 2002),
such that carrying 1 or 2 copies of the 10-repeat (10R) allele is associated with
increased DAT1 expression. In addition, adults who are 10/10 homozygotes have
significantly reduced DA transporter binding in the striatum relative to those having at
least one 9-repeat (9R) allele (Jacobsen et al., 2000). In this way, the DAT1 genotype is
thought to effect DA levels indirectly by altering translational efficiency and the amount
of protein expressed.
Given the central role of DA in the regulation of mood, it is unsurprising that
association studies of DAT1 have linked this gene to various stress-related psychiatric
problems including depression (Dunlop & Nemeroff, 2007). Literature indicates links
between DAT1 30bp VNTR and childhood disorders, such as attention-deficit
hyperactivity disorder/ADHD (Cook et al., 1995; Durston et al., 2008) and conduct
disorder (Lahey et al., 2011). There is also evidence for interactions between this
genotype and psychosocial adversity predicts ADHD (Laucht et al., 2007; Neuman et
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al., 2007). For example, adolescents homozygous for the 10R allele of the DAT1 40bp
VNTR polymorphism who grew up in greater psychosocial adversity exhibited
significantly more inattention and hyperactivity-impulsivity than adolescents with other
genotypes or who lived in less adverse family conditions; a finding recently replicated by
Li and colleagues (2013) in a sample of six- to nine-year-olds. Furthermore, DAT1 has
also been implicated in the etiology of depression and anxiety more generally, with
inconsistencies regarding which genotype confers risk. Some have implicated the 9R
allele rather than the 10R allele as being the risk allele (Lee et al., 2007; Young et al.,
2002), while others have suggested that it is the 10R. Given this pattern of results from
previous studies, I will examine links between the 9R and 10R allele and children’s
cortisol responses and internalizing symptoms.
Based on this brief review, it seems possible that the DA gene variants discussed
in the sections above are linked to both cortisol response and stress-related disorders in
adolescents and adults. However, a gap in knowledge remains concerning whether
links are evident at an early age, which could have implications for early intervention.
Therefore, I examined links between variants in DA candidate gene variants (DRD2,
DRD4, DAT1) and both cortisol reactivity to stress and emerging symptoms of
depression and anxiety in early childhood. Specifically, I examined the following
questions: First, given the role of cortisol reactivity to stress in the etiology of stressrelated mood disorders, I examined links between DA gene variants and children’s
cortisol responses. Second, I examined whether associations existed between DA gene
variants and children’s symptoms of depression and anxiety. Third, given the evidence
for moderation of early adversity by DA genes on physiological stress responses and
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internalizing symptoms, I examined the evidence for gene-environment interaction in
this community sample of preschoolers.
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Figure 4.3. Diagrammatic representation of the human SLC6A3 (DAT1) gene. Exons are indicated by solid black blocks
and introns by lines. The location of the 30bp exon 14 variable number tandem repeat (VNTR) is indicated. The 7
7- to 11repeat variants of the VNTR are indicated by dashed arrows (Vandenberg et al., 1992).
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4.2

Methods
Detailed sample demographic are provided in Chapter 2, pg. 44. Similar to

Chapter 2, I used the child’s primary caregiver reports on the Child Behavior Checklist
(CBCL; Achenbach, 2000). As described in Chapter 2, the overall life stress aggregate
score was used as a measure of life stress in all analyses in this chapter. The AUCi,
baseline to peak cortisol change, and AUCg were used as measures of cortisol
response as previously described in detail on page 57. Finally, population stratification
was minimized by restricting all analyses to include Caucasian participants (N = 371)
only.
4.2.1 Genotyping methods
Participant DNA was extracted as described previously in Chapter 2. The 48base pair VNTR located in the third exon of the DRD4 gene was amplified using a 25 µl
reaction containing 25 ng of genomic DNA template with forward primer 5’CGCGACTACGTGGTCTACTCG-3’ and reverse primer 5’-AGGACCCTCATGGCCTTG3’, and 1 U of NovaTaq polymerase (Novagen, Gibbstown, New Jersey, USA). The
reaction also included 2 mM each of dATP, dCTP and dTTP, 1mM each of dGTP, dITP,
with 10% DMSO and 1X PCR amplification buffer (20 mmol/l Tris-HCL pH 8.4, 50
mmol/L KCL). PCR amplification was carried out in a GeneAmp PCR System 9700 (ABI
Biosystems, Foster City, California, USA). Following an initial denaturation at 95°C for 5
minutes, thirty cycles of amplification were run with each cycle consisting of
denaturation at 95°C for 20 sec, annealing at 54°C for 20 sec, and extension at 72°C for
40 sec, ending with a final extension step of 5 min at 72°C. The PCR amplicons were
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then resolved on a 2% agarose gel, stained with ethidium bromide (Sigma, Oakville,
Ontario, Canada) and documented on the Bio-Rad 1300 Gel documentation system
(Mississauga, ON, Canada). Product sizes were determined against a 100 bp molecular
weight standard (Invitrogen, Carlsbad, California, USA).
The DAT1 exon 3 VNTR was genotyped using the primers: 5'TGTGGTGTAGGGAACGGCCTGAG-3' (forward) and 5'-CTTCCTGGAGGTCACGG
CTCAAGG-3' (reverse). The PCR conditions were as follows: 5 min initial denaturation
at 95 °C and 30 cycles of 30 s initial denaturation at 94 °C, 45 s annealing at 67.5 °C,
45 s extension at 72 °C, followed by 5 min of final extension at 72 °C. The 9R and 10R
products yield a 440 bp and 480 bp fragment, respectively.
For the detection of the polymorphism in the Taq1A site, oligonucleotide primers
5′-CACGGCTGGCCAAGTTGT CTA-3′ (forward) and 5′CACCTTCCTGAGTGTCATCAA-3′ (reverse) were used to amplify a 300-bp region
comprising the Taq1A site (Grandy et al., 1993). The PCR conditions used were initial
denaturation for 5 min at 95°C followed by 30 cycles of 30 s denaturation at 94°C, 30 s
annealing at 58°C, and a 30 s extension at 72°C, followed by a 5 min final extension at
72°C. The 300 bp PCR product was digested overnight with 1U of TaqαI restriction
enzyme (New England BioLabs, Massachusetts, USA).
4.2.2 Data Analysis
To test the hypothesis that DA candidate gene variants moderated the influence
of childhood stress (CS) on emerging symptoms of anxiety and depression, similar to
Chapters 2 and 3 I analyzed the interaction between life stress and genotypes using a
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macro for PASW developed by Hayes (2013) with parent reports of children’s anxious
and depressive symptoms as the dependent variables. This macro uses a regressionbased path analytical framework for estimating direct and indirect effects in simple and
multiple mediator models, along with simple slopes for probing interactions. All predictor
values were centered as needed. Additionally, I once again tested the integrated
pathway in Figure 1.3 using a path analysis framework. Details of the path analysis and
guidelines for model interpretation are provided in Chapter 3, page 120.
4.3

Results
The DRD4 VNTR polymorphism, like other VNTRs, has many possible variants

(Wang et al., 2004), ranging from 2- to 11-repeat copies reported in the literature to
date. In our sample, the following variants were present: 2/2 (N = 10, 2.4%), 2/4 (N =
67,16.3%), 2/5 (N = 1, 0.2%), 2/7 (N = 8, 2.0%), 2/8 (N = 2, .5%), 3/3 (N = 3, .7%), 3/4
(N = 9, 2.2%), 3/5 (N = 7, 1.7%), 3/7 (N = 2, .5%), 3/11 (N = 1, .2%), 4/4 (N = 157,
38.3%), 4/5 (N = 4, 1.0%), 4/7 (N = 96, 23.4%), 4/8 (N = 3, .7%), 5/5 (N =1, .2%), 7/7 (N
= 21, 5.1%), and 7/11 (N = 1, .2%). This distribution is not consistent with HardyWeinberg equilibrium (Pearson X2 (45) = 163.31, p < 0.05), but is comparable to
recently reported frequencies (Ding et al., 2002). Consistent with the majority of
published research (e.g., Faraone et al., 2001; Sheese et al., 2007), groups for data
analysis were formed based on whether children had (N = 128) or did not have (N =
266) a 7R allele.
Although genotypes were successfully obtained for 371 children, for the
purposes of our analyses, six participants with rare variants of the DAT1 were excluded.
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The genotypes of the remaining 365 children were distributed as follows: 177 (48%)
children had the 10/10 genotype, 153 (42%) had the 9/10 genotype, and 35 (10%) had
the 9/9 genotype. This distribution is in Hardy-Weinberg equilibrium, X2 = 0.05, p = 0.82.
For the DRD2 Taq1A polymorphism, 369 children were genotyped successfully and the
distributed as follows: 12 (3.2%) children had the A1A1 genotype, 114 (30.7%) had the
A1A2 genotype, and 243 (65.5%) had the A2A2 genotype. This distribution is in HardyWeinberg equilibrium, X2 = 0.10, p = 0.76.
4.3.1 Main effects
Table 4.1 shows associations between study variables and DA pathway gene
polymorphisms stratified by genotypes. One-way analysis of variance revealed no
associations existed between DA gene polymorphisms and symptoms of anxiety and
depression measured via the CBCL. I also did not find any associations between DA
gene variants and our three indices of cortisol reactivity. The DA gene polymorphisms
were also not associated with either the child’s gender or ethnicity (all ps > 0.21).
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Table 4.1. Study variables stratified by DA pathway gene polymorphism genotypes.
Genotype
DRD2
Variable
Sex (N, boys)

A1A1+A1A2
(N=143)

DRD4

A2A2 (N=260)

<7-repeat
(N=262)

DAT1
9/9 + 9/10
(N=207)

≥7-repeat
(N=136)

10/10 (N=183)

64

134

125

69

98

94

3.67 (1.18)

3.77 (1.12)

3.69 (1.13)

3.80 (1.17)

3.60 (1.16)

3.84 (1.11)

110.35 (15.11)

112.96 (13.45)

112.2 (14.21)

111.70 (13.69)

112.36 (13.68)

111.41 (14.57)

-1.11 (0.35)

-1.08 (0.37)

-1.09 (0.37)

-1.09 (0.36)

-1.11 (0.38)

-1.06 (0.35)

AUCi

0.05 (0.09)

0.05 (0.11)

0.05 (0.09)

0.06 (0.10)

0.05 (0.08)

0.05 (0.12)

AUCg

0.18 (0.13)

0.18 (0.13)

0.18 (0.13)

0.19 (0.15)

0.18 (0.13)

0.18 (0.13)

CBCL Depression

1.35 (1.46)

1.24 (1.62)

1.39 (1.64)

1.16 (1.58)

1.25 (1.42)

1.37 (1.82)

CBCL Anxiety

1.17 (1.27)

1.40 (1.71)

1.36 (1.61)

1.25 (1.50)

1.39 (1.51)

1.26 (1.65)

Family income
PPVT
Baseline to peak
cortisol change

Note: DRD2, DA receptor-D2; DRD4, DA receptor-D4; DAT1, DA Transporter-1; AUCi, Area Under Curve with respect to
baseline; AUCg, Area Under Curve with respect to ground; CBCL, Child Behavior Checklist; Family income was coded as
1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000; 4 = $70,001-$100,000; 5 = > $100,001.
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4.3.2 Moderation analyses
Based on a large body of literature implicating DA pathway genes in geneenvironment interactions, I tested whether DA gene variants moderated the effect of life
stress on symptoms of depression and anxiety. Details for moderation analyses have
been discussed in Chapters 2 & 3.
4.3.2.1

DRD2

Multiple regression analysis showed evidence for moderation of the association
between CS and children’s cortisol responses, measured via AUCi by DRD2 genotype
(β = 0.04, se = 0.21, p = 0.03).6 Analyses showed that children carrying at least one
copy of the A1 allele exhibited higher cortisol reactivity as function of increasing CS (β
= 1.03, se = 0.09, p = 0.001), but for children homozygous for the A2 allele, CS was not
associated with cortisol response (β = -0.03, se = 0.13, p = 0.77; Figure 4.4A).
Similarly, the interaction term predicting AUCg was significant as well (β = 0.04, se =
0.02, p = 0.03). Analyses showed that children carrying at least one copy of the A1
allele exhibited higher AUCg as function of increasing CS (β = 1.05, se = 0.13, p <
0.001), but for children homozygous for the A2 allele, CS was not associated with
cortisol response (β = 0.00, se = 0.18, p = 0.86; Figure 4.4B). There was no evidence

6

Since AUCi and change score analyses yielded virtually identical results, only analyses

predicting AUCi are reported here. However, the interaction term between DRD2 genotype and CS also
predicted cortisol response measured via baseline to peak cortisol change (p = 0.02). As both baseline to
peak cortisol change and AUCi represent the intensity of cortisol response after stress, only one of these
DVs is reported.
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for interaction between DRD2 genotype and CS in predicting children’s symptoms of
depression (β = 0.03, se = 0.27, p = 0.89) or anxiety (β = -0.03, se = 0.26, p = 0.92).
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Figure 4.4. Relationship between childhood stress and AUCi (A) and AUCg (B) by DRD2 Taq1A (rs1870493) allelic
groups.
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4.3.2.2

DRD4

Although I found no main effects of DRD4 genotype on either cortisol response or
emerging anxious and depressive symptoms, based on previous reports of evidence for
GxE involving this genotype (Adkins et al., 2012), I proceeded to conduct interaction
analyses to explore the possibility of GxE in this sample. Using multiple regression
analyses, I examined whether the DRD4 genotype moderated the effect of early stress
on cortisol response. The interaction terms were nonsignificant for AUCi (β = -0.03, se =
0.02, p = 0.08) and AUCg (β = -0.04, se = 0.03, p = 0.10).7 Similarly, in the next set of
analyses, I examined whether the DRD4 genotype moderated the effect of early stress
on emerging symptoms of depression or anxiety. Once again, the interaction term for
DRD4 genotype and CS did not predict child depressive symptoms (β = 0.02, se = 0.28,
p = 0.93) or child anxiety symptoms (β = -0.14, se = 0.27, p = 0.61).
4.3.2.3

DAT1

Once again, multiple regression analyses showed that the interaction between
DAT1 genotype and CS did not predict AUCi (β = 0.00, se = 0.16, p = 0.87) and AUCg
(β = -0.02, se = 0.02, p = 0.42). However, the interaction term for DAT1 genotype and
CS was a significant predictor of children’s depressive symptoms (β = 1.04, se = 0.26, p
< 0.001). Analyses showed that children homozygous for the 10R allele exhibited higher
symptoms of depression as a function of CS (β = 1.29, se = 0.20, p = 0.001). However,

7

The interaction term between DRD4 genotype and CS did not predict cortisol response

measured via baseline to peak cortisol change or internalizing symptoms (all ps > 0.05).
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CS was not associated with childhood depressive symptoms in children who had at
least one copy of the DAT1 9R allele (β = 0.25, se = 0.16, p = 0.13; Figure 4.5A).
Similarly, the interaction between DAT1 genotype and CS also predicted child
anxiety symptoms (β = 0.59, se = 0.26, p = 0.02). Analyses showed that children
homozygous for the 10R allele exhibited higher symptoms of depression with increasing
life stress (β = 0.74, se = 0.20, p < 0.001), but CS was not associated with anxious
symptoms in children with at least one copy of the 9R allele (β = 0.14, se = 0.16, p =
0.36; Figure 4.5B).
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Figure 4.5. Relationship between childhood stress and CBCL depression (A) and CBCL anxiety (B) by DAT1 30bpVNTR
allelic groups.
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4.3.3 Path analyses
In previous sections, I examined associations between DA genetic variants and
children’s cortisol responses to stress. Second, I examined the moderating role of DA
gene polymorphisms on the association between CS and children’s depressive and
anxious symptoms. In the final set of analyses, I examined an integrative model where I
tested the moderating role of cortisol response on the effect DA gene polymorphisms
and CS on emerging symptoms of depression and anxiety in a combined analytical
framework.
Figure 4.6A shows the results of the path analyses. The CS measure was
positively associated with cortisol responses to stress (β = 0.22, p = 0.01), but the
associations between genotype and cortisol were non-significant (β = 0.06, p = 0.21).
Child cortisol reactivity, AUCi, was also positively correlated with emerging symptoms of
anxiety (β = 0.14, p < 0.01). The DRD2-CS interaction path predicting AUCi was also
non-significant (β = -0.04, p = 0.67). The overall model fit was very good (χ2 = 26.28, df
= 7, p < 0.001; root mean square error of approximation [RMSEA]= 0.02; normed fit
index = 0.97 (guidelines for interpreting path analyses are provided on page 118).
Figure 4.6B shows the results of the path analyses. The CS measure was
positively associated with cortisol responses to stress (β = 0.18, p < 0.01), but the
associations between genotype and cortisol were non-significant (β = 0.01 p = 0.87).
Child cortisol reactivity, AUCi, was also positively correlated with emerging symptoms of
anxiety (β = 0.14, p < 0.01). The DRD4-CS interaction path predicting AUCi was also
non-significant (β = -0.04, p = 0.67). The overall model fit was very good (χ2 = 21.25, df
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= 7, p < 0.01; root mean square error of approximation [RMSEA]= 0.00; normed fit index
= 1.00.
Figure 4.6C shows the results of the path analyses. CS was positively associated
with cortisol responses to stress (β = 0.13, p = 0.04), but the associations between
genotype and cortisol were non-significant (β = 0.07 p = 0.25). Child cortisol reactivity,
AUCi, was also positively correlated with emerging symptoms of anxiety (β = 0.14, p <
0.01). The DAT1-CS interaction path predicting AUCi was also non-significant (β = 0.04, p = 0.04). However, the overall model fit was mediocre as indexed by the RMSEA
and normed fit index analyses (χ2 = 28.39, df = 7, p < 0.001; root mean square error of
approximation [RMSEA]= 0.08; normed fit index = 0.65).8

8

Similar to AUCi, I also conducted pathway analyses where AUCg was modeled as an index of

total cortisol produced. The results of these analyses were identical to the models presented in section
4.3.4 (all ps < 0.001). Therefore, these pathways were not included in the main text.
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Figure 4.6. Pathway analysis. The path shows interaction between DRD2 rs1804973 genotype and childhood stress as
predictor of child anxious symptoms via AUCi (A) and AUCg (B). Child anxious symptoms are based on parent reports
from the Child Behavior Checklist (Achenbach et al., 2000). Standardized β-weights are shown for each path. *p < 0.05,
**p < 0.01, ***p <0.001.
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4.4

Discussion
In this chapter, I conducted an analysis of the links between dopaminergic

gene variants, cortisol reactivity and emerging symptoms of depression and
anxiety in preschoolers. In the first set of analyses, I found that the DRD2
rs1800473 SNP was associated with children’s internalizing symptoms. Analyses
did not show associations between this gene variant and either emerging
symptoms of depression and anxiety or cortisol reactivity to stress in
preschoolers. These findings are consistent with a number of studies that have
also reported no associations between DRD2 Taq1A variant and symptoms (Rot,
Mathew & Charney, 2009). However, a few studies have reported positive
associations between DA receptor genes and internalizing problems, including a
previous study from our group that reported an association between the DRD2
genotype and symptoms of depression and anxiety (Hayden et al., 2010; Lucht et
al., 2006). Similarly, there were no associations between the DRD2 genotype
and cortisol reactivity. However, the interaction between the DRD2 Taq1A
polymorphism and CS predicted both cortisol intensity (AUCi) and total cortisol
response over time (AUCg). Specifically, the cortisol response increased as a
function of CS in carriers with at least one copy of the A1 allele, while childhood
stress was not associated with cortisol response in A2 homozygous children. My
findings are the first to report moderation of the association between CS and
cortisol reactivity by this polymorphism.
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There was also evidence for moderation of the association between CS
and symptoms of anxiety and depression by the DAT1 VNTR polymorphism.
Specifically, the 9R allele carriers had increasing symptoms as a function of CS,
whereas no association between CS and symptoms was present in children with
at least one copy of the 10R allele. Previous work from our lab and others has
shown that genetic influences on children’s psychopathology risk may be
moderated by contextual factors (Hayden et al., 2013). Other studies have
reported that interactions between DAT1 and life stress predicted the
development of conduct disorder and attention-deficit hyperactivity disorder in
children (Bidwell et al., 2011; Lahey et al., 2011). Specifically, the children
carriers for the DAT1 9R allele had higher risk as a function of increasing
negative early life contexts such as negative parenting. My findings complement
this literature by showing that interaction between CS and DAT1 genotype may
also contribute to early symptoms of depression and anxiety.
I also conducted path analyses in which I examined the role of DA gene
variants, CS and cortisol reactivity in predicting children’s symptoms of
depression and anxiety. Analyses showed that the path models were only
significant for anxiety as an outcome. To my knowledge, no research in literature
to date has explored these variables in a path analysis framework, although
some research has linked contextual risk exposure to differential DA secretion in
brain’s limbic regions. Specifically, excessive mesocortical DA released upon
exposure to varying levels of stressful life events (such as childhood
maltreatment) may increase vulnerability to depression through an inhibition of
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subcortical DA transmission (Ventura et al., 2002; Cabib et al., 2002). While
directly establishing that regional DA levels are different in children exposed
varying levels of stress is not possible, the analyses in this chapter point to a
positive link between functional DA gene polymorphisms, levels of CS and
emerging symptoms of anxiety.
Taken together, the analyses presented in this chapter suggest that the
DRD2 and DAT1 gene polymorphisms contribute to emerging risk for anxiety in
young children. However, there were no associations between DRD4 VNTR and
cortisol reactivity and emerging symptoms of depression and anxiety. Current
GxE research involving the DRD4 gene polymorphism suggests that adults with
the 7R allele are more likely to be affected by life stress than are those with
carriers of less than 7R allele. Additionally, a large amount of GxE literature
involving DRD4 comes from cohorts suffering from substance abuse disorders
where carriers the 2R and 4R allele did not relapse back to drug use when they
experienced high levels of life stress when compared to 7R carriers, suggesting
some implication for this gene in stress resilience. Due to the role of DA circuits
in reward processing in the brain, it is plausible to assume that some of the DA
receptor polymorphisms may be linked to individual differences towards stress
contexts. However, future research should examine the role of the DRD4
polymorphism in contextual processes at various levels of analysis (family, peer,
school, or neighborhood) over middle and late childhood.
Some limitations of the research in this chapter should be noted. Only one
genetic polymorphism for each gene was examined; this does not represent all of
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the genetic variation important to shaping cortisol reactivity or emerging
symptoms. As discussed previously, many genetic variants may alter risk, the
expression of which may emerge only under particular contextual conditions.
These limitations notwithstanding, the present chapter offers several novel points
for stress research and examines common DA pathway candidate genes
implicated in adult psychopathology. Analyses suggest that DA gene
polymorphisms contribute to early childhood development and likely contribute to
future behaviour outcomes.
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Chapter 5 - The serotonin candidate genes and emerging symptoms of
psychopathology: The roles of cortisol reactivity and childhood stress
Along with the dopamine pathway, the serotonin pathway has been widely
implicated in shaping early neurodevelopment. Among the multiple
neurochemical processes involved, reduced brain serotonin (5-HT) seems to be
feature of depression and anxiety (Van Praag, 2004). Although there are
questions about the exact role of 5-HT in the onset and course of depression, 5HT dysfunction is commonly found in depressed patients as captured by lower
brain availability of tryptophan and 5-hydroxytryptophan (Agren & Reibring, 1994;
Maes et al, 1990). Specifically, impaired reuptake and degradation in the
synapse have been implicated in stress-related mood disorders such as
depression (Arango et al. 2002; Markus & Firk, 2011; Malison et al, 1998;
Sargent et al, 2000) and antidepressant drugs act by improving brain 5-HT
function (van Praag, 2004). Candidate genes with functional effects on the 5-HT
reuptake and its degradation, and their links to the stress response, are
discussed in the following sections.
5.1.1 5-Hydroxytryptophan transporter (SLC6A4) gene polymorphism
Probably the most widely-studied and controversial candidate genes for
depression is the serotonin transporter gene (5-HTT). The 5-HTT (SLC6A4) gene
spans 31kb and contains 14 exons (Lesch et al., 1994). A common functional
polymorphism has been described in the promoter region this gene known as the
5-HTTLPR (Figure 5.1). Variants of the 5-HTTLPR consist of a long (L) allele,
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comprised of 16 copies of an approximately 22 base pair (bp) repeat unit, and a
short (S) allele, consisting of 14 copies (for a review, see Hariri & Holmes, 2006).
Compared to the L allele, the S allele is associated with decreased transcriptional
efficiency of the promoter (Lesch et al., 1994). Reduced density of the 5-HT
transporter has been found in subjects with depression and in the postmortem
brain tissue of suicide victims (Arango et al. 2002, Drevets et al., 1992). In
addition to associations between 5-HTTLPR and psychopathology, a large body
of research suggests that the 5-HTTLPR moderates the effects of adverse life
experiences on the probability and severity of a diverse array of mental health
related conditions and constructs, including depression (Taylor et al., 2006;
Caspi et al., 2003), suicide (Roy et al., 2007; Retz et al., 2008) and anxiety
(Gunthert et al., 2007; Stein et al., 2007). Across these diverse stress-related
psychological disorders, the majority of studies associate the 5-HTTLPR S-allele,
and particularly the S/S genotype, with greater psychological sensitivity to stress
(Uher et al., 2007). However, there is variability in the success of replicating such
findings as some meta-analysis studies have found no evidence that the 5HTTLPR genotype alone or in interaction with stressful life events is associated
with elevated depression risk (Risch et al., 2009). However, these meta-analyses
have been criticized on the grounds that they are heavily influenced by large
studies that typically have the poorest measurement of life events (i.e., self-report
checklists) and, as a consequence, are poorly equipped to detect conditional
effects of the environment (Caspi et al., 2010; Karg et al., 2011). However, it is
also possible that the 5-HTTLPR may be more closely associated with the
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regulation of the hypothalamic-pituitary-adrenal (HPA) axis response to stress
than it is with specific psychological states that are influenced by stress (Markus
& Firk, 2011). Thus, the cortisol response to stressful life events may represent
an intermediate phenotype between the 5-HTTLPR and psychological disorder.
Literature shows that serotonin fibers activate the hypothalamic CRH neurons
(Heisler et al., 2007; Liposits, Phelix & Paul, 1987) that initiate the hormonal
cascade leading to cortisol release. The S/S genotype of the 5-HTTLPR is
associated with greater cortisol reactivity to psychosocial stress in adults (Way &
Taylor, 2010). Additionally, a study by Wust and colleagues (2009) linked this
polymorphism to basal cortisol secretion over the course of the day, showing a
link between HPA axis function and this gene. However, two recent independent
studies in adults have failed to find positive associations between this
polymorphism and cortisol reactivity in adults (Markus & Firk, 2009; Vinberg et
al., 2010). Taken together, the present literature suggests a need for further
research to ascertain the relationship between this polymorphism and cortisol
responses to stress, as well as links to emerging symptoms of depression and
anxiety.
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Figure 5.1. Diagrammatic representation of the human SLC6A4 (5-HTT) gene. Exons are indicated by solid black blocks
and introns by lines. The location of the 44bp promoter region variable number tandem repeat (VNTR) are indicated. The
16-repeats (Long) and 14-repeats (Short) variants of the VNTR are indicated by dashed arrows (Adapted from Lesch et
al., 1996).
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5.1.2 Monoamine Oxidase-A
Along with the 5-HTTLPR and its possible role in the etiology of mood disorders,
the MAOA enzyme also regulates availability of serotonin in the synaptic cleft and
therefore regulates serotonergic tone in response to external stimuli (Jacob et al.,
2005). MAOA is an enzyme involved in the metabolism of biological amines, including
the monoaminergic neurotransmitters serotonin and norepinephrine (Jacob et al., 2005).
MAO contributes to controlling amine availability by oxidative deamination of neuronal
serotonin (Shih et al., 1999). MAOA enzyme expression is dependent on the MAOA
gene (Gene ID: 4128), which is located on chromosome Xp11.3 and contains 16 exons,
spanning 60 kilobases (Figure 5.2). A naturally occurring sequence polymorphism exists
in the MAOA promoter region with functional effects on MAOA transcription. This VNTR
polymorphism consists of 30-bp repeat elements with 3, 3.5, 4, 5 or 6 copies (Sabol et
al., 1998). Relative to the longer alleles, the 3-repeat allele results in a significantly
decreased expression of MAOA gene, and is therefore commonly referred to as the low
activity variant compared to the longer or high activity alleles (Deckert et al., 1999). The
latter allelic variant also results in higher cerebrospinal fluid (CSF) homovanillic acid
levels, a byproduct of catecholamine catabolysis, indicating functional effects of this
polymorphism in humans (Zalsman et al, 2005). As the MAOA gene is X linked, males
(XY) carry only a single copy of the MAOA allele, whereas females (XX) carry two, one
of which is subject to random X-chromosome inactivation in the cell. Thus, high activity
boys have a single long or “high activity” allele, whereas girls must have the high/high
genotype in order to be unequivocally established as having the high activity allele for
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the purposes of research, as one copy will be randomly inactivated due to X-linked
inactivation (Deckert et al., 1999).
Given the functional nature of MAOA VNTR and its effect on serotonin signaling
(or serotonergic tone) in the brain, it is plausible that this polymorphism may be linked to
individual differences in cortisol response to stress. Only a single study so far has
examined associations between the MAOA VNTR polymorphism and cortisol reactivity,
and found a positive association between the low activity MAOA allele and elevated
cortisol reactivity to psychosocial stress task (Bouma et al., 2012). In addition to this
recent study, a few studies have also examined the main effects of MAOA genotype on
stress-related disorders such as depression and anxiety, but the findings in this
literature have been mixed. Some have found positive links between the MAOA VNTR
polymorphism and anxiety (Gutierrez et al., 2004; Tochigi et al., 2006) but others have
failed to replicate such findings (Arbelle et al., 2003; Eley et al., 2003; Jacob et al.,
2005; Syaglio et al., 2001), suggesting a need for further work to clarify the link between
this polymorphism and anxiety. There are similar mixed results for associations with
depression, with depression associated with MAOA VNTR in some studies (Tochigi et
al., 2006) and not in others (Gutierrez et al., 2004).
In addition to main effects, this gene has been implicated in GxE. For example,
GxE has been found for MAOA and adversity (Prom-Wormley et al., 2009), life trauma
(Frazzetto et al., 2007), and childhood maltreatment (Taylor & Kim-Cohen, 2007) in
predicting both internalizing and externalizing outcomes. More complex interactions
have also been noted, with high MAOA activity buffering the effects of early adversity on
later antisocial behaviour in Caucasian participants (Widom & Brzustowicz, 2006).
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Similarly, Cicchetti and colleagues (2007) found that depressive symptoms were
elevated in maltreated children only if they had the low-activity MAOA variant. These
findings were also replicated in adults by Kinnally and colleagues (2009), who reported
that adults having lower activity MAOA and exposed to early family stressors showed
higher impulsivity/aggression than girls with good parental care. Other data (Kim-Cohen
et al., 2006) indicate that adolescents with the low MAOA activity allele who were
exposed to physical abuse had more mental health problems. Taken together, these
studies suggest that MAOA plays a role in moderating the effects of the early
environment on psychopathology.
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Figure 5.2. Diagrammatic representation of the human MAOA gene. Exons are indicated by solid black blocks and introns
by lines. The location of the 30bp promoter region variable number tandem repeat (VNTR) are indicated. The approximate
location of 3-5 repeats VNTR is indicated by dashed arrows (Adapted from Sabol et al., 1998).
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In addition to gene-environment interaction in influencing symptoms of
depression and anxiety, a limited literature has also examined the effect of interaction
between MAOA and 5-HTTLPR gene polymorphisms (gene-gene interaction; GxG) on
symptoms of anxiety and depression. For example, interactions between MAOA VNTR
and 5-HTTLPR have been linked to cognitive performance in a large, population-based
sample of 6000 children (Barnett et al., 2011). Specifically, an epistatic interaction
between the two loci was associated with better working memory in children with the
long alleles of both MAOA and SLC6A4 genes. However, studies to date have not
reported epistasis between the MAOA and 5-HTTLPR loci in predicting risk for
psychopathology in humans. In additions to GxG, a report by Eley and colleagues
(2004) reported that the interaction between MAOA and 5-HTTLPR moderated the
effect of life stress on anxious and depressive symptoms. Specifically, adults
homozygous for the low activity alleles of MAOA and 5-HTTLPR VNTR polymorphisms
interacted with low socio-economic status to predict higher number of anxious and
depressive symptoms. Taken together, this limited literature suggests GxG are linked to
emotional problems in adults. However, whether GxG predicts emerging symptoms of
depression or anxiety remains unexplored.
In sum, the aim of this chapter is to explore main effects of 5-HTTLPR and
MAOA polymorphisms on children’s cortisol responses to stress and emerging
symptoms of depression and anxiety. Based on research reporting positive associations
between cortisol function and 5-HTTLPR and MAOA genes (Bouma et al., 2012; Way &
Taylor, 2010), and the possible role of cortisol reactivity as a vulnerability marker for
later psychopathology, I examined these links in a community sample of preschoolers.
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Second, based on previous evidence for moderation of early environment risk contexts
by serotonin genes on symptoms of internalizing psychopathology risk, I predicted that
these links would also exist at an early age as well. The final set of analyses in this
chapter would aim to examine and extend the evidence for epistasis as moderator of
childhood stress (CS) on cortisol response and emerging symptoms.
5.2

Methods
Participant DNA was extracted as described previously in chapter 2. Also, as

described in Chapters 2 and 3, parent reports on the Child Behavior Checklist
(Achenbach et al., 2000) were used to ascertain levels of depression and anxiety. AUCi,
baseline to cortisol change, and AUCg were used as measures of cortisol response as
previously described in detail on page 54. Finally, details of the CS variable are detailed
in Chapter 2 as well.
5.5.1 Genotyping
The 5-HTTLPR polymorphisms were assayed using methods described by
Chorbov et al. (2007). Briefly, the forward primer was 5GGCGTTGCCGCTCTGAATGC-3’, and the reverse primer was 5GAGGGACTGAGCTGGACAACCAC-3, which yielded 486-bp (short) and 529-bp (long)
amplicons. Polymerase chain reaction (PCR) was performed in a total volume of 25µl,
containing 100 ng of DNA, 160 nM of each primer, 1mM Tris-HCL (pH 8.3), 5mM KCl,
1.5 mM MgCl2, 2% DMSO (v/v), 2.5 U AmpliTaq Gold DNA polymerase (Applied
Biosystems, Foster City, CA), 200 µM of dATP, dCTP, dTTP, and 100 µM of dGTP, and
7-deaza-2-dGTP. After an initial denaturation at 94°C for 5 min, 35 cycles of
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denaturation (94°C for 30 sec), annealing (63°C for 30 sec), and extension (72°C for 1
min) was performed followed by a final extension at 72°C for 20 min. Amplicons were
separated on 6% polyacrylamide gels, visualized using SYBR-Green and documented
using the Bio-Rad 2000 gel documentation system (Bio-Rad Laboratories, Mississauga,
ON, Canada).
MAOA promoter VNTR was amplified using the primer sequences forward 5’CCCAGGCTGCTCCAGAAACATG-3’ and reverse 5’GTTCGGGACCTGGGCAGTTGTG-3’. Conditions used for amplification were one cycle
at 94°C for 5 min followed by 30 cycles of 94°C for 15 s, 60°C for 15 s, 72°C for 30s,
and a final 7 min extension at 72°C (Sabol et al., 1998). To improve reaction fidelity, we
used the Invitrogen PCRx Enhancer (Invitrogen, Carlsbad, CA, USA) as an adjuvant in
PCR amplifications. Amplicons were separated on 6% polyacrylamide gels, visualized
using SYBR-Green and documented using the Bio-Rad 2000 gel documentation system
(Bio-Rad Laboratories, Mississauga, ON, Canada).
5.3

Results
5.3.1 Main effects
In this sample, 119 children (32.1%) were homozygous for the long (L) allele of

the 5-HTTLPR, 171 (46.1%) were heterozygous, and 76 (20.5%) were homozygous for
the short (S) allele. I was unable to genotype five children due to non-specificity of PCR
amplification. This distribution is in Hardy-Weinberg equilibrium, χ2 = 0.31, p > 0.52.
Analysis of variance was used to test the associations between genotype and study
variables including cortisol response and behaviour measures (Table 5.1). The 5-
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HTTLPR
TLPR polymorphism was not associated with child gender ((χ2 = 4.78, p > 0.09) or
family income (χ2 = 41.25, p = 0.59). I found a main effect of the 5-HTTLPR
TLPR
polymorphism on emerging anxiety symptoms such that children with at least one copy
of the S-allele
allele had higher symptoms of anxiety compared to their L
L-allele
allele counterparts
co
(t
(365)= 2.14, p = 0.03).

*

1.60
1.40

CBCL anxious symptoms

1.20
1.00
0.80
0.60
0.40
0.20

N=119

N=247

0.00
SS/SL

LL
SLC6A4 (5HTTLPR)
genotype

Figure 5.3. Relationship between the 5HTTLPR 44bp VNTR polymorphism and
symptoms of anxiety in preschoolers (N=366).
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Table 5.1. Demographic and study variables by child 5-HTTLPR 44bp VNTR genotype.

5-HTTLPR genotype
s/s + s/l
(short allele)
(N=241)
Variable

M

l/l
(long allele)
(N=114)
SD

Sex (N, boys)

N

M

SD

N

114

69

Family income

3.80

1.05

3.70

1.2

PPVT

112.19

13.80

111.22

Baseline to peak change

-1.10

0.35

-1.06

0.36

AUCi

0.05

0.10

0.05

0.08

AUCg

0.17

0.12

0.18

0.12

CBCL Depression

1.36

1.62

1.22

1.48

CBCL Anxiety*

1.32

1.09

1.00

1.33

14.89

Note: PPVT = Peabody Picture Vocabulary Test; Family income coded as 1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000;
4 = $70,001-$100,000; 5 = > $100,001; AUCi, Area Under Curve with respect to increase; AUCg, Area Under Curve with respect to
ground; CBCL, Child Behavior Checklist.

* p < 0.05 †p < 0.10.
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I was unable to genotype three children for the MAOA polymorphism due to lack
of PCR amplification. For boys, the MAOA hemizygous frequencies were: 3R (N = 74,
19.8%), 3.5R (N = 8, 2.2%), 4R (N = 101, 27.2%) and 5R (N = 4, 1.1%). MAOA
genotypes in girls were, 3/3 (N = 54, 13.7%), 3.5/4 (N = 1, 0.3%), 3/4 (N = 52, 14.0%),
3/5 (N = 4, 1.1%), 4/4 (N = 65, 17.5%) and 4/5 (N = 5, 1.1%). This distribution is not in
Hardy-Weinberg equilibrium (Pearson X2 (38) = 91.02, p < 0.05), but is comparable to
recently reported frequencies (Sabol et al., 1998). Consistent with the majority of
published research (e.g., Zalsman et al., 2005; Ducci et al., 2006), groups for data
analysis were formed based on whether children had 3R polymorphism (N = 183) or did
not have (N = 185) a 3R allele. Following previous studies (Zalsman et al., 2005),
heterozygous females (N = 62) were excluded from analyses, as it is not possible to
know which X-chromosome escaped inactivation. Furthermore, four boys homozygous
for the MAOA 5R allele were excluded from analyses as the literature is unclear with
respect to functionality of the translated protein associated with this allele. This meant
that the final sample size available for analyses in the chapter was 301.
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Table 5.2. Demographic and study variables by child MAOA 30bp VNTR repeat status.

Child MAOA genotypes
3-repeats (N = 131)
Variable

M

SD

Sex (N, boys)

≥ 3.5 repeats (N = 171)
N

M

SD

N

80

Family income

3.73

1.11

PPVT

113.11

15.46

Baseline to peak change

-1.12

AUCi

100
3.8

1.11

111.01

13.03

0.38

-1.07

0.35

0.05

0.08

0.05

0.10

AUCg

0.18

0.13

0.18

0.13

CBCL Depressive symptoms

1.19

1.45

1.25

1.48

CBCL Anxious symptoms

1.14

1.27

1.22

1.46

Note: PPVT = Peabody Picture Vocabulary Test; Family income coded as 1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000;
4 = $70,001-$100,000; 5 = > $100,001; AUCi, Area Under Curve with respect to baseline; AUCg, Area Under Curve with respect to
ground; CBCL, Child Behavior Checklist; ODD, Oppositional Defiance Disorder; ADHD, Attention-Deficit Hyperactivity Disorder.
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5.3.2

Moderation analyses
5.3.2.1

5-HTTLPR

Using multiple regression, in my next set of analyses I examined whether GxE
predicted children’s cortisol response and symptoms of depression and anxiety.
Analyses showed no evidence for moderation of CS by 5-HTTLPR in predicting any
index of cortisol reactivity or symptoms of depression and anxiety. More specifically, the
interaction between CS and 5-HTTLPR did not predict baseline to peak cortisol change
(β = -.03, se = 0.05, p = 0.58), AUCi (β = 0.01, se = 0.02, p = 0.77) or AUCg (β = -0.01,
se = 0.03, p = 0.59). Similarly, there was no evidence for moderation by 5HTTLPR of
CS association with emerging symptoms of depression (β = 0.03, se = 0.26, p = 0.88)
and anxiety (β = 0.40, se = 0.30, p = 0.18).
5.3.2.2

MAOA

Similarly, I conducted GxE analysis with MAOA as a moderator variable.
Regression analyses showed that the interaction between MAOA and CS did not predict
individual baseline to peak cortisol change (β = 0.02, se = 0.05, p = 0.56), AUCi (β =
0.01, se = 0.02, p = 0.72) or AUCg (β = 0.01, se = 0.02, p = 0.61). However, analyses
showed significant moderation of CS by MAOA genotype on child anxious symptoms (β
= 0.77, se = 0.27, p = 0.004). Further analysis showed that children without the 3-repeat
allele exhibited higher anxiety symptoms as a function of increasing CS (β = 0.63, se =
0.17, p = 0.001), but CS was not associated with symptoms of anxiety in children with
the 3-repeat allele (β = -0.14, se = 0.20, p = 0.50; Figure 5.4). I did not find evidence of
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moderation of CS by MAOA when child depressive symptoms were the dependent
variable (β = 0.08, se = 0.28, p = 0.79).

3.50

CBCL Anxious symptoms

3.00
2.50
Long allele
Short allele

2.00
1.50
1.00
0.50
0.00
1SD
-1SD

mean

+1SD

Childhood stress

Figure 5.4. Relationship between childhood stress and child anxious symptoms by
MAOA 3-repeat (short allele) status
status.
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5.3.3 Gene-Gene interactions
Previous literature has also implicated an interactive effect of the 5HTTLPR VNTR and MAOA VNTR on developmental risk for psychopathology
(Barnett et al., 2011; Roiser et al., 2007). Therefore, I also investigated whether
such a gene-gene interaction (GxG) also predicted symptoms of depression and
anxiety in preschoolers. Analysis showed that the GxG terms were nonsignificant
and did predict either cortisol response or emerging risk for internalizing
problems (all ps > 0.16; figure not presented).
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5.4

Discussion
The aim of this chapter was to examine links between serotogenic gene

functional polymorphisms and symptoms of depression and anxiety in
preschoolers. The first finding was a positive association between the 5-HTTLPR
polymorphism and child anxious symptoms. Specifically, children with at least
one copy of the S-allele had higher levels of anxiety than children homozygous
for the L-allele. This finding extends and compliments extant literature linking this
polymorphism and internalizing symptoms. For example, literature has reported
that the S-allele of the 5-HTTLPR was associated with anxiety traits (Katsuragi et
al., 1999; Lesch et al., 1996; Ohara et al., 1998; Gonda et al., 2007) and with
anxiety-related personality traits such as neuroticism and impulsivity (Gorwood,
2004; Sen et al., 2004). The presence of associations between emerging anxiety
symptoms in three-year-olds and this polymorphism is a novel finding and
suggests a possible role of this variant in the early development of anxiety
vulnerability. Along with anxiety traits, research has also linked this
polymorphism with depression in adults (Arya et al., 2009), but such associations
did not exist in this sample. The lack of associations could be due to a few
possibilities including the young age and the non-clinical nature of this sample.
As discussed in Chapter 3 and 4, depressive symptoms are rare during
preschool years; it is possible that associations between this gene and
depressive symptoms may emerge later when such symptoms are more
common and variable across children. A number of prior studies have detected
an interaction between 5-HTTLPR and stressful life experiences such as

201

childhood abuse (Caspi et al. 2003; Araya et al., 2009) in predicting depressive
symptoms. However, I did not find evidence for such an interaction in this
sample. As discussed in earlier chapters, the lack of an extreme stressor context
could be one of the reasons for the lack of replication in this sample (see this
discussion in Chapter 4). Additionally, a reason for the failure to find a significant
association between 5-HTTLPR and emerging symptoms (and cortisol reactivity)
may reflect insufficient power to detect such associations.
In addition to 5HTTLPR polymorphism, previous research on GxE in
adults has implicated the MAOA 30bp VNTR in moderating the effect of
childhood maltreatment on psychiatric symptoms (Kraft et al., 2006; Wendland et
al., 2006); therefore, I tested this model in the current sample. My analyses
complemented this earlier literature in adults by showing that the interaction
between MAOA genotype and CS predicts children’s anxious symptoms. In
addition to anxiety problems, previous GxE studies in literature have linked
MAOA VNTR polymorphism with other psychiatric phenotypes in the presence of
early adversity. For example, in their seminal work, Caspi et al. (2002) found that
individuals possessing the 3-repeat genotype of MAOA showed increased risk for
antisocial behaviour, but only if they had experienced an adverse early
environment. Other studies have found similar interactions between MAOA gene
polymorphism and early maltreatment for behaviours reflecting conduct disorder
(Foley et al., 2004), antisocial behaviour (Kim-Cohen et al., 2006), antisocial
alcoholism (Ducci et al., 2007), and physical aggression (Frazzetto et al., 2007).
These findings add to this literature by showing the moderation of symptoms by
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MAOA VNTR genotype in the presence of more subtle forms of life stress. As
most research has reported the moderation effect of this genotype on extreme
forms of adverse experience (such as physical and sexual abuse), the findings in
this chapter suggests that this variant may moderate a broad contexts of early life
stressors, and is a novel finding in literature with implications on early childhood
development.
In my final set of analyses, I looked at the effect of MAOA and SLC6A4 (5HTTLPR) on either cortisol response or emerging symptoms at preschool age
and found no evidence for GxG. My analyses did not support literature from
previous adult studies, which reported that GxG predicted symptoms of
psychopathology (Roiser et al., 2007). However, my findings are in line with
literature from young samples such as adolescents, which show that the
interaction between MAOA and 5HTTLPR variants did not predict symptoms of
anxiety (Armbruster et al., 2011). Although speculative, these findings suggest
that the interaction between these two variants may be evident at a later age
rather than in early childhood.
In sum, I present evidence that functional polymorphisms in 5-HTTLPR
and MAOA, two gene involved in the functional deactivation of serotonin, are
linked to emerging symptoms of anxiety in young children. While neither gene
has been unquestionably linked to psychiatric symptoms, the data in this chapter
suggests that serotonergic polymorphisms linked to normal variation in brain
function are at play in influencing early-emerging symptoms of depression and
anxiety in the presence of life stress. The lack of links between these genes and
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cortisol reactivity suggests that such links may possible be influenced by other
hormone and/or components of the HPA axis pathway or more evident at a later
age.
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Chapter 6 - Discussion
The current thesis is an examination of genetic markers of children’s
cortisol responses to stress and their possible role in contributing to emerging
internalizing disorder symptoms. The implications of my findings for our
understanding of the biological and environmental bases of children’s
internalizing disorders risk are discussed in the following sections.
6.1

Context of study findings

6.1.1 Chapter 2 – The CRH system genes
Chapter 2 expanded on the hypothesis that variation of the CRH system
genes would be linked to individual differences in cortisol responses to stress.
Specifically, single nucleotide polymorphisms (SNPs) spanning the coding and
regulatory regions of CRH, CRHR1 and CRHBP genes were examined. I
identified significant main effects of gene variants of CRHR1 and CRHBP coding
regions on childhood cortisol reactivity. In addition to main effects, I identified
GxE with multiple individual SNPs, as well as with common variants of the
CRHR1 and CRHBP locus, that were associated with children’s internalizing
symptoms in the presence of stress (Figures 2.7 & 2.9). The associations
between SNPs of the CRHR1 and CRHBP coding region and cortisol reactivity
are the first reported in the literature. Additionally, the GxEs I found are an
extension of previous work suggesting that CRH system gene variant SNPs
moderate the effect of early adversity on future psychopathology (Bradley et al.,
2008). The SNP variants involved in these studies were the same as those
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described previously in two separate studies by Bradley and colleagues (2008)
and Polanczyk and colleagues (2009). However, the stress contexts in the
present study and previous studies by Bradley and colleagues (2008) were
different. Specifically, the CS variable used in this study included family income,
dyadic adjustment and family stressors such as illness, job loss, etc. over the
past 12 months, and were in some cases less extreme forms of stress than those
typically examined in the field. For example, Bradley and colleagues (2008)
examined severe or extreme forms of stressors such as physical and sexual
abuse. Taken together, findings in Chapter 2 and previous findings (Bradley et
al., 2008; Cicchetti et al., 2009; Heim et al., 2009; Polancyzk et al., 2009)
suggest that the CRH gene variants interact with a broad range of forms of early
adversity to influence adjustment in childhood and later in life.
6.1.2 Chapter 3 - The Catechol-O-Methyltransferase (COMT) gene
As an important regulator of dopaminergic signaling in the prefrontal and
limbic systems of the brain, the functional polymorphism of the COMT gene
(val158met) has been extensively studied in psychiatric literature (MeyerLindenberg & Weinberger, 2006). Based on previous findings in animal models
where COMT gene knockouts exhibited abnormal HPA axis function, I examined
the association between the val158met polymorphism and cortisol reactivity in
preschoolers. The analyses showed a main effect of the val158met
polymorphism on children’s cortisol reactivity, supporting previous work by Jabbi
and colleagues (2005), who showed that adolescents who were val homozygotes
showed heightened cortisol responses to psychosocial stress tasks.
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In addition to evidence for direct associations, I also investigated GxE.
Analyses showed that the val158met polymorphism moderated the link between
CS and emerging symptoms of anxiety; expanding on recent work by Klauke and
colleagues (2012) who found that COMT genotype moderated the effect of
childhood trauma on startle response, which is considered an endophenotype for
anxiety disorders. Additionally, in a study by Kolassa and colleagues (2010), the
interaction between COMT genotype and recent traumatic events predicted an
increased risk for posttraumatic stress disorder, such that val homozygotes who
experienced trauma were more likely to develop posttraumatic stress disorder. In
sum, analyses in Chapter 3 along with recent studies in the literature suggest
that val homozygous carriers are especially vulnerable to stress during early
childhood.
6.1.3 Chapter 4 - The dopamine pathway candidate genes
In Chapter 4 of this dissertation, I looked at common variants of the
dopamine (DA) pathway and their links to cortisol reactivity to stress and
children’s symptoms of depression and anxiety. Analyses did not yield evidence
for main effects of DA candidate genes on any of these outcomes; however, I did
find evidence for GxE in my analyses. Specifically, the DRD2 genotype
moderated the effect of CS on children’s cortisol responses to stress. Although
this is the first study to report such an effect, these findings expand on a previous
study from our group that reported a positive association between the DRD2
genotype and symptoms of depression and anxiety (Hayden et al., 2010). In
Chapter 4, I also reported evidence for moderation of the association between
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CS and symptoms of anxiety and depression in preschoolers by the DAT1 VNTR
polymorphism. Specifically, the 9R allele carriers had increasing symptoms as a
function of CS, whereas there was no significant association between CS and
symptoms in children with at least one copy of the 10R allele. These findings
extend previous work from our lab showing that genetic influences on children’s
psychopathology risk were moderated by contextual factors (Hayden et al.,
2013). Other studies have reported an interaction between DAT1 and life stress
in shaping the development of conduct disorder and attention-deficit hyperactivity
disorder in children (Bidwell et al., 2011; Lahey et al., 2011). Specifically, the
children carriers for the DAT1 9R allele had higher risk as a function of increasing
negative early life contexts such as negative parenting. Taken together, these
studies combined with my findings suggest that this polymorphisms may play a
role in etiology of mood and emotion problems.
I did not find associations between the DRD4 VNTR genotype and cortisol
reactivity or internalizing symptoms. The lack of associations could be due to
several factors. Recent work from our lab suggests that DRD4 genotype
moderated the association between parenting and child effortful control, a
temperament trait associated with both internalizing and externalizing
psychopathology (Smith et al., 2013). Specifically, the association between
children’s effortful control and positive parenting was moderated by children’s
DRD4 7R status, such that children with at least one 7R allele displayed both
better and worse effortful control than children without this allele, depending on
the degree of positive parenting. These findings suggest that this gene may be
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linked to other endophenotypes, such as child temperament, rather than
children’s psychophysiological stress responses.
6.1.4 Chapter 5 - The serotonin pathway candidate genes
In Chapter 5, I reported analyses examining links between serotonin
pathway candidate gene variants and cortisol reactivity. There was no evidence
for associations between MAOA and 5-HTTLPR and measures of children’s
cortisol responses to stress. However, I did find evidence for a main effect of 5HTTLPR genotype on symptoms of anxiety in preschoolers. This finding extends
previous work showing that the S-allele of the 5-HTTLPR is associated with
anxiety traits (Katsuragi et al., 1999; Lesch et al., 1996; Ohara et al., 1998;
Gonda et al., 2007) and with anxiety traits such as neuroticism and impulsivity
(Gorwood, 2004; Sen et al., 2004). In addition to main effects, I also tested geneenvironment interactions and found significant evidence for moderation of the
effect of CS on child anxiety symptoms by MAOA genotype. Specifically, children
without the 3-repeat allele exhibited higher anxious symptoms as a function of
increasing CS. These results extended previous findings where MAOA genotype
moderated the link between childhood adversity and risk for conduct disorder and
antisocial behaviour (Foley et al., 2004; Kim-Cohen et al., 2006), although this
report of GxE predicting symptoms of anxiety in preschoolers is the first to be
reported, to my knowledge.
In addition to GxE, literature has suggested that interactions between
these serotonin candidate gene variants may also moderate the effect of life
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stress on psychopathology in adults (Roiser et al., 2007). My analyses extended
the work by Roiser and colleagues (2007) and recent work by Barnett and
colleagues (2013), suggesting that interaction between MAOA and 5-HTTLPR
moderated the effect of childhood stress also predicted symptoms of anxiety.
6.2

Implications for risk and resilience
Epidemiological and clinical research studies have consistently identified

early exposure to stress as a major risk factor for mood and anxiety disorders
(Chapman et al., 2004; Dube et al., 2001; Felitti et al., 1998; Gladstone et al.,
2004). The parallel study of individuals who emerge from such adverse
environments without significant mood or anxiety disorder (Rutter, 2006) has
resulted in the identification of psychosocial and biological variables associated
with psychological resilience (Feder et al., 2009). As with environmental
variables, predisposing genetic factors also influence vulnerability (Stein et al.,
2002; Sullivan, Neale & Kendler, 2000) and resilience (Rijsdijk et al., 2003) in
terms of risk for mood and anxiety disorders. However, the relationship between
individual genetic variability and exposure to various forms of early life stress and
how these interactions translate to early risk remains largely unclear and was the
main focus of this dissertation.
Analyses in this thesis show the importance of gene-environment
interactions in predicting cortisol reactivity and symptoms of depression and
anxiety. More specifically, in Chapters 2, 3 and 4, I report findings that confirm
gene-environment interactions as predictors of depressive and anxious
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symptoms. These findings extend a literature which has documented the role of
gene-environment interaction in conferring risk. This line of work started over a
decade ago with the publication of seminal studies by Caspi and colleagues
(2002a, 2002b), where gene-environment interaction, predict risk for conduct
disorders and risk for depression. In both studies, specific risk alleles drawn from
prior biological research on candidate genes were shown to predict behaviour
problems, but only under specific environmental contexts, such as childhood
maltreatment. Caspi and colleagues (2010) recently provided a cogent review of
studies based on their initial discovery that variation in the promoter region of the
serotonin transporter gene (5-HTT/SLC6A4) moderated the link between
stressful life events and depression. The present work may not have replicated
the exact finding for this variant, but my analyses nonetheless point to the
importance of functional monoaminergic variation in moderating the role of more
subtle contexts of stress faced by a vast majority of children during early
development.
Taken together, what’s especially interesting from these studies is that
some gene variants contribute to vulnerability by virtue of direct and indirect
pathways. Moreover, the data confirm and extend Caspi and colleagues (2010)
assertion that risk alleles may carry risk for behavioural disorders because they
moderate reactions to the environment. The implication, then, is that specific
gene markers are influential but only in combination with environmental triggers,
not as main effects on behavioural dimensions and disorders.
6.3

Methodological considerations
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6.3.1 Study strengths
The study had a number of strengths. First, I chose to examine genes that
are an integral part of the HPA axis pathways activation and inhibition. The gene
and pathway-based association analysis considers a gene or a pathway as the
basic unit of analysis, and aim to study simultaneously the association of a group
of genetic variants in the same biological pathway, in this case, the CRH system
pathway (Neale & Sham, 2004). This can help unravel the complex genetic
structure of phenotypes in order to gain insight into the biological processes and
developmental mechanisms (Curtis, Oresic & Vidal-Puig, 2005). Additionally, in
case of the CRH system genes (CRH, CRHR1 and CRHBP) the haplotyping of
tag-SNPs captured entire genetic variation in the coding and regulatory regions
of these genes, making the analyses comprehensive. Similarly, monoaminergic
candidate genes polymorphisms examined in this thesis were also functional in
nature, with well-documented functional effects on brain neurotransmitter
systems. Furthermore, in Chapter 2, I also controlled for Type I error by using
permutation-based procedures (Schmidt et al., 2002, 2003) that randomly
assigned the sample AUCi scores to subjects (sampled without replacement)
while holding each subject’s genotype fixed. This permutation method is
preferred as it accounts for linkage disequilibrium among SNPs in a haplotype
block; therefore conserving power compared to commonly used correction
techniques such as the Bonferroni method (Schmidt et al., 2003). Moreover, I
tried to keep population stratification to a minimum by conducting all analyses in
Caucasians only.
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In addition to precautions taken during data analyses, conducting this
research in a young sample should be considered a major strength. Specifically,
as mood disorders are rare in preschoolers, our data was not confounded by
previous or current psychopathology. Additionally, literature has linked sex
hormone status such as estrogen during the menstrual cycle with cortisol
reactivity to stress. However, sex hormones are not a confounder in my study
due the young nature of this sample. Similarly, precautions were taken during
cortisol sampling as well to obtain an accurate index of children’s stress
reactivity. For example, the stress task was conducted during the same time of
the day to control for diurnal variance of cortisol in humans (Gunnar, Talge &
Herrera), and parents were instructed not to feed their children immediately prior
to cortisol sampling to address the influence of certain foods on cortisol levels
(Gunnar, Talge & Herrera). The stress task was conducted after an
acclimatization period of 30 minutes to capture normalized baseline cortisol and
was conducted by trained study personnel. Additionally, all cortisol samples were
measured in duplicates in a single batch for a given participant usually within 24
hours of sample collection. All measurements were repeated if cortisol variance
within the duplicates or even different plates exceeded >5-6 % variance, a very
stringent criteria for ELISA assays. Furthermore, 10 % of all genotyping was
repeated and all probes were sequenced for accuracy. Of the ~13000 genotypes,
99.8 % were in concordance.
6.3.2 Limitations
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Some limitations of this thesis should be considered as well. Even though
the sample size of this study was relatively large compared other studies in
developmental literature, it is small for a genetic study. However, it may be
logistically challenging and not financially viable to perform stress tasks for
cortisol assessment on a very large sample. Additionally, due to the sample size,
all the variants in this thesis are common genetic variants in the Caucasian
population. Biological interactions that involve rare genetic variants or rare
environment exposures are unlikely to detect as significant statistical interactions
(Uher, 2008). In this case, therefore, even a very large sample size will only be
powerful enough to detect moderately strong GXE. Therefore, replication of
findings in independent samples is very important. For some studies, I examined
a limited number of markers at each gene, and I did not correct for multiple
statistical tests in some analyses due to the hypothesis-driven nature of the work.
The study also used parent-reported measures of child behaviour. The
difference between objective interview and self-report or parent-report measures
of behaviour is a question of specificity and objective validity (Monroe, 2008). For
example, parental psychopathology may “color” descriptions of child problems as
may occur when abusive or depressed mothers provide negative or exaggerated
descriptions of their children (Gotlib & Hammen, 1992). Similarly,
dismissive/avoidant adult informants deny the presence of emotional problems at
the same time that professionals observe a high level of symptoms (Dozier &
Lee, 1995), or parents downplay the importance of a given behaviour or
sometimes individuals simply try to avoid thinking of past traumatic events (Uher
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et al., 2011). In some cases, some parents take the instruction too literally, which
may lead to omission of data that could otherwise be an important stressful life
event. Additionally, parents could misunderstand and misinterpret questions; the
opportunity to clarify symptoms is an important asset of interview measures.
However, it should be noted that, due to the young age of the sample, parentreports were more logistically feasible. Further, the CBCL is the most widelyused measure of children’s symptoms, and has been shown to be a reliable
indicator of current symptomatology.
In addition to the limitations described above, I conducted most analyses
in candidate genes previously described in psychopathology research. However,
one of the limitation of the current analyses is that I did not utilize the current
knowledge from ENCODE or HaploReg databases to predict a possible
regulatory effect of polymorphisms genotyped in this study on remote genes. It is
likely that some of the variants genotyped in this study may code for DNA
regulatory elements with functional effects on genes not investigated here but
may be linked to early risk for psychopathology. Additionally, complex traits being
polygenic in nature are also influenced by other gene variants and extant
literature has documented their associations with stress-related problems such
as depressive and anxious symptoms. Of importance amongst these are the
glucocorticoid receptor complex genes such as NR3C1 and FKBP5 (Binder et al.,
2009; Roy et al., 2012). Also widely implicated are the oxytocin receptor gene
and the brain neurotrophins, which directly influence synaptic plasticity and
therefore regulate the effects of stress and HPA axis response at the neuronal
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level (Zheng et al., 2014). Below, some of the current knowledge is discussed to
add to our understanding of the complex underpinning of the developmental risk.
6.3.2.1

The glucocorticoid complex genes

The regulating effects of cortisol on brain and behaviour are mediated by
binding of the hormone to specific receptors. Glucocorticoid receptors (GR) are
widely distributed throughout the PFC, amygdala, hippocampus, and brainstem,
and are critical to regulating responses during conditions of elevated cortisol
secretion or stress (Myers, McKlveen & Herman, 2014; Timmermans et al.,
2013). Relative GR resistance is a core feature of depression, perhaps leading to
disinhibition of central CRH secretion and HPA axis hyperactivity (Silverman &
Sternberg, 2012). For example, Bet and colleagues (2009) demonstrated that, in
a longitudinal aging study, SNPs in the GR gene interacted with adverse life
events during youth, including war experiences, sexual abuse, parental loss, or
physical illness in the prediction of major depressive disorder (MDD).
However, the sensitivity of the GR is fine-tuned by a co-chaperone
chaperone protein, FKBP5. When bound to the GR complex, FKBP5 decreases
GR affinity for cortisol and prevents translocation of the GR to the nucleus
(Binder et al., 2009). Given the important role of GR in regulating stress
responses and the evidence for GR resistance in depression, variation of the
FKBP5 gene likely is a critical modulator of the relationship between childhood
maltreatment and depression (Binder et al., 2009). In a recent populationrepresentative sample of more than 2000 Caucasians, Appel et al., (2011)
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reported an interaction between the rs1360780 of the FKBP5 gene and
maltreatment in predicting both depressive symptoms and diagnoses of
depression. Another recent study in 884 adolescent and young adult individuals
confirmed an interaction of different FKBP5 variants and traumatic life events in
predicting the onset of MDD (Zimmermann et al., 2011). These results, taken
together, strongly implicate the GR and related pathway gene variants in the
pathogenesis of stress-related depression. My future work will investigate the
role of these genes and emerging symptoms to inform whether these variants are
involved in developmental risk pathways.
6.3.2.2

Oxytocin Receptor

The human oxytocin (OXT) system mediates social attachment, including
mother–infant bonding, and demonstrated to buffer emotional and physiological
responses to stress (Meyer-Lindenberg et al., 2011). For example, in patients
with MDD, plasma oxytocin concentrations are inversely correlated with symptom
severity (Scantamburlo et al., 2007). Additionally, women reporting exposure to
childhood maltreatment exhibit deceases in cerebrospinal fluid oxytocin
concentrations, which in turn were associated with increased anxiety (Heim et al.,
2009). Similarly, interaction of between oxytocin receptor gene (OXTR) SNP
rs2254298 and adverse parental environment predicted symptoms of depression
in 9–14 years old girls (Thompson et al., 2011). Other studies have also reported
interactions between OXTR variants and childhood stress predicting cortisol
reactivity in adults (Chen et al., 2011). Future work from our group will investigate
these links in our sample as well.
226

6.3.2.3

Brain-Derived Neurotrophic Factor

Brain-derived neurotrophic factor (BDNF) is a widely expressed
neurotrophin in the brain that is implicated in neuronal growth, synaptic plasticity,
and neuronal survival. In animal models, prolonged stress exposure and elevated
glucocorticoid levels down-regulate BDNF expression, whereas administration of
antidepressant drugs induces BDNF expression; antidepressant treatment
normalizes hippocampal volume in depressed patients (Nestler et al., 2002). The
BDNF gene contains a functional polymorphism (rs6265), which is associated
with a valine to methionine substitution (val66met) and leads to reduced BDNF
expression in the brain. Literature reports on interaction between this
polymorphism and childhood sexual abuse in the prediction of adult depression
(Aguilera et al., 2009). A report from our group demonstrated found that BDNF
val66met polymorphism moderated the interactive effects between 5-HTTLPR
and stress on HPA axis reactivity in a sample of preschool children (Dougherty et
al., 2010). Furthermore, the BDNF val66met × 5-HTTLPR × childhood
maltreatment interaction also predicted depression (Wichers et al., 2008).
In addition to DNA sequence variants that may contribute to risk for later
psychopathology, structural DNA variation also regulates gene expression in
response to external stress stimuli. The biology of gene regulation via DNA
structural variation is the emerging field of epigenetics that may provide a
promising avenue of research, which may aid in our understanding of biological
bases of psychopathology and briefly discussed in this section. The influence of
genetic variations in the DNA sequences of HPA axis related genes on mood
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disorders is clear, but may only be one of the many factors contributing to our
understanding of mood disorders. One of the most promising pathways of future
research is the investigation of epigenetic processes modulating the relationship
between Gene × CS interactions and depression. Epigenetic changes are
changes in gene expression, which remain stable during cell divisions but do not
affect the DNA sequence itself. Such changes are heritable and can be caused
by changes such as those found in DNA methylation, the modeling of chromatin,
and the deacetylation of histones in the DNA (Spijker & van Rossum, 2012).
Epigenetic control of gene regulation has been implicated as influencing early
development. For example, quality of maternal care was found to influence HPA
function in rats through epigenetic programing of GR expression (Meaney, 2001).
Poor quality of maternal care was associated with changes in the promoter
region methylation of the GR gene. These rodents also exhibited enhanced
hormonal and anxiety-like behavioural responses to stress, suggesting a role of
epigenetic status in early neurodevelopment. In humans, recent work showed
that the brain tissue of human suicide victims who were also exposed to
childhood abuse had considerably higher methylation in the promoter region of
the GR gene when compared to controls (McGowan et al., 2009). Additionally
poor maternal rearing conditions led to differential DNA methylation in the
prefrontal cortex glial cells of rhesus macaques (Provencal et al., 2012). In a
recent study by Klengel and colleagues (2013), methylation pattern differences
were observed in FKBP5 gene following childhood trauma. However, a large gap
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in knowledge still remains when it comes to epigenetic mechanisms that play a
role in early childhood.
6.5

Future directions

6.5.1 Additional stress contexts that contribute to risk: The role of parenting
Due to the complexity and multifactorial nature of depressive and anxious
disorders, this thesis focused on well-studied dimensions of life stress such as
family income, dyadic adjustment and stressful life events in the child’s family in
the past 12 months. However, along with genetic factors which may be at play
and described in the previous sections, an equally important contextual risk in the
child’s life is parenting. Parental effects on children’s emotional development are
hypothesized to be due, in part, to the influence of early childhood parental care
on stress reactivity (Leuken et al., 2004; Loman & Gunnar, 2010). In addition, by
shaping the nature of the response to stress and challenge, such an influence is
also likely to determine the impact a broad range of environmental factors across
development (Ellis & Boyce, 2008) and have a broad and lasting influence across
time. However, despite the importance of the hypothesis that early parenting
influences stress reactivity, support for this notion is indirect. For example, animal
research has demonstrated lasting effects of parenting on stress reactivity later in
life. In rodents, the offspring of mothers who exhibit high levels of licking,
grooming and arched-back nursing (which facilitates pups’ access to milk) show
increased hippocampal glucocorticoid receptor expression, enhanced negative
feedback regulation, decreased hypothalamic CRH expression, more modest
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HPA-axis responses to stress, and less fearful behaviour (Levine, 2005; Zhang et
al., 2006; Zhang & Meaney, 2010).
In addition to the research in rodents, studies in nonhuman primates
demonstrate that in the presence of low maternal caregiving led to higher levels
of plasma CRH in the offspring (Coplan et al., 2001). Parenting behaviours may
alter cortisol levels, potentially representing a link in the overall pathway by which
low income and cumulative risk eventually disrupts children's cortisol levels.
Research has examined the relation of parenting to HPA axis functioning both in
high-risk samples, such as low maternal education and high maternal stress, and
low risk samples. In general, parenting that is lower in sensitivity, higher in
intrusiveness and harshness is associated with lower morning cortisol levels
(Roisman et al., 2009), flatter diurnal slope (Papp, Pendry & Adam, 2009),
greater reactivity (Bugental et al., 2003), and slower cortisol recovery after a
stressor (Albers et al., 2008). Studies typically examine one or two parenting
variables at a time, with more emphasis on affective (i.e. sensitivity, harshness)
parenting behaviours compared to control-related parenting behaviours (i.e. limit
setting). This study sought to examine several parenting behaviours
simultaneously to see which specific parenting behaviours, if any, accounted for
the relations of income and cumulative family risk to disrupted cortisol patterns.
Parenting has been posited to mediate the relationship between other
early risks and child cortisol levels. Specifically, two studies have examined
environmental risk and parenting as mediators of the relation between poverty
and disruptions to children's cortisol. In a sample of preschool-aged children
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representing the full range of income, there was a trend toward an association
between maternal negative affect and children's diurnal cortisol pattern, with
negative affect trending toward mediating the relation between poverty status
and a low, flat diurnal pattern (Zalewski et al., 2012). Another study found that
positive parenting, but not negative parenting, explained a small but significant
portion of higher basal cortisol levels in young children, over and above
environmental risk factors (Blair et al., 2011). These two studies point to the
possibility that parenting may mediate the relations of poverty and cumulative risk
to disruptions in children's cortisol levels. In sum, a large amount of literature has
suggested the importance of parenting in shaping neuroendocrine responsivity to
childhood stress and will be a focus of future research from our group.
6.5.2 Differential susceptibility to the environment
The GxE model described above has historical roots in diathesis-stress
models of psychopathology. Diathesis-stress models propose that clinically
relevant phenotypes are the product of both high-risk genes and high-risk
environments typically to lead to a psychological disorder (Caspi et al., 2010).
Some of the data in this thesis supports this model by showing risk alleles
interaction with high early life stressor to predict either high cortisol response to
stress or higher depressive and/or anxious symptoms. However, my analyses
also suggest that in some cases the supposed “risk allele” was associated with
either lower cortisol response to stress or lower symptoms when compares to the
advantageous or “resilience” gene in the presence of low life stress. For
example, in Figure 3.4 the COMT val-allele carriers had lower anxiety symptoms
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than their met-allele counterparts under low stress conditions, even though valallele is widely considered the risk allele. This finding, along with other examples
in this thesis (Figure 5.6B), may not entirely fit the notion that risk alleles only
lend to vulnerability traits and specifically under high environmental stress. Based
on similar findings in extant literature, theorists have posited that the “risk” alleles
may also confer a particular ability to respond positively to environment based on
the context. The key idea is that specific genes do not confer only vulnerability in
the face of environmental adversity but they may also sensitize individuals to
positive experiences and influences. This notion of dual action of a given allele is
now commonly known as “differential susceptibility” to the environment (Belsky &
Pluess, 2009; Ellis & Boyce, 2008).
Theorists suggest that specific genes may function more like “plasticity
factors” rather than “vulnerability factors.” Data from our group and others
support this concept. For example, Hankin and colleagues (2011) examined
interactions between 5-HTTLPR genotype and degree of positive and supportive
parenting (ranging from low to high) in adolescents and young adults. Other
studies replicate these findings and show the same effect, that youth
homozygous for the short allele of 5-HTTLPR were more responsive to
parenting, whether it was positive or negative. Youth at high genetic risk, or
homozygous for the short allele, had low-levels of positive affect if their parents
were unsupportive. However, the same group also had high levels of positive
affect if their parents were supportive. Thus, the short allele group was not only
vulnerable to negative parenting but also benefited from positive parenting as
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well. In sum, based on these findings, the ontogenetic origins of differential
susceptibility and, more specifically, identifying specific genetic variants linked to
heightened susceptibility to environmental influence, need further attention in the
future.
6.5.3 Beyond GxE: The role of gene-environment correlations
In large part, studies of gene–environment interplay (including this thesis)
have been motivated by the search for gene–environment interactions, following
recent demonstrations of genetic sensitivity to environmental effects on human
phenotypes. By the late 1970s, behavioural geneticists had amassed a large
body of research on twins and adoptees that attested to the importance of
genetic influences on individual differences in personality, cognitive abilities and
liability to disease (Plomin et al., 1994). These studies demonstrated that genetic
factors influencing an individual's exposure to particular environments could
make those environments themselves heritable. This phenomenon is referred to
as gene-environment correlation, or rGE (Plomin, DeFries & Eaves, 1977).
rGEs reflect genetic differences in exposure to particular environments
(Kendler & Eaves, 1986). Three separate types of rGE have been described:
passive, evocative/ reactive, and active (Plomin, DeFries & Fulker, 1977). In
passive rGE, parents pass on genes and also provide an environment, both of
which influence the child’s development. For example, depressed parents may
pass on depressogenic genes to their children, and also provide low levels of
warmth and emotional support. These correlated genetic and environmental
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influences increase the risk of depressive symptoms in the child. In evocative
rGE, heritable traits influence the reaction of others and hence the environment
provided by others. For example, a shy child may be perceived as less fun by
other children, making other children less likely to spend time with him or her. In
active rGE, a child’s heritable traits influence his or her choice of environment.
For example, a shy child may have reduced motivation to engage with peers.
This reduced exposure to positive environments may increase depressive
symptoms. The presence of significant correlation between genetic and
environmental factors can make interpretation of results difficult, because it is
difficult to distinguish whether it is the genes, the environment, or both that
influence an outcome of interest (Jaffee & Price, 2013).
Developmental studies looking at evidence for rGE are rare (only 5
publications), but some studies from our group (Hayden et al., 2010, 2013) and
others (Dick et al., 2006; Lucht et al., 2006) reported rGE in community samples.
For example, Lucht et al. (2006) reported an association between perceived
negative paternal parenting (reported retrospectively by adult offspring) and
offspring variants of both DRD2 and GABRA6. Similarly, DAT1 9-repeat variant
was associated with child negative affect expressed toward the parent during
parent-child interactions, and parents of children with a DAT1 9-repeat allele
exhibited more hostility and lower guidance/engagement during the tasks than
parents of children without a copy of the DAT1 9-repeat polymorphism. These
gene-environment associations were partially mediated by child negative affect
toward the parent, suggesting that evocative associations play a role in elevating
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children’s psychopathology risk (Hayden et al., 2013). Even though examining
rGEs was beyond the scope of this thesis, the implications of this phenomenon
on emerging risk for mood and anxiety disorders will receive further attention in
my future research.
6.6

Conclusions
This thesis set out to examine the role of neurotransmitter systems

commonly implicated in stress reactivity and pathogenesis of stress-related
disorders. The findings support a role for CRH system gene variants in early age
cortisol response and internalizing symptoms. Along with direct associations,
common variants of CRH and monoaminergic system genes also acted as
moderators of early environment’s effect on developmental risk in young
preschool age children. This research further supports a large body of GxE
literature implicating the role of both genes and environment in etiology of mood
disorders. Identifying the genetic underpinnings of stress response and emerging
risk may ultimately aid in public health prevention efforts and help identifying atrisk individuals or subgroups of the population. This knowledge could eventually
guide intervention efforts and may help to reduce the effects of chronic life stress
on at-risk children. Since many of the genes studied here are targets of drug
development for stress-related disorders, it may be possible to pharmacologically
treat intermediate phenotypes that share genetic etiology with internalizing
problems. In closing, the better understanding of nature and nurture will help
reduce the tremendous toll mental health disorders exact of individuals and
society.
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